<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6445942\results\search\virus\results.xml">
   <result pre="EV-D68, have low gastrointestinal tropism, hindering stool isolation (the standard" exact="poliovirus" post="diagnostic technique). It is noteworthy that while enterotropic polioviruses,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6745427\results\search\virus\results.xml">
   <result pre="Saudi Arabia and Yemen. Most cases are related to predominant" exact="dengue virus" post="serotypes (DENV 1, 2, 3, and 4), climate change/extreme"/>
   <result pre="Sep;15(9):1347-1350. 10.3201/eid1509.09044219788800 6MadaniTAAbuelzeinTMAl-BarHMAzharEIKaoMAlshoebHOet al.Outbreak of viral hemorrhagic fever caused by" exact="dengue virus" post="type 3 in Al-Mukalla, Yemen.BMC Infect Dis2013 Mar;13(13):136. 10.1186/1471-2334-13-13623497142"/>
   <result pre="what you say, itÆ’??s also how you say it: communicating" exact="nipah virus" post="prevention messages during an outbreak in Bangladesh.BMC Public Health2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6820696\results\search\virus\results.xml">
   <result pre="Available at: https://www.iapac.org/909090-workshop/presentations/909090tw18-Sa0915-Saldanha.pdf. Accessed November 15, 2018. 13.DaileyAFHootsBEHallHIet al.Vital signs:" exact="human immunodeficiency virus" post="testing and diagnosis delaysâ€&quot;United States. MMWR Morb Mortal Wkly"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6832525\results\search\virus\results.xml">
   <result pre="against this re-emerging pathogen which continues to cause devastating disease." exact="yellow fever virus" post="flavivirus entry factor global diversity yellow fever virus tropism"/>
   <result pre="devastating disease. yellow fever virus flavivirus entry factor global diversity" exact="yellow fever virus" post="tropism animal models transmission and vector control vaccine host"/>
   <result pre="described viral hemorrhagic fever (VHF) and its causative agent, the" exact="yellow fever virus" post="(YFV), is the prototypic member of the family Flaviviridae."/>
   <result pre="of important human pathogens which can cause acute infections, including" exact="dengue virus" post="(DENV), West Nile virus (WNV), Japanese encephalitis virus (JEV)"/>
   <result pre="(TBEV) [69], as well as unrelated viruses, including HSV and" exact="human immunodeficiency virus" post="(HIV) [70,71]. Indeed, the antiviral effect of PI-88, a"/>
   <result pre="[189]. This issue can be best addressed by stabilization. Indeed," exact="poliovirus" post="has been experimentally stabilized by the addition of pirodavir"/>
   <result pre="Yellow Fever in Angola, 2015â€&quot;2016Emerg. Infect. Dis.2016221854185510.3201/eid2210.16081827536787 13.KraemerM.U.G.FariaN.R.ReinerR.C.GoldingN.NikolayB.StasseS.JohanssonM.A.SaljeH.FayeO.WintG.R.W.et al.Spread of" exact="yellow fever virus" post="outbreak in Angola and the Democratic Republic of the"/>
   <result pre="feverScience201836184784810.1126/science.aau822530139914 16.FariaN.R.KraemerM.U.G.HillS.C.Goes de JesusJ.AguiarR.S.IaniF.C.M.XavierJ.QuickJ.Du PlessisL.DellicourS.et al.Genomic and epidemiological monitoring of" exact="yellow fever virus" post="transmission potentialScience201836189489910.1126/science.aat711530139911 17.DorigattiI.HamletA.AguasR.CattarinoL.CoriA.DonnellyC.A.GarskeT.ImaiN.FergusonN.M.International risk of yellow fever spread from"/>
   <result pre="vitro ligationNew Biol.198912852962487295 20.HahnC.S.DalrympleJ.M.StraussJ.H.RiceC.M.Comparison of the virulent Asibi strain of" exact="yellow fever virus" post="with the 17D vaccine strain derived from itProc. Natl."/>
   <result pre="derived from itProc. Natl. Acad. Sci. USA1987842019202310.1073/pnas.84.7.20193470774 21.BredenbeekP.J.KooiE.A.LindenbachB.HuijkmanN.RiceC.M.SpaanW.J.M.A stable full-length" exact="yellow fever virus" post="cDNA clone and the role of conserved RNA elements"/>
   <result pre="and evolutionScience198522972673310.1126/science.40237074023707 23.McElroyK.L.TsetsarkinK.A.VanlandinghamD.L.HiggsS.Characterization of an infectious clone of the wild-type" exact="yellow fever virus" post="Asibi strain that is able to infect and disseminate"/>
   <result pre="virusProc. Natl. Acad. Sci. USA2009106204352043910.1073/pnas.090701010619918064 38.ByrdC.M.GrosenbachD.W.BerhanuA.DaiD.JonesK.F.CardwellK.B.SchneiderC.YangG.TyavanagimattS.HarverC.et al.Novel benzoxazole inhibitor of" exact="dengue virus" post="replication that targets the NS3 helicaseAntimicrob. Agents Chemother.2013571902191210.1128/AAC.02251-1223403421 39.ByrdC.M.DaiD.GrosenbachD.W.BerhanuA.JonesK.F.CardwellK.B.SchneiderC.WineingerK.A.PageJ.M.HarverC.et"/>
   <result pre="the NS3 helicaseAntimicrob. Agents Chemother.2013571902191210.1128/AAC.02251-1223403421 39.ByrdC.M.DaiD.GrosenbachD.W.BerhanuA.JonesK.F.CardwellK.B.SchneiderC.WineingerK.A.PageJ.M.HarverC.et al.A novel inhibitor of" exact="dengue virus" post="replication that targets the capsid proteinAntimicrob. Agents Chemother.201357152510.1128/AAC.01429-1223070172 40.PatkarC.G.LarsenM.OwstonM.SmithJ.L.KuhnR.J.Identification"/>
   <result pre="targets the capsid proteinAntimicrob. Agents Chemother.201357152510.1128/AAC.01429-1223070172 40.PatkarC.G.LarsenM.OwstonM.SmithJ.L.KuhnR.J.Identification of inhibitors of" exact="yellow fever virus" post="replication using a replicon-based high-throughput assayAntimicrob. Agents Chemother.2009534103411410.1128/AAC.00074-0919651907 41.GuoF.WuS.JulanderJ.MaJ.ZhangX.KulpJ.CuconatiA.BlockT.M.DuY.GuoJ.-T.et"/>
   <result pre="by Specifically Targeting NS4B ProteinJ. Virol.201690107741078810.1128/JVI.01253-1627654301 42.PaccaC.C.SeverinoA.A.MondiniA.RahalP.Dâ€™Avila SG.CordeiroJ.A.NogueiraM.C.BronzoniR.V.NogueiraM.L.RNA interference inhibits" exact="yellow fever virus" post="replication in vitro and in vivoVirus Genes20093822423110.1007/s11262-009-0328-319169857 43.JulanderJ.G.Experimental therapies"/>
   <result pre="46.PiersonT.C.KielianM.Flaviviruses: Braking the enteringCurr. Opin. Virol.2013331210.1016/j.coviro.2012.12.00123352692 47.PatkarC.G.JonesC.T.ChangY.-H.WarrierR.KuhnR.J.Functional requirements of the" exact="yellow fever virus" post="capsid proteinJ. Virol.2007816471648110.1128/JVI.02120-0617526891 48.Op de BeeckA.RouillÃ©Y.CaronM.DuvetS.DubuissonJ.The transmembrane domains of"/>
   <result pre="BeeckA.RouillÃ©Y.CaronM.DuvetS.DubuissonJ.The transmembrane domains of the prM and E proteins of" exact="yellow fever virus" post="are endoplasmic reticulum localization signalsJ. Virol.200478125911260210.1128/JVI.78.22.12591-12602.200415507646 49.KielianM.Class II virus"/>
   <result pre="diversity in the flavivirus fusion peptideVirol. J.200852710.1186/1743-422X-5-2718275613 51.VolkD.E.MayF.J.GandhamS.H.A.AndersonA.von LindernJ.J.BeasleyD.W.C.BarrettA.D.T.GorensteinD.G.Structure of" exact="yellow fever virus" post="envelope protein domain IIIVirology2009394121810.1016/j.virol.2009.09.00119818466 52.RymanK.D.LedgerT.N.CampbellG.A.WatowichS.J.BarrettA.D.Mutation in a 17D-204 vaccine"/>
   <result pre="17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of" exact="yellow fever virus" post="in miceVirology1998244596510.1006/viro.1998.90579581778 53.DaffisS.KontermannR.E.KorimbocusJ.ZellerH.KlenkH.-D.Ter MeulenJ.Antibody responses against wild-type yellow fever"/>
   <result pre="yellow fever virus in miceVirology1998244596510.1006/viro.1998.90579581778 53.DaffisS.KontermannR.E.KorimbocusJ.ZellerH.KlenkH.-D.Ter MeulenJ.Antibody responses against wild-type" exact="yellow fever virus" post="and the 17D vaccine strain: Characterization with human monoclonal"/>
   <result pre="for exploratory research and analysisJ. Comput. Chem.2004251605161210.1002/jcc.2008415264254 56.ChenZ.LiuL.LvY.ZhangW.LiJ.ZhangY.DiT.ZhangS.LiuJ.LiJ.et al.A fatal" exact="yellow fever virus" post="infection in China: Description and lessonsEmerg. Microbes Infect.20165e6910.1038/emi.2016.8927406389 57.HeinzF.X.AllisonS.L.Flavivirus"/>
   <result pre="treatment of HIV infectionImmunol. Rev.201727531332310.1111/imr.1250628133794 63.MillerJ.L.de WetB.J.M.Martinez-PomaresL.RadcliffeC.M.DwekR.A.RuddP.M.GordonS.The mannose receptor mediates" exact="dengue virus" post="infection of macrophagesPLoS Pathog.20084e1710.1371/annotation/98b92fca-fa6e-4bf3-9b39-13b66b64047618266465 64.TassaneetrithepB.BurgessT.H.Granelli-PipernoA.TrumpfhellerC.FinkeJ.SunW.EllerM.A.PattanapanyasatK.SarasombathS.BirxD.L.et al.DC-SIGN (CD209) mediates dengue"/>
   <result pre="dengue virus infection of macrophagesPLoS Pathog.20084e1710.1371/annotation/98b92fca-fa6e-4bf3-9b39-13b66b64047618266465 64.TassaneetrithepB.BurgessT.H.Granelli-PipernoA.TrumpfhellerC.FinkeJ.SunW.EllerM.A.PattanapanyasatK.SarasombathS.BirxD.L.et al.DC-SIGN (CD209) mediates" exact="dengue virus" post="infection of human dendritic cellsJ. Exp. Med.200319782382910.1084/jem.2002184012682107 65.KrishnanM.N.NgA.SukumaranB.GilfoyF.D.UchilP.D.SultanaH.BrassA.L.AdametzR.TsuiM.QianF.et al.RNA"/>
   <result pre="Dis.20126e182010.1371/journal.pntd.000182023029581 67.MeertensL.CarnecX.LecoinM.P.RamdasiR.Guivel-BenhassineF.LewE.LemkeG.SchwartzO.AmaraA.The TIM and TAM families of phosphatidylserine receptors mediate" exact="dengue virus" post="entryCell Host Microbe20121254455710.1016/j.chom.2012.08.00923084921 68.GermiR.CranceJ.-M.GarinD.GuimetJ.Lortat-JacobH.RuigrokR.W.H.ZarskiJ.-P.DrouetE.Heparan sulfate-mediated binding of infectious dengue"/>
   <result pre="dengue virus entryCell Host Microbe20121254455710.1016/j.chom.2012.08.00923084921 68.GermiR.CranceJ.-M.GarinD.GuimetJ.Lortat-JacobH.RuigrokR.W.H.ZarskiJ.-P.DrouetE.Heparan sulfate-mediated binding of infectious" exact="dengue virus" post="type 2 and yellow fever virusVirology200229216216810.1006/viro.2001.123211878919 69.KroschewskiH.AllisonS.L.HeinzF.X.MandlC.W.Role of heparan"/>
   <result pre="infectivityCell. Mol. Life Sci.2010672773278610.1007/s00018-010-0357-z20372965 75.SessionsO.M.BarrowsN.J.Souza-NetoJ.A.RobinsonT.J.HersheyC.L.RodgersM.A.RamirezJ.L.DimopoulosG.YangP.L.PearsonJ.L.et al.Discovery of insect and human" exact="dengue virus" post="host factorsNature20094581047105010.1038/nature0796719396146 76.LiuK.QianY.JungY.-S.ZhouB.CaoR.ShenT.ShaoD.WeiJ.MaZ.ChenP.et al.mosGCTL-7, a C-Type Lectin Protein, Mediates"/>
   <result pre="That Promote Early Viral Protein AccumulationJ. Virol.20179110.1128/JVI.01706-1627974556 83.ChambersT.J.GrakouiA.RiceC.M.Processing of the" exact="yellow fever virus" post="nonstructural polyprotein: A catalytically active NS3 proteinase domain and"/>
   <result pre="Biology of FlavivirusesElsevierAmsterdam, The Netherlands200323619780120398591 86.FilomatoriC.V.LodeiroM.F.AlvarezD.E.SamsaM.M.PietrasantaL.GamarnikA.V.A 5â€² RNA element promotes" exact="dengue virus" post="RNA synthesis on a circular genomeGenes Dev.2006202238224910.1101/gad.144420616882970 87.YuL.NomaguchiM.PadmanabhanR.MarkoffL.Specific requirements"/>
   <result pre="the RNA cap structureRNA2009152340235010.1261/rna.160970919850911 92.WelschS.MillerS.Romero-BreyI.MerzA.BleckC.K.E.WaltherP.FullerS.D.AntonyC.Krijnse-LockerJ.BartenschlagerR.Composition and three-dimensional architecture of the" exact="dengue virus" post="replication and assembly sitesCell Host Microbe2009536537510.1016/j.chom.2009.03.00719380115 93.JunjhonJ.PenningtonJ.G.EdwardsT.J.PereraR.LanmanJ.KuhnR.J.Ultrastructural characterization and"/>
   <result pre="94.ChambersT.J.WeirR.C.GrakouiA.McCourtD.W.BazanJ.F.FletterickR.J.RiceC.M.Evidence that the N-terminal domain of nonstructural protein NS3 from" exact="yellow fever virus" post="is a serine protease responsible for site-specific cleavages in"/>
   <result pre="RNA Polymerase ActivityVirology199621631732510.1006/viro.1996.00678607261 98.KapoorM.ZhangL.RamachandraM.KusukawaJ.EbnerK.E.PadmanabhanR.Association between NS3 and NS5 proteins of" exact="dengue virus" post="type 2 in the putative RNA replicase is linked"/>
   <result pre="linked to differential phosphorylation of NS5J. Biol. Chem.1995270191001910610.1074/jbc.270.32.191007642575 99.BhattacharyaD.HooverS.FalkS.P.WeisblumB.VestlingM.StrikerR.Phosphorylation of" exact="yellow fever virus" post="NS5 alters methyltransferase activityVirology200838027628410.1016/j.virol.2008.07.01318757072 100.KÃ¼mmererB.M.RiceC.M.Mutations in the yellow fever"/>
   <result pre="yellow fever virus NS5 alters methyltransferase activityVirology200838027628410.1016/j.virol.2008.07.01318757072 100.KÃ¼mmererB.M.RiceC.M.Mutations in the" exact="yellow fever virus" post="nonstructural protein NS2A selectively block production of infectious particlesJ."/>
   <result pre="production of infectious particlesJ. Virol.2002764773478410.1128/JVI.76.10.4773-4784.200211967294 101.MillerS.KastnerS.Krijnse-LockerJ.BÃ¼hlerS.BartenschlagerR.The non-structural protein 4A of" exact="dengue virus" post="is an integral membrane protein inducing membrane alterations in"/>
   <result pre="NS2A in flavivirus assemblyJ. Virol.2008824731474110.1128/JVI.00002-0818337583 103.SternO.HungY.-F.ValdauO.YaffeY.HarrisE.HoffmannS.WillboldD.SklanE.H.An N-terminal amphipathic helix in" exact="dengue virus" post="nonstructural protein 4A mediates oligomerization and is essential for"/>
   <result pre="by West Nile virus non-structural protein 4BPLoS ONE20149e8404010.1371/journal.pone.008404024465392 106.DesprÃ¨sP.GirardM.BouloyM.Characterization of" exact="yellow fever virus" post="proteins E and NS1 expressed in Vero and Spodoptera"/>
   <result pre="Rev. RNA2013472373510.1002/wrna.119123929625 110.PongW.-L.HuangZ.-S.TeohP.-G.WangC.-C.WuH.-N.RNA binding property and RNA chaperone activity of" exact="dengue virus" post="core protein and other viral RNA-interacting proteinsFEBS Lett.20115852575258110.1016/j.febslet.2011.06.03821771593 111.ElshuberS.AllisonS.L.HeinzF.X.MandlC.W.Cleavage"/>
   <result pre="secrete interferonsSci. Rep.201881088910.1038/s41598-018-29235-730022130 118.Laurent-RolleM.MorrisonJ.RajsbaumR.MacleodJ.M.L.PisanelliG.PhamA.AyllonJ.MiorinL.MartinezC.tenOeverB.R.et al.The interferon signaling antagonist function of" exact="yellow fever virus" post="NS5 protein is activated by type I interferonCell Host"/>
   <result pre="exerts a critical early restriction on replication and dissemination of" exact="yellow fever virus" post="vaccine strain 17D-204NPJ Vaccines20183510.1038/s41541-017-0039-z29387474 122.DouamF.HrebikovaG.AlbrechtY.E.S.SellauJ.SharonY.DingQ.PlossA.Single-cell tracking of flavivirus RNA"/>
   <result pre="in Resisting FlavivirusJ. Immunol. Res.20182018610658210.1155/2018/610658229888293 128.OlagnierD.ScholteF.E.M.ChiangC.AlbulescuI.C.NicholsC.HeZ.LinR.SnijderE.J.van HemertM.J.HiscottJ.Inhibition of dengue and" exact="chikungunya virus" post="infections by RIG-I-mediated type I interferon-independent stimulation of the"/>
   <result pre="human hepatocytesPLoS ONE201510e011982010.1371/journal.pone.011982025782010 147.BarrettA.D.GouldE.A.Comparison of neurovirulence of different strains of" exact="yellow fever virus" post="in miceJ. Gen. Virol.19866763163710.1099/0022-1317-67-4-6313958694 148.AlmeidaM.A.B.CardosoJ.d.C.Dos SantosE.da FonsecaD.F.CruzL.L.FaracoF.J.C.BerciniM.A.VettorelloK.C.PortoM.A.MohrdieckR.et al.Surveillance for"/>
   <result pre="Negl. Trop. Dis.201957721310.1371/journal.pntd.0007299 152.EricksonA.K.PfeifferJ.K.Dynamic viral dissemination in mice infected with" exact="yellow fever virus" post="strain 17DJ. Virol.201387123921239710.1128/JVI.02149-1324027319 153.DouamF.Soto AlbrechtY.E.HrebikovaG.SadiminE.DavidsonC.KotenkoS.V.PlossA.Type III Interferon-Mediated Signaling Is"/>
   <result pre="VivoMBio20178e00819-1710.1128/mBio.00819-1728811340 154.MeierK.C.GardnerC.L.KhoretonenkoM.V.KlimstraW.B.RymanK.D.A mouse model for studying viscerotropic disease caused by" exact="yellow fever virus" post="infectionPLoS Pathog.20095e100061410.1371/journal.ppat.100061419816561 155.MiorinL.Laurent-RolleM.PisanelliG.CoP.H.AlbrechtR.A.Garcia-SastreA.MorrisonJ.Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus"/>
   <result pre="humoral and cellular parameters of immune activation after vaccination with" exact="yellow fever virus" post="strain 17D: A model of human flavivirus infectionJ. Med."/>
   <result pre="T-Cell Responses after VaccinationPLoS ONE201611e014987110.1371/journal.pone.014987126977808 167.NiedrigM.LademannM.EmmerichP.LafrenzM.Assessment of IgG antibodies against" exact="yellow fever virus" post="after vaccination with 17D by different assays: Neutralization test,"/>
   <result pre="Yellow Fever 17D vaccine expressing Lassa virus glycoproteinsVirology200634529930410.1016/j.virol.2005.12.00116412488 177.FrancoD.LiW.QingF.StoyanovC.T.MoranT.RiceC.M.HoD.D.Evaluation of" exact="yellow fever virus" post="17D strain as a new vector for HIV-1 vaccine"/>
   <result pre="vaccination: Past, present and futureFuture Microbiol.20151079180810.2217/fmb.15.1925824845 215.KlittingR.RizikiT.MoureauG.PiorkowskiG.GouldE.A.de LamballerieX.Exploratory re-encoding of" exact="yellow fever virus" post="genome: New insights for the design of live-attenuated virusesVirus"/>
   <result pre="219.CarringtonC.V.F.AugusteA.J.Evolutionary and ecological factors underlying the tempo and distribution of" exact="yellow fever virus" post="activityInfect. Genet. Evol.20131319821010.1016/j.meegid.2012.08.01522981999 220.LemoineF.CorreiaD.LefortV.Doppelt-AzeroualO.MareuilF.Cohen-BoulakiaS.GascuelO.NGPhylogeny.fr: New generation phylogenetic services for"/>
   <result pre="frontier of genome engineering with CRISPR-Cas9Science2014346125809610.1126/science.125809625430774 223.PugachevK.V.GuirakhooF.OcranS.W.MitchellF.ParsonsM.PenalC.GirakhooS.PougatchevaS.O.ArroyoJ.TrentD.W.et al.High fidelity of" exact="yellow fever virus" post="RNA polymeraseJ. Virol.2004781032103810.1128/JVI.78.2.1032-1038.200414694136 224.VlachakisD.KoumandouV.L.KossidaS.A holistic evolutionary and structural study"/>
   <result pre="Negl. Trop. Dis.201711e000607510.1371/journal.pntd.000607529155823 227.McMullanL.K.FraceM.SammonsS.A.ShoemakerT.BalinandiS.WamalaJ.F.LutwamaJ.J.DowningR.G.StroeherU.MacNeilA.et al.Using next generation sequencing to identify" exact="yellow fever virus" post="in UgandaVirology20124221510.1016/j.virol.2011.08.02421962764 228.QuickJ.LomanN.J.DuraffourS.SimpsonJ.T.SeveriE.CowleyL.BoreJ.A.KoundounoR.DudasG.MikhailA.et al.Real-time, portable genome sequencing for Ebola"/>
   <result pre="epidemicInt. J. Infect. Dis.2016489810310.1016/j.ijid.2016.04.02527156836 233.ChenC.JiangD.NiM.LiJ.ChenZ.LiuJ.YeH.WongG.LiW.ZhangY.et al.Phylogenomic analysis unravels evolution of" exact="yellow fever virus" post="within hostsPLoS Negl. Trop. Dis.201812e000673810.1371/journal.pntd.000673830188905 234.SallA.A.FayeO.DialloM.FirthC.KitchenA.HolmesE.C.Yellow fever virus exhibits"/>
   <result pre="Arbovirus Vertical Transmission in MosquitoesPLoS Pathog.201612e100554810.1371/journal.ppat.100554827171170 237.DialloM.ThonnonJ.FontenilleD.Vertical transmission of the" exact="yellow fever virus" post="by Aedes aegypti (Diptera, Culicidae): Dynamics of infection in"/>
   <result pre="techniques combined eliminate mosquitoesNature201910.1038/s41586-019-1407-931316207 247.OlmoR.P.FerreiraA.G.A.Izidoro-ToledoT.C.AguiarE.R.G.R.de FariaI.J.S.de SouzaK.P.R.OsÃ³rioK.P.KuhnL.HammannP.de AndradeE.G.et al.Control of" exact="dengue virus" post="in the midgut of Aedes aegypti by ectopic expression"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6857389\results\search\virus\results.xml">
   <result pre="epidemiology of dengue in Delhi, IndiaVirol J200639217083743 15DashPKParidaMMSaxenaPAbhyankarASinghCTewariKet al.Reemergence of" exact="dengue virus" post="type-3 (subtype-III) in India: Implications for increased incidence of"/>
   <result pre="for increased incidence of DHF and DSSVirol J200635516824209 16ChakravartiAKumarAMatlaniMDisplacement of" exact="dengue virus" post="type 3 and type 2 by dengue virus type"/>
   <result pre="16ChakravartiAKumarAMatlaniMDisplacement of dengue virus type 3 and type 2 by" exact="dengue virus" post="type 1 in Delhi during 2008Indian J Med Microbiol201028412"/>
   <result pre="J Med Microbiol201028412 17KukretiHChaudharyARautelaRSAnandRMittalVChhabraMet al.Emergence of an independent lineage of" exact="dengue virus" post="type 1 (DENV-1) and its co-circulation with predominant DENV-3"/>
   <result pre="DelhiInt J Infect Dis200812542918495513 18BharajPChaharHSPandeyADiddiKDarLGuleriaRet al.Concurrent infections by all four" exact="dengue virus" post="serotypes during an outbreak of dengue in 2006 in"/>
   <result pre="of dengue in 2006 in Delhi, IndiaVirol J20085118182120 19ChaharHSBharajPDarLGuleriaRKabraSKBroorSCo-infections with" exact="chikungunya virus" post="and dengue virus in Delhi, IndiaEmerg Infect Dis20091510778019624923 20Wilder-SmithARupaliPEstimating"/>
   <result pre="2006 in Delhi, IndiaVirol J20085118182120 19ChaharHSBharajPDarLGuleriaRKabraSKBroorSCo-infections with chikungunya virus and" exact="dengue virus" post="in Delhi, IndiaEmerg Infect Dis20091510778019624923 20Wilder-SmithARupaliPEstimating the dengue burden"/>
   <result pre="burden in IndiaLancet Glob Health20197e988931201129 21ChaturvediUCMathurAMehrotraRMExperimentally produced cardiac injury following" exact="dengue virus" post="infectionIndian J Pathol Bacteriol197417218204457475 22GublerDJSuharyonoWLubisIEramSGunarsoSEpidemic dengue 3 in central"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6883514\results\search\virus\results.xml">
   <result pre="10.1186/s12879-019-4635-6 : Research Article Meningitis gone viral: description of the" exact="echovirus" post="wave 2013 in Germany GrafJonas1HartmannChristian J.23LehmannHelmar C.4OttoCarolin5AdamsOrtwin6KarenfortMichael7SchneiderChristian4RuprechtKlemens5BosseHans Martin7DiedrichSabine8BÃ¶ttcherSindy8SchnitzlerAlfons3HartungHans-Peter1AktasOrhan1http://orcid.org/0000-0001-7987-658XAlbrechtPhilippphil.albrecht@gmail.com1[1], 0000"/>
   <result pre="72 patients, 38 (52.8%) were enterovirus positive and typed as" exact="echovirus" post="(18 pediatric and 20 adult cases, median age 18.5â€‰years;"/>
   <result pre="echovirus (18 pediatric and 20 adult cases, median age 18.5â€‰years;" exact="echovirus" post="18 (1), echovirus 2 (1), echovirus 30 (31), echovirus"/>
   <result pre="and 20 adult cases, median age 18.5â€‰years; echovirus 18 (1)," exact="echovirus" post="2 (1), echovirus 30 (31), echovirus 33 (1), echovirus"/>
   <result pre="cases, median age 18.5â€‰years; echovirus 18 (1), echovirus 2 (1)," exact="echovirus" post="30 (31), echovirus 33 (1), echovirus 9 (4)). At"/>
   <result pre="18.5â€‰years; echovirus 18 (1), echovirus 2 (1), echovirus 30 (31)," exact="echovirus" post="33 (1), echovirus 9 (4)). At the same time,"/>
   <result pre="(1), echovirus 2 (1), echovirus 30 (31), echovirus 33 (1)," exact="echovirus" post="9 (4)). At the same time, 45 aseptic meningitis"/>
   <result pre="viral meningitis are mainly driven by an EV predominance of" exact="echovirus" post="30 [7]. EV meningitis epidemics in Shandong (Peopleâ€™s Republic"/>
   <result pre="and 20 adult cases, median age 18.5 (5.25; 31.25) years;" exact="echovirus" post="18 (1), echovirus 2 (1), echovirus 30 (31), echovirus"/>
   <result pre="cases, median age 18.5 (5.25; 31.25) years; echovirus 18 (1)," exact="echovirus" post="2 (1), echovirus 30 (31), echovirus 33 (1), echovirus"/>
   <result pre="18.5 (5.25; 31.25) years; echovirus 18 (1), echovirus 2 (1)," exact="echovirus" post="30 (31), echovirus 33 (1), echovirus 9 (4)), 1"/>
   <result pre="years; echovirus 18 (1), echovirus 2 (1), echovirus 30 (31)," exact="echovirus" post="33 (1), echovirus 9 (4)), 1 patient was enterovirus"/>
   <result pre="(1), echovirus 2 (1), echovirus 30 (31), echovirus 33 (1)," exact="echovirus" post="9 (4)), 1 patient was enterovirus 71 (EV-A71)-positive, 1"/>
   <result pre="(Î·â€‰=â€‰âˆ’â€‰0,32) correlated with the duration of inpatient stay. In contrast," exact="echovirus" post="status, gender, and location (Neurological center the patient was"/>
   <result pre="protein, delay between symptom onset and spinal tap enterovirus status," exact="echovirus" post="status, gender, treating center (Berlin, Cologne, Duesseldorf)). A total"/>
   <result pre="(adjusted R2â€‰=â€‰0.302, standardized Beta values: ageâ€‰=â€‰0.354, CSF protein 0.247, and" exact="echovirus" post="status âˆ’â€‰0.169, respectively). Therapy The cases diagnosed with varicella"/>
   <result pre="positive for EV, of which 672 cases were typed as" exact="echovirus" post="30. Therefore, our study includes 5.8% (72 of 1242"/>
   <result pre="(DASGIB)Clinical Microbiology and Infection201824101102.e1-1102.e510.1016/j.cmi.2018.01.016 7.HolmesCWKooSSFOsmanHet al.Predominance of enterovirus B and" exact="echovirus" post="30 as cause of viral meningitis in a UK"/>
   <result pre="EVSurv, https://evsurv.rki.de/ (accessed 8 Oct 2018). 18.KurykÅ�WieczorekMDiedrichSet al.Genetic analysis of" exact="poliovirus" post="strains isolated from sewage in PolandJ Med Virol2014861243124810.1002/jmv.2380324123142 19.BÃ¶ttcherSObermeierPENeubauerKet"/>
   <result pre="C1 strains, Germany, 2015Emerg Infect Dis2016221843184610.3201/eid2210.16035727439117 20.LeitchECMHarvalaHRobertsonIet al.Direct identification of" exact="human enterovirus" post="serotypes in cerebrospinal fluid by amplification and sequencing of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6893414\results\search\virus\results.xml">
   <result pre="of ZIKV infectivity. Furthermore, Ery-Est also showed inhibitory activity against" exact="dengue virus" post="(DENV) and yellow fever virus (YFV). Thus, Ery-Est may"/>
   <result pre="Ery-Est also showed inhibitory activity against dengue virus (DENV) and" exact="yellow fever virus" post="(YFV). Thus, Ery-Est may be a promising drug for"/>
   <result pre="The Flaviviridae family also contains other enveloped viruses, such as" exact="dengue virus" post="(DENV), yellow fever virus (YFV), West Nile virus, and"/>
   <result pre="also contains other enveloped viruses, such as dengue virus (DENV)," exact="yellow fever virus" post="(YFV), West Nile virus, and Japanese encephalitis virus, which"/>
   <result pre="were detected by the plaque assay. The pseudotyped MERS-CoV and" exact="vesicular stomatitis virus" post="(VSV) were chosen as control enveloped viruses and prepared"/>
   <result pre="with Middle East Respiratory SyndromeInt. J. Infect. Dis.20198118419010.1016/j.ijid.2019.01.04130690213 18.YokotaS.OkabayashiT.HirakawaS.TsutsumiH.HimiT.FujiiN.Clarithromycin suppresses" exact="human respiratory syncytial virus" post="infection-induced Streptococcus pneumoniae adhesion and cytokine production in a"/>
   <result pre="virus production in Vero cellsSci. Rep.201991146110.1038/s41598-019-47956-131391514 30.MounceB.C.CesaroT.CarrauL.ValletT.VignuzziM.Curcumin inhibits Zika and" exact="chikungunya virus" post="infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 31.LuL.LiuQ.ZhuY.ChanK.H.QinL.LiY.WangQ.ChanJ.F.JiangS.YuF.et al.Structure-based discovery"/>
   <result pre="antibodies and screen for viral entry inhibitors against the novel" exact="human coronavirus" post="MERS-CoVVirol. J.20131026610.1186/1743-422X-10-26623978242 33.SiL.MengK.TianZ.SunJ.LiH.ZhangZ.SolovevaV.XiaoS.ZhangL.ZhouD.et al.Triterpenoids manipulate a broad range of"/>
   <result pre="fusion intermediate induced by CD4 D1D2 domainsRetrovirology2012910410.1186/1742-4690-9-10423217195 35.LokS.M.CostinJ.M.HrobowskiY.M.HoffmannA.R.RoweD.K.KukkaroP.WimleyW.C.IsernS.RossmannM.G.MichaelS.F.et al.Release of" exact="dengue virus" post="genome induced by a peptide inhibitorPLoS ONE20127e5099510.1371/journal.pone.005099523226444 36.AliotaM.T.CaineE.A.WalkerE.C.LarkinK.E.CamachoE.OsorioJ.E.Characterization of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958409\results\search\virus\results.xml">
   <result pre="the HA and NA genes were replaced to encode the" exact="vesicular stomatitis virus" post="(VSV) glycoprotein G. With these modifications, the influenza virus"/>
   <result pre="activationPLoS ONE20116e2021510.1371/journal.pone.002021521698289 167.WangP.PaleseP.Oâ€™NeillR.E.The NPI-1/NPI-3 (karyopherin alpha) binding site on the" exact="influenza a virus" post="nucleoprotein NP is a nonconventional nuclear localization signalJ. Virol.199771185018569032315"/>
   <result pre="215.BrightyD.W.RosenbergM.A cis-acting repressive sequence that overlaps the Rev-responsive element of" exact="human immunodeficiency virus" post="type 1 regulates nuclear retention of env mRNAs independently"/>
   <result pre="of Actin DynamicsPLoS Pathog.20106e100095410.1371/journal.ppat.100095420585561 218.SessionsO.M.BarrowsN.J.Souza-NetoJ.A.RobinsonT.J.HersheyC.L.RodgersM.A.RamirezJ.L.DimopoulosG.YangP.L.PearsonJ.L.et al.Discovery of insect and human" exact="dengue virus" post="host factorsNature20094581047105010.1038/nature0796719396146 219.MukherjeeS.HanleyK.A.RNA interference modulates replication of dengue virus"/>
   <result pre="human dengue virus host factorsNature20094581047105010.1038/nature0796719396146 219.MukherjeeS.HanleyK.A.RNA interference modulates replication of" exact="dengue virus" post="in Drosophila melanogaster cellsBMC Microbiol.20101012710.1186/1471-2180-10-12720420715 220.MuellerS.GaussonV.VodovarN.DeddoucheS.TroxlerL.PerotJ.PfefferS.HoffmannJ.A.SalehM.-C.ImlerJ.-L.RNAi-mediated immunity provides strong"/>
   <result pre="Microbiol.20101012710.1186/1471-2180-10-12720420715 220.MuellerS.GaussonV.VodovarN.DeddoucheS.TroxlerL.PerotJ.PfefferS.HoffmannJ.A.SalehM.-C.ImlerJ.-L.RNAi-mediated immunity provides strong protection against the negative-strand RNA" exact="vesicular stomatitis virus" post="in DrosophilaProc. Natl. Acad. Sci. USA2010107193901939510.1073/pnas.101437810720978209 221.CherryS.VSV infection is"/>
   <result pre="269.KogureT.SuzukiT.TakahashiT.MiyamotoD.HidariK.I.GuoC.T.ItoT.KawaokaY.SuzukiY.Human trachea primary epithelial cells express both sialyl(alpha2-3)Gal receptor for" exact="human parainfluenza" post="virus type 1 and avian influenza viruses, and sialyl(alpha2-6)Gal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6958466\results\search\virus\results.xml">
   <result pre="organisms. In the Flaviviridae family, vaccines are available for the" exact="yellow fever virus" post="(YFV) and Japanese encephalitis virus (JEV). There are two"/>
   <result pre="discoveryJ. Biomol. Struct. Dyn.2018361118113310.1080/07391102.2017.131317528351337 41.BalasubramanianA.TeramotoT.KulkarniA.A.BhattacharjeeA.K.PadmanabhanR.Antiviral activities of selected antimalarials against" exact="dengue virus" post="type 2 and Zika virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 42.SinigagliaA.RiccettiS.TrevisanM.BarzonL.In silico approaches"/>
   <result pre="Clin. Investig.20021101765176810.1172/JCI1740512488425 64.LiuF.FeuerR.HassettD.E.WhittonJ.L.Peptide vaccination of mice immune to LCMV or" exact="vaccinia virus" post="causes serious CD8+ T cell mediated, TNF-dependent immunopathologyJ. Clin."/>
   <result pre="years of dengue drug discovery: Progress and prospectsAntivir. Res.201310050051910.1016/j.antiviral.2013.09.01324076358 117.XieX.ZouJ.WangQ.Y.ShiP.Y.Targeting" exact="dengue virus" post="NS4B protein for drug discoveryAntivir. Res.2015118394510.1016/j.antiviral.2015.03.00725796970 118.XieX.WangQ.Y.XuH.Y.QingM.KramerL.YuanZ.ShiP.Y.Inhibition of dengue"/>
   <result pre="dengue virus NS4B protein for drug discoveryAntivir. Res.2015118394510.1016/j.antiviral.2015.03.00725796970 118.XieX.WangQ.Y.XuH.Y.QingM.KramerL.YuanZ.ShiP.Y.Inhibition of" exact="dengue virus" post="by targeting viral NS4B proteinJ. Virol.201185111831119510.1128/JVI.05468-1121865382 119.van CleefK.W.OverheulG.J.ThomassenM.C.KapteinS.J.DavidsonmA.D.JacobsM.NeytsJ.van KuppeveldF.J.van"/>
   <result pre="NS4B proteinJ. Virol.201185111831119510.1128/JVI.05468-1121865382 119.van CleefK.W.OverheulG.J.ThomassenM.C.KapteinS.J.DavidsonmA.D.JacobsM.NeytsJ.van KuppeveldF.J.van RijR.P.Identification of a new" exact="dengue virus" post="inhibitor that targets the viral NS4B protein and restricts"/>
   <result pre="Soc.2016138162121621510.1021/jacs.6b1039927998085 121.StevensA.J.GahanM.E.MahalingamS.KellerP.A.The medicinal chemistry of dengue feverJ. Med. Chem.2009527911792610.1021/jm900652e19739651 122.LimS.P.NobleC.G.ShiP.Y.The" exact="dengue virus" post="NS5 protein as a target for drug discoveryAntivir. Res.2015119576710.1016/j.antiviral.2015.04.01025912817"/>
   <result pre="immune responsesCell Rep.20171832433310.1016/j.celrep.2016.12.04528076778 138.WangZ.Y.WangZ.ZhenZ.D.FengK.H.GuoJ.GaoN.FanD.Y.HanD.S.WangP.G.AnJ.Axl is not an indispensable factor for" exact="zika virus" post="infection in miceJ. Gen. Virol.2017982061206810.1099/jgv.0.00088628786784 139.BlazquezA.B.Escribano-RomeroE.Merino-RamosT.SaizJ.-C.Martin-AcebesM.A.Stress responses in flavivirus-infected"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6968813\results\search\virus\results.xml">
   <result pre="Low levels of drug resistance amidst rapidly increasing tuberculosis and" exact="human immunodeficiency virus" post="co-epidemics in Botswana. Int J Tuberc Lung Dis. 1999;3(1):4â€&quot;11.10094163"/>
   <result pre="et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with" exact="human immunodeficiency virus" post="infection in an urban hospital: epidemiologic and restriction fragment"/>
   <result pre="doi:10.1093/infdis/168.4.10528104226 35.BusilloC, LessnauK-D, SanjanaV. Multidrug-resistant Mycobacterium tuberculosis in patients with" exact="human immunodeficiency virus" post="infection. Chest. 1992;102(3):797â€&quot;801. doi:10.1378/chest.102.3.7971516405 36.ShaferRW, SmallPM, LarkinC, et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6977312\results\search\virus\results.xml">
   <result pre="Day 4â€&quot; 60 1â€&quot;5% of symptomatic cases Neurologic disorders HIV" exact="human immunodeficiency virus," post="EBV Epstein Barr virus, CMV cytomegalovirus, HSV herpes simplex"/>
   <result pre="scan EBV Epstein Barr virus ELISA enzyme-linked immunosorbent assay HIV" exact="human immunodeficiency virus" post="HSV herpes simplex viruses HVFs hemorrhagic viral fevers Ig"/>
   <result pre="construed as potential competing interests. References References 1.DaubneyRHudsonJRGarnhamPCEnzootic hepatitis or" exact="rift valley fever." post="An undescribed virus disease of sheep cattle and man"/>
   <result pre="field quantitative real-time PCR test to rapidly identify highly viremic" exact="rift valley fever" post="casesJ Clin Microbiol2009471166117110.1128/JCM.01905-0819171680 55.HiseAGTraylorZHallNBSutherlandLJDahirSErmlerMEet al.Association of symptoms and severity"/>
   <result pre="casesJ Clin Microbiol2009471166117110.1128/JCM.01905-0819171680 55.HiseAGTraylorZHallNBSutherlandLJDahirSErmlerMEet al.Association of symptoms and severity of" exact="rift valley fever" post="with genetic polymorphisms in human innate immune pathwaysPLoS Negl"/>
   <result pre="important implications for therapeutic developmentPLoS Negl Trop Dis.20137e215610.1371/journal.pntd.000215623593523 76.HartmanALPowellDSBethelLMCarolineALSchmidRJOuryTet al.Aerosolized" exact="rift valley fever" post="virus causes fatal encephalitis in african green monkeys and"/>
   <result pre="al.Lymphoplasmacytic endotheliitis and anterior uveitis in sheep infected experimentally with" exact="rift valley fever" post="virusJ Comp Pathol2012146404310.1016/j.jcpa.2011.03.01321601870 91.NiklassonBLiljestrandJBergstrÃ¶mSPetersCJRift Valley fever: a sero-epidemiological survey"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC6993835\results\search\virus\results.xml">
   <result pre="Â Â Â Â â€¢Â Â Â Non-arthropod-borne togavirus â€&quot;" exact="rubella virus" post="Bunyaviruses Â Â Â Â â€¢Â Â Â California"/>
   <result pre="agents include primary neurotropic viruses such as arboviruses, herpesviruses, and" exact="rabies virus" post="as well as other â€œincidentalâ€� nervous system pathogens such"/>
   <result pre="confirmed in 52.5% of patients. The most common pathogen was" exact="human enterovirus" post="(EV) (27.7%). The etiology of viral meningitis was identified"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7001263\results\search\virus\results.xml">
   <result pre="CentralLondon 8294 doi: 10.1186/s12889-020-8294-8 : Research Article High prevalence of" exact="human immunodeficiency virus," post="hepatitis B and C viral infections among people who"/>
   <result pre="Tanzania has witnessed a significant decrease in the prevalence of" exact="human immunodeficiency virus" post="(HIV) and viral hepatitis in the general population attributed"/>
   <result pre="Tanzania has reported a steady fall in the prevalence of" exact="human immunodeficiency virus" post="(HIV) infection in the general population, from 7% in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7004624\results\search\virus\results.xml">
   <result pre="http://creativecommons.org/licenses/by-nc-nd/4.0cm9-133-318.pdf Abstract Abstract This paper reviews the current epidemics of" exact="human immunodeficiency virus" post="(HIV) infection in China, particularly the globally available prevention"/>
   <result pre="virus infection Epidemic Prevention strategies China Introduction The epidemic of" exact="human immunodeficiency virus" post="(HIV) infection has changed remarkably around the world and"/>
   <result pre="Transfus2014; 12:166â€&quot;171. doi: 10.2450/2013.0103-13.24333076 22.LuJXuJReillyKHLiYZhangCMJiangYet al.The proportion and trend of" exact="human immunodeficiency virus" post="infections associated with men who have sex with men"/>
   <result pre="December 21, 2019. 36.QuinnTCWawerMJSewankamboNSerwaddaDLiCWabwire-MangenFet al.Viral load and heterosexual transmission of" exact="human immunodeficiency virus" post="type 1. Rakai Project Study Group. N Engl J"/>
   <result pre="Columbia, Canada: a population-based study. Lancet2010; 376:532â€&quot;539. doi: 10.1016/S0140-6736(10)60936-1.20638713 46.MaYDouZGuoWMaoYZhangFMcGooganJMThe" exact="human immunodeficiency virus" post="care continuum in China: 1985-2015. Clin Infect Dis2018; 66:833â€&quot;839."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7020194\results\search\virus\results.xml">
   <result pre="previously implicated in several viral infections including papillomavirus, cytomegalovirus and" exact="human immunodeficiency virus" post="(Thali, 2011; Scheffer et al., 2014; Hochdorfer et al.,"/>
   <result pre="treatments.Lancet389299â€&quot;311. 10.1016/S0140-6736(16)30958-827574741 HochdorferD.FlorinL.SinzgerC.LieberD. (2016). Tetraspanin CD151 promotes initial events in" exact="human cytomegalovirus" post="infection.J. Virol.906430â€&quot;6442. 10.1128/JVI.00145-1627147745 HuaL. V.GreenM.WongA.WarshJ. J.LiP. P. (2001). Tetraspan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7054940\results\search\virus\results.xml">
   <result pre="nCoV isolates was found lower (40.2%) with the mild respiratory" exact="human coronavirus" post="isolate HCoV-OC43 of same subgenus Embecovirus containing animal-origin coronaviruses."/>
   <result pre="other SARS like CoVs, respectively. The per cent identity with" exact="human coronavirus" post="isolate HCoV-OC43 was also found lower (28.0%) (Supplementary data"/>
   <result pre="therapeutics Several attempts have been made to develop vaccines against" exact="human coronavirus" post="infection in the past decades. But the degree of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7057477\results\search\virus\results.xml">
   <result pre="ZIKV is related to the two other imperative arbo-viruses including" exact="dengue virus" post="(DENV) and chikungunya virus (CHIVKV) [3]. In a quest"/>
   <result pre="the two other imperative arbo-viruses including dengue virus (DENV) and" exact="chikungunya virus" post="(CHIVKV) [3]. In a quest to solve the dilemma"/>
   <result pre="through Aedes genus. Other members of this family include arboviruses," exact="dengue virus" post="and Japanese encephalitis viruses [11]. ZIKV antibodies were also"/>
   <result pre="65.UllmanDControlled clinical trials evaluating the homeopathic treatment of people with" exact="human immunodeficiency virus" post="or acquired immune deficiency syndromeJ Altern Complement Med2003913314110.1089/10755530332122300812676041 66.PatwardhanBVaidyaADBChorghadeMAyurveda"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7061886\results\search\virus\results.xml">
   <result pre="of the genus Ebolavirus have been identified. They include Zaire" exact="ebolavirus" post="(ZEBOV), Bundibugyo ebolavirus (BEBOV), Sudan ebolavirus (SEBOV), Reston ebolavirus"/>
   <result pre="Ebolavirus have been identified. They include Zaire ebolavirus (ZEBOV), Bundibugyo" exact="ebolavirus" post="(BEBOV), Sudan ebolavirus (SEBOV), Reston ebolavirus and CÃ´te d'Ivoire"/>
   <result pre="identified. They include Zaire ebolavirus (ZEBOV), Bundibugyo ebolavirus (BEBOV), Sudan" exact="ebolavirus" post="(SEBOV), Reston ebolavirus and CÃ´te d'Ivoire ebolavirus. Most of"/>
   <result pre="Zaire ebolavirus (ZEBOV), Bundibugyo ebolavirus (BEBOV), Sudan ebolavirus (SEBOV), Reston" exact="ebolavirus" post="and CÃ´te d'Ivoire ebolavirus. Most of the outbreaks in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7064018\results\search\virus\results.xml">
   <result pre="Times.2020Available at https://www.japantimes.co.jp/news/2020/02/22/asia-pacific/covid-19-south-korea/#.XlbglGhKg_E [Accessed: 29.02.2020] 32GagneurAValletSTalbotPJLegrand-QuillienMCPicardBPayan C and SizunJOutbreaks of" exact="human coronavirus" post="in a pediatric and neonatal intensive care unit.Eur J"/>
   <result pre="lung injury.Nat Med200511887587910.1038/nm126716007097 38LiWSuiJHuangICKuhnJHRadoshitzkySRMarascoWAChoe H and FarzanMThe S proteins of" exact="human coronavirus" post="NL63 and severe acute respiratory syndrome coronavirus bind overlapping"/>
   <result pre="Control and Prevention.JAMA.202010.1001/jama.2020.2648 43SeveranceEGBossisIDickersonFBStallingsCROrigoniAESullensAYolken RH and ViscidiRPDevelopment of a nucleocapsid-based" exact="human coronavirus" post="immunoassay and estimates of individuals exposed to coronavirus in"/>
   <result pre="CoV â€&quot; coronavirus; COVID-19 â€&quot; coronavirus disease 2019; HCoV â€&quot;" exact="human coronavirus;" post="MERS â€&quot; Middle-East respiratory syndrome; SARI â€&quot; severe acute"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7073332\results\search\virus\results.xml">
   <result pre="evidence. HBV hepatitis B virus, HCV hepatitis C virus, HDV" exact="hepatitis delta virus," post="EBOV Ebola viruses, ZEBOV-GP Zaire Ebola virus glycoprotein, HIV"/>
   <result pre="virus, EBOV Ebola viruses, ZEBOV-GP Zaire Ebola virus glycoprotein, HIV" exact="human immunodeficiency virus," post="EBV Epstein-Barr virus, ANDV Andes orthohantavirus, EMCV encephalomyocarditis virus,"/>
   <result pre="human immunodeficiency virus, EBV Epstein-Barr virus, ANDV Andes orthohantavirus, EMCV" exact="encephalomyocarditis virus," post="FECV feline enteric coronavirus, RSV respiratory syncytial virus, EV71"/>
   <result pre="in inhibiting the entry of Zaire Ebola virus glycoprotein and" exact="human immunodeficiency virus" post="(ZEBOV-GP/HIV)18. Altogether, network-predicted SERMs (such as toremifene and equilin)"/>
   <result pre="preS1-specific receptor for the hepatitis B virus (HBV) and the" exact="hepatitis delta virus" post="(HDV). Irbesartan can inhibit NTCP, thus inhibiting viral entry45,46."/>
   <result pre="(2020). 28.ChengFKovacsIABarabasiALNetwork-based prediction of drug combinationsNat. Commun.201910119710.1038/s41467-019-09186-x30867426 29.ForniDCaglianiRClericiMSironiMMolecular evolution of" exact="human coronavirus" post="genomesTrends Microbiol.201725354810.1016/j.tim.2016.09.00127743750 30.KirchdoerferRNWardABStructure of the SARS-CoV nsp12 polymerase bound"/>
   <result pre="olmesartan on the development of murine acute myocarditis caused by" exact="coxsackievirus" post="B3Clin. Sci.200611037938610.1042/CS2005029916336207 44.ErlandsonKMet al.The impact of statin and angiotensin-converting"/>
   <result pre="inhibitor/angiotensin receptor blocker therapy on cognitive function in adults with" exact="human immunodeficiency virus" post="infectionClin. Infect. Dis.2017652042204910.1093/cid/cix64529020174 45.WangXJet al.Irbesartan, an FDA approved drug"/>
   <result pre="syndromeBMC Immunol.20056210.1186/1471-2172-6-215655079 95.JossetLet al.Cell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7089181\results\search\virus\results.xml">
   <result pre="for several reasons, one of them being the risk that" exact="variola virus" post="might be brought back with the methods of synthetic"/>
   <result pre="drug was available at the time to treat infections with" exact="variola virus," post="a drug effective against orthopoxviruses, tecovirimat, has recently been"/>
   <result pre="at REGA, in Belgium [31, 35]) and FDA approved against" exact="human cytomegalovirus" post="(HCMV). The ether lipid analogue brincidofovir (CMX001), a prodrug"/>
   <result pre="pneumonia in infants and children. Measles (morbilli, rubeola) caused by" exact="measles virus" post="(MeaslesV) was responsible for around 733,000 deaths globally in"/>
   <result pre="motif of the viral polymeraseJ Virol201710.1128/JVI.00487-1728381577 3.AbdelnabiRJochmansDVerbekenENeytsJDelangLAntiviral treatment efficiently inhibits" exact="chikungunya virus" post="infection in the joints of mice during the acute"/>
   <result pre="antiviral targeting Venezuelan equine encephalitis virus infectionsAntivir Res2019164616910.1016/j.antiviral.2019.02.00230738837 5.AltmannSESmithALDyallJJohnsonRFDoddLEJahrlingPBParagasJBlaneyJEInhibition of" exact="cowpox virus" post="and monkeypox virus infection by mitoxantroneAntivir Res20129330530810.1016/j.antiviral.2011.12.00122182595 6.Alves GalvÃ£oMGRocha"/>
   <result pre="equine encephalitis virus infectionsAntivir Res2019164616910.1016/j.antiviral.2019.02.00230738837 5.AltmannSESmithALDyallJJohnsonRFDoddLEJahrlingPBParagasJBlaneyJEInhibition of cowpox virus and" exact="monkeypox virus" post="infection by mitoxantroneAntivir Res20129330530810.1016/j.antiviral.2011.12.00122182595 6.Alves GalvÃ£oMGRocha Crispino SantosMAAlves da"/>
   <result pre="identification of compounds from Kalanchoe pinnata having human alphaherpesvirus and" exact="vaccinia virus" post="antiviral activityPharm Biol2017551586159110.1080/13880209.2017.131090728395583 28.Dahl (1986) MEASLES: a dangerous illness."/>
   <result pre="Faria NetoHCBoechatNRehenSKBrÃ¼ningKBozzaFABozzaPTSouzaTMLBeyond members of the Flaviviridae family, Sofosbuvir also inhibits" exact="chikungunya virus" post="replicationAntimicrob Agents Chemother201910.1128/AAC.01389-1831844010 41.Ferreira-RamosASLiCEydouxCContrerasJMMoriceCQuÃ©ratGGiganteAPÃ©rez PÃ©rezM-JJungM-LCanardBGuillemotJ-CDecrolyECoutardBApproved drugs screening against the"/>
   <result pre="outbreakViruses201710.3390/v911032029773767 45.FrancoEJRodriquezJLPomeroyJJHanrahanKCBrownANThe effectiveness of antiviral agents with broad-spectrum activity against" exact="chikungunya virus" post="varies between host cell linesAntivir Chem Chemother201826204020661880758010.1177/204020661880758030354193 46.Fraser-bellCJGlobal re-emergence"/>
   <result pre="NS2B-NS3 proteaseAntivir Res2018201815021722510.1016/j.antiviral.2017.12.018 87.LieberherrCZhangGGrafenASingethanKKendlSVogtVMaierJBringmannGSchneider-SchauliesJThe plant-derived naphthoquinone droserone inhibits in vitro" exact="measles virus" post="infectionPlanta Med20178323223810.1055/s-0042-11182527420351 88.LoMKJordanRArveyASudhamsuJShrivastava-RanjanPHotardALFlintMMcMullanLKSiegelDClarkeMOMackmanRLHuiHCPerronMRayASCihlarTNicholSTSpiropoulouCFGS-5734 and its parent nucleoside analog inhibit"/>
   <result pre="Biol20091151052010.1038/ncb0509-51019404330 101.MilliganGNWhiteMZavalaDPylesRBSarathyVVBarrettADTBourneNSpectrum of activity testing for therapeutics against all four" exact="dengue virus" post="serotypes in AG129 mouse models: proof-of-concept studies with the"/>
   <result pre="Res20087811612410.1016/j.antiviral.2007.10.00918061688 104.MuckerEMGoffAJShamblinJDGrosenbachDWDamonIKMehalJMHolmanRCCarrollDGallardoNOlsonVAClemmonsCJHudsonPHrubyDEEfficacy of Tecovirimat (ST-246) in Nonhuman primates infected with" exact="variola virus" post="(smallpox)Antimicrob Agents Chemother201357126246625310.1128/aac.00977-1324100494 105.MumtazNJimmersonLCBushmanLRKiserJJAronGReuskenCBEMKoopmansMPGvan KampenJJACell-line dependent antiviral activity of"/>
   <result pre="agent for Chikungunya virus infectionAntivir Res201815010111110.1016/j.antiviral.2017.12.01229269135 114.Osuna-RamosJFReyes-RuizJMBautista-CarbajalPCervantes-SalazarMFarfan-MoralesCNDe JesÃºs-GonzÃ¡lezLAHurtado-MonzÃ³nAMDel Ã�ngelRMEzetimibe inhibits" exact="dengue virus" post="infection in Huh-7 cells by blocking the cholesterol transporter"/>
   <result pre="of seasonality and climate changeEpidemics201910.1016/j.epidem.2019.05.00331175008 125.RosenkeKFeldmannHWestoverJBHanleyPWMartellaroCFeldmannFSaturdayGLovaglioJScottDPFurutaYKomenoTGowenBBSafronetzDUse of favipiravir to treat" exact="lassa virus" post="infection in macaquesEmerg Infect Dis2018241696169910.3201/eid2409.18023329882740 126.RothanHABahraniHAbdulrahmanAYMohamedZTeohTCOthmanSRashidNNRahmanNAYusofRMefenamic acid in combination"/>
   <result pre="acid in combination with ribavirin shows significant effects in reducing" exact="chikungunya virus" post="infection In vitro and In vivoAntivir Res2016127505610.1016/j.antiviral.2016.01.00626794398 127.Schmidt-ChanasitJEssbauerSPetraityteRYoshimatsuKTackmannKConrathsFJSasnauskasKArikawaJThomasAPfefferMScharninghausenJJSplettstoesserWWenkMHeckelGUlrichRGExtensive host"/>
   <result pre="disease in Syrian golden hamstersAntivir Res2018156384510.1016/j.antiviral.2018.05.01329864447 146.WhitehouseERRaoAKYuYCYuPAGriffinMGormanSAngelKAMcDonaldECManlutacALPerioMAMcCollumAMDavidsonWWilkinsKOrtegaESatheshkumarPSTownsendMBIsakariMPetersenBWNovel treatment of a" exact="vaccinia virus" post="infection from an occupational needlestickâ€&quot;San Diego, CaliforniaMMWR Morb Mortal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7090748\results\search\virus\results.xml">
   <result pre="viruses, including SARS-CoV, MERS-CoV, EBOV, influenza A virus, Chikungunya virus," exact="human immunodeficiency virus," post="dengue virus, West Nile virus, Crimean Congo hemorrhagic fever"/>
   <result pre="MERS-CoV, EBOV, influenza A virus, Chikungunya virus, human immunodeficiency virus," exact="dengue virus," post="West Nile virus, Crimean Congo hemorrhagic fever virus, and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7091691\results\search\virus\results.xml">
   <result pre="MERS-CoV in 2012), seasonal epidemics caused by influenza viruses and" exact="dengue virus." post="Extracts from Lycoris radiate, Artemisia annua and Lindera aggregate,"/>
   <result pre="cordata, showed anti-SARS effects1â€&quot;5. The plant flavone baicalein can prevent" exact="dengue virus" post="entry into the host and inhibit post-entry replication6. Additionally,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7093024\results\search\virus\results.xml">
   <result pre="10.1002/(sici)1096-9071(200005)61:1&amp;lt;94::aid-jmv15&amp;gt;3.0.co;2-c10745239 DuR.CuiQ.RongL. (2019). Competitive cooperation of hemagglutinin and neuraminidase during" exact="influenza a virus" post="entry.Viruses11:E458. 10.3390/v1105045831137516 GrienkeU.SchmidtkeM.von GrafensteinS.KirchmairJ.LiedlK. R.RollingerJ. M. (2012). Influenza neuraminidase:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7098069\results\search\virus\results.xml">
   <result pre="to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and" exact="human adenovirus," post="indicating its potential as an antiviral agent. In this"/>
   <result pre="coronavirus SARS-CoV MERS-CoV SARS-CoV-2 (COVID-19) flavivirus Zika virus Ebola virus" exact="human adenovirus" post="This article is made available for a limited time"/>
   <result pre="(HCV), Ebola virus (EBOV), human rhinoviruses (HRVs), Chikungunya virus (CHIKV)," exact="human adenovirus" post="(HAdV), and Epsteinâ€&quot;Barr virus (EBV). We envision that this"/>
   <result pre="viruses in the family Flaviviridae, includes the Zika virus (ZIKV)," exact="dengue virus" post="four serotypes (DENV 1â€&quot;4), West Nile virus (WNV), yellow"/>
   <result pre="dengue virus four serotypes (DENV 1â€&quot;4), West Nile virus (WNV)," exact="yellow fever virus" post="(YFV), and Japanese encephalitis virus (JEV). Many of these"/>
   <result pre="severe acute respiratory syndrome coronavirus HCV hepatitis C virus DENV" exact="dengue virus" post="ZIKV Zika virus JEV Japanese encephalitis virus WNV West"/>
   <result pre="virus JEV Japanese encephalitis virus WNV West Nile virus YFV" exact="yellow fever virus" post="EBOV Ebola virus HRV human rhinovirus CHIKV Chikungunya virus"/>
   <result pre="Nile virus YFV yellow fever virus EBOV Ebola virus HRV" exact="human rhinovirus" post="CHIKV Chikungunya virus HAdV human adenovirus EBV Epsteinâ€&quot;Barr virus"/>
   <result pre="EBOV Ebola virus HRV human rhinovirus CHIKV Chikungunya virus HAdV" exact="human adenovirus" post="EBV Epsteinâ€&quot;Barr virus (EBV) SKP2 S-phase kinase-associated protein 2"/>
   <result pre="10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC. M. (1991) Processing of the" exact="yellow fever virus" post="nonstructural polyprotein: a catalytically active NS3 proteinase domain and"/>
   <result pre="NS2B and NS3 are required for the proteolytic processing of" exact="dengue virus" post="nonstructural proteins. J. Virol.65, 2467â€&quot;2475. 10.1128/JVI.65.5.2467-2475.1991.2016768 LuoD.; VasudevanS. G.;"/>
   <result pre="CaoS.; ChenH.; SongY. (2013) Identification of three antiviral inhibitors against" exact="japanese encephalitis virus" post="from library of pharmacologically active compounds 1280. PLoS One8,"/>
   <result pre="KuoS.-C.; HoY.-J. (2016) Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya virus" post="entry and transmission. Antiviral Res.135, 81â€&quot;90. 10.1016/j.antiviral.2016.10.003.27742486 Marrugal-LorenzoJ. A.;"/>
   <result pre="relationship studies on diversified salicylamide derivatives as potent inhibitors of" exact="human adenovirus" post="infection. J. Med. Chem.10.1021/acs.jmedchem.9b01950. MookR. A.; WangJ.; RenX.-R.; ChenM.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102556\results\search\virus\results.xml">
   <result pre="or influenza virus protein [32,33]; virus vectors, such as modified" exact="vaccinia virus" post="Ankara (MVA) or Adenovirus carrying S protein [34,35]; S"/>
   <result pre="antibodies in convalescent SARS patientsâ€™ sera against the emerging novel" exact="human coronavirus" post="EMC (2012) by both immunofluorescent and neutralizing antibody testsJÂ"/>
   <result pre="antibodies and screen for viral entry inhibitors against the novel" exact="human coronavirus" post="MERS-CoVVirol J10201326623978242 7LuH.StrattonC.W.TangY.W.Outbreak of pneumonia of unknown etiology in"/>
   <result pre="East respiratory syndrome coronavirusJÂ Clin Microbiol522014677524153118 15CormanV.M.EckerleI.BleickerT.ZakiA.LandtO.Eschbach-BludauM.Detection of a novel" exact="human coronavirus" post="by real-time reverse-transcription polymerase chain reactionEuro Surveill1720122028523041020 16HashemzadehM.S.RasouliR.ZahraeiB.IzadiM.TatM.SaadatS.H.Development of"/>
   <result pre="for rapid and accurate diagnostic test of MERS-CoV: a novel" exact="human coronavirus," post="ahead of Hajj pilgrimageIran Red Crescent Med J182016e2387428191331 17WHO:"/>
   <result pre="mice against challenge with SARS-CoVVaccine2920116606661321762752 34VolzA.KupkeA.SongF.JanyS.FuxR.Shams-EldinH.Protective efficacy of recombinant modified" exact="vaccinia virus" post="Ankara delivering Middle East respiratory syndrome coronavirus spike glycoproteinJÂ"/>
   <result pre="in spike protein of SARS-CoV do not cross-neutralize the novel" exact="human coronavirus" post="hCoV-EMCJÂ Infect67201334835023685240 37ChiH.ZhengX.WangX.WangC.WangH.GaiW.DNA vaccine encoding Middle East respiratory syndrome"/>
   <result pre="Commun52014306724473083 61XiaS.YanL.AÂ pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci Adv52019eaav458030989115 62BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the structural proteins of severe"/>
   <result pre="Virol74Pt 419937457497682252 64BakkerA.B.MarissenW.E.KramerR.A.RiceA.B.WeldonW.C.NiezgodaM.Novel human monoclonal antibody combination effectively neutralizing natural" exact="rabies virus" post="variants and individual inÂ vitro escape mutantsJÂ Virol7920059062906815994800 65QiuH.SunS.XiaoH.FengJ.GuoY.TaiW.Single-dose"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102570\results\search\virus\results.xml">
   <result pre="al., 2016). We observed a transition of influenza virus and" exact="poliovirus" post="in cultures treated with favipiravir but did not assess"/>
   <result pre="incorporated site during the elongation of herpes simplex virus and" exact="varicella-zoster virus" post="DNA and prevents viral DNA synthesis. However, the incorporated"/>
   <result pre="are guanosine analogues, function as an anti-herpes simplex virus and" exact="varicella-zoster virus" post="agent and anti-cytomegalovirus agent, respectively, with mechanisms similar to"/>
   <result pre="simplex virus resistant to acyclovir, phosphonoacetic acid, and foscarnet, a" exact="varicella-zoster virus" post="resistant to acyclovir, penciclovir, foscarnet, and vidarabine, and a"/>
   <result pre="with favipiravir We tried to isolate favipiravir-resistant influenza virus and" exact="poliovirus" post="from 28 and 10 25Â cm2 flasks, respectively, after"/>
   <result pre="Spontaneous mutation rates of the influenza virus RdRp complex and" exact="poliovirus" post="3D RdRp are both approximately 1Â Ã—Â 10âˆ’4 (Cheung"/>
   <result pre="1993; Gubareva &amp;amp; Fry, 2019). Titers of influenza virus and" exact="poliovirus" post="in the culture reach approximately 108 infectious viral particles/mL"/>
   <result pre="favipiravir-resistant mutants. We isolated susceptibility variants of influenza virus and" exact="poliovirus" post="in the cultures treated with favipiravir for a month"/>
   <result pre="Recently, mutants of influenza virus (Goldhill et al., 2018) and" exact="chikungunya virus" post="(Abdelnabi et al., 2017; Delang et al., 2014) that"/>
   <result pre="mutation in the F1 motif of the RdRp (nsP4) in" exact="chikungunya virus" post="is less susceptible to favipiravir, displays a reduced growth"/>
   <result pre="et al., 2014). The corresponding K-to-R substitution (K159R) of the" exact="chikungunya virus" post="K291R mutation was introduced in the coxsackievirus B3 RdRp,"/>
   <result pre="of the chikungunya virus K291R mutation was introduced in the" exact="coxsackievirus" post="B3 RdRp, but the engineered virus with the K159R"/>
   <result pre="placebo-controlled trial. As an example of this situation, PEP of" exact="human immunodeficiency virus" post="has been performed to protect against needle sticks or"/>
   <result pre="sent to the institution. References References AbdelnabiR.JochmansD.VerbekenE.NeytsJ.DelangL.Antiviral treatment efficiently inhibits" exact="chikungunya virus" post="infection in the joints of mice during the acute"/>
   <result pre="phosphoribosyltransferasesThe Journal of Biological Chemistry2752000202312023410816600 DaikokuT.MizuguchiM.ObitaT.YokoyamaT.YoshidaY.TakemotoM.ShirakiK.Characterization of susceptibility variants of" exact="poliovirus" post="grown in the presence of favipiravirJournal of Microbiology, Immunology,"/>
   <result pre="and emerging RNA virusesAntiviral Research1532018859429524445 DelangL.Segura GuerreroN.TasA.QueratG.PastorinoB.FroeyenM. â€¦LeyssenP.Mutations in the" exact="chikungunya virus" post="non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum"/>
   <result pre="Science232000637210699766 IdaM.KageyamaS.SatoH.KamiyamaT.YamamuraJ.KurokawaM. â€¦ShirakiK.Emergence of resistance to acyclovir and penciclovir in" exact="varicella-zoster virus" post="and genetic analysis of acyclovir-resistant variantsAntiviral Research40199915516610027650 JacobsM.AaronsE.BhaganiS.BuchananR.CropleyI.HopkinsS. â€¦RodgerA.Post-exposure"/>
   <result pre="and Chemotherapy6020164620462927185803 JulanderJ.G.ShaferK.SmeeD.F.MorreyJ.D.FurutaY.Activity of T-705 in a hamster model of" exact="yellow fever virus" post="infection in comparison with that of a chemically related"/>
   <result pre="compound, T-1106Antimicrobial Agents and Chemotherapy53200920220918955536 JulanderJ.G.SmeeD.F.MorreyJ.D.FurutaY.Effect of T-705 treatment on" exact="western equine encephalitis" post="in a mouse modelAntiviral Research82200916917119428608 KamiyamaT.KurokawaM.ShirakiK.Characterization of the DNA"/>
   <result pre="health service guidelines for the management of occupational exposures to" exact="human immunodeficiency virus" post="and recommendations for postexposure prophylaxisInfection Control and Hospital Epidemiology34201387589223917901"/>
   <result pre="in Experimental Medicine and Biology1045201810312229896665 ShirakiK.OginoT.YamanishiK.TakahashiM.Isolation of drug-resistant mutants of" exact="varicella-zoster virus" post="- cross resistance of acyclovir resistant mutants with phosphonoacetic"/>
   <result pre="TalaricoC.L.PhelpsW.C.BironK.K.Analysis of the thymidine kinase genes from acyclovir-resistant mutants of" exact="varicella-zoster virus" post="isolated from patients with AIDSJournal of Virology671993102410338380452 TanakaT.KamiyamaT.DaikokuT.TakahashiK.NomuraN.KurokawaM.ShirakiK.T-705 (Favipiravir)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7102591\results\search\virus\results.xml">
   <result pre="Development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesAcs Central Sci202010.1021/acscentsci.0c00272 76ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.-Y.Coronaviruses - drug discovery and therapeutic"/>
   <result pre="trialLancet Infect Dis11201167768310.1016/s1473-3099(11)70065-221550310 87RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya virus" post="infectionViruses10201826810.3390/v10050268 88VincentM.J.BergeronE.BenjannetS.EricksonB.R.RollinP.E.KsiazekT.G.Chloroquine is a potent inhibitor of SARS coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7105126\results\search\virus\results.xml">
   <result pre="use injectable drugs; WWNID: women who use non-injectable drugs; HIV:" exact="human immunodeficiency virus" post="Discussion The prevalence of gender-based vulnerability found in our"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7106608\results\search\virus\results.xml">
   <result pre="Advancing Translational Sciences UL1TR002369 Background Opioid use disorder (OUD) and" exact="human immunodeficiency virus" post="(HIV) are intertwined epidemics worldwide; around one-third of all"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7108526\results\search\virus\results.xml">
   <result pre="and Ritonavir are known anti-retroviral drug targeting protease of the" exact="human immunodeficiency virus" post="(HIV). However, CoVs are characterized by a 3C-like protease"/>
   <result pre="funding. Conflicts of interest None declared. References REFERENCES ChannappanavarR, PerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7110270\results\search\virus\results.xml">
   <result pre="present, and futureEpidemiology20051679180110.1097/01.ede.0000181633.80269.4c16222170 ChenLLiuWZhangQXuKYeGWuWSunZLiuFWuKZhongBRNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7118644\results\search\virus\results.xml">
   <result pre="studies involved Gilead Sciences. References References 1VassilaraF.SpyridakiA.PothitosG.DeliveliotouA.PapadopoulosA.A rare Case of" exact="human coronavirus" post="229E associated with acute respiratory distress syndrome in a"/>
   <result pre="co-factorsNat. Commun.1012019234231138817 34VabretA.DinaJ.MourezT.GouarinS.PetitjeanJ.van der WerfS.Inter- and intra-variant genetic heterogeneity of" exact="human coronavirus" post="OC43 strains in FranceJ. Gen. Virol.87Pt 1120063349335317030869 35WoganL.Legal Treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7127009\results\search\virus\results.xml">
   <result pre="severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis.2020ciaa23732150618 10ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin."/>
   <result pre="miceCell Host Microbe192201618119326867177 17ZhengJ.PerlmanS.Immune responses in influenza A virus and" exact="human coronavirus" post="infections: an ongoing battle between the virus and hostCurr."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138156\results\search\virus\results.xml">
   <result pre="sign of COVID-19 infection, suggesting involvement of the neuraxis. Another" exact="human coronavirus" post="HCoV-OC43, which is generally associated with mild upper respiratory"/>
   <result pre="etÂ al., 2016b). Reassuringly, five patients on natalizumab infected with" exact="dengue virus" post="cleared the virus without complications similar to those on"/>
   <result pre="ArbourN.CÃ´tÃ©G.LachanceC.TardieuM.CashmanN.R.TalbotP.J.Acute and persistent infection of human neural cell lines by" exact="human coronavirus" post="OC43J. Virol.7319993338335010074188 CookS.VermerschP.ComiG.GiovannoniG.RammohanK.RieckmannP.SÃ¸rensenP.S.HamlettA.MiretM.WeinerJ.VigliettaV.MuschB.GreenbergS.J.collab: CLARITY Study GroupSafety and tolerability of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7138382\results\search\virus\results.xml">
   <result pre="commercial, or not-for-profit sectors. 1 Main text SARS-CoV-2 is a" exact="human coronavirus" post="causing the COVID-19 disease. It emerged in China in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7144238\results\search\virus\results.xml">
   <result pre="5ChengXW, LuJ, WuCL, et al.Three fatal cases of pandemic 2009" exact="influenza a virus" post="infection in Shenzhen are associated with cytokine storm. Respir"/>
   <result pre="doi: 10.1007/BF0340204012865942 9WangR, ZhuY, ZhaoJ, et al.Autophagy promotes replication of" exact="influenza a virus" post="in vitro. J Virol. 2019 Feb;93(4):e01984-18. 10PankivS, ClausenTH, LamarkT,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7147535\results\search\virus\results.xml">
   <result pre="a lower severity and mortality rate than two other previous" exact="human coronavirus" post="(CoV) infections (SARS-CoV and MERS-CoV), a subgroup of patients"/>
   <result pre="bedside?PLoS ONE20149e8871610.1371/journal.pone.008871624551142 39.JossetLMenacheryVDGralinskiLEet al.Cell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7151436\results\search\virus\results.xml">
   <result pre="2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infectionsViruses122020194 2ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7155909\results\search\virus\results.xml">
   <result pre="(3CLpro). 3CLpro has been postulated to be a target of" exact="human immunodeficiency virus" post="protease inhibitors lopinavir or ritonavir, although in silico studies"/>
   <result pre="drugs that show promise. SARS-CoV-2 is an RNA virus, like" exact="human immunodeficiency virus" post="(HIV) and Ebola, and molecules developed for other RNA"/>
   <result pre="in China.Lancet Oncol2020; 21:335â€&quot;732066541 36.Geiben-LynnRGreenlandJRFrimpong-BoatengKLetvinNLKinetics of recombinant adenovirus type 5," exact="vaccinia virus," post="modified vaccinia ankara virus, and DNA antigen expression in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7162773\results\search\virus\results.xml">
   <result pre="3 CCR, creatinine clearance rate; NHC, National Health Commission; HIV," exact="human immunodeficiency virus." post="âˆ—The guidelines of the NHC did not recommend the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7167217\results\search\virus\results.xml">
   <result pre="for public health interventionsJ Clin Med202092462 TortoriciMAWallsACLangYWangCLiZKoerhuisDet al.Structural basis for" exact="human coronavirus" post="attachment to sialic acid receptorsNat Struct Mol Biol201926648148931160783 Tuite"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7169409\results\search\virus\results.xml">
   <result pre="When F and G genes were individually expressed in recombinant" exact="human parainfluenza" post="virus-type 1 (hPIV-1) constructs and tested in hamsters, the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7169770\results\search\virus\results.xml">
   <result pre="Cell Res202010.1038/s41422-020-0282-0 16KonoM, TatsumiK, ImaiAM, SaitoK, KuriyamaT, ShirasawaH. Inhibition of" exact="human coronavirus" post="229E infection in human epithelial lung cells (L132) by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7171518\results\search\virus\results.xml">
   <result pre="acid sequences in the sample vary from those of known" exact="human coronavirus" post="species. The laboratory findings also showed SARS CoV-2 is"/>
   <result pre="50BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia virus" post="protectively immunizes miceProc Natl Acad Sci1011720046641664615096611 51BuchholzU.J.BukreyevA.YangL.LamirandeE.W.MurphyB.R.SubbaraoK.Contributions of the"/>
   <result pre="monkeys of purified inactivated Vero-cell SARS vaccineVaccine24720061028103416388880 54WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.Immunization with modified" exact="vaccinia virus" post="Ankara-based recombinant vaccine against severe acute respiratory syndrome is"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174922\results\search\virus\results.xml">
   <result pre="and evolution of SARS-CoV-2Infect Genet Evolu202010.1016/j.meegid.2020.104260 26.PfeifferJKirkegaardKA single mutation in" exact="poliovirus" post="RNA-dependent RNA polymerease confers resistance to mutagenic nucleotide analogs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7174982\results\search\virus\results.xml">
   <result pre="its bioactive apocarotenoidsBiomed. Pharmacother.201810.1016/j.biopha.2017.12.090 CagnoV.CivraA.KumarR.PradhanS.DonalisioM.SinhaB.N.GhoshM.LemboD.Ficus religiosa L. bark extracts inhibit" exact="human rhinovirus" post="and respiratory syncytial virus infection in vitroJ. Ethnopharmacol.176201525225710.1016/j.jep.2015.10.04226528588 CambraL.M.A.The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7179500\results\search\virus\results.xml">
   <result pre="originated in a non-human species. The closest match to the" exact="human coronavirus" post="has been found in a bat in Chinaâ€™s Yunnan"/>
   <result pre="(SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infectionsViruses122020194 15WongS.F.ChowK.M.LeungT.N.Pregnancy and perinatal outcomes of women with severe"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180238\results\search\virus\results.xml">
   <result pre="coronaviruses. Trends Microbiol24:490â€&quot;502. doi:10.1016/j.tim.2016.03.003.27012512 19.ForniD, CaglianiR, ClericiM, SironiM2017Molecular evolution of" exact="human coronavirus" post="genomes. Trends Microbiol25:35â€&quot;48. doi:10.1016/j.tim.2016.09.001.27743750 20.WangM, XuHF, ZhangZB, ZouXZ, GaoY,"/>
   <result pre="non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during" exact="human coronavirus" post="229E replication. Antiviral Res173:104620. doi:10.1016/j.antiviral.2019.104620.31634494"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7180381\results\search\virus\results.xml">
   <result pre="the recent emergence in East Africa and global spread of" exact="chikungunya virus" post="(CHIKV) [8], as well as the ongoing and expanding"/>
   <result pre="virus (CHIKV) [8], as well as the ongoing and expanding" exact="dengue virus" post="(DENV) pandemic in the tropics and subtropics [9] have"/>
   <result pre="DENV, but it has also been found to exist for" exact="rabies virus," post="coxsackievirus B3, coronaviruses, and even HIV. To answer the"/>
   <result pre="it has also been found to exist for rabies virus," exact="coxsackievirus" post="B3, coronaviruses, and even HIV. To answer the question,"/>
   <result pre="route in a Phase 1 clinical trial; and a chimeric" exact="measles virus" post="vaccine that expresses the prM and E genes of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7182166\results\search\virus\results.xml">
   <result pre="2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infectionsViruses32020SchwartzDAGrahamAL0122020 19A novel coronavirus from patients with pneumonia in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7185310\results\search\virus\results.xml">
   <result pre="or enhancement of disease as illustrated in the case of" exact="dengue virus" post="infection (23). Currently, major efforts are underway to develop"/>
   <result pre="observed involve chronic infection with various viruses such as the" exact="human immunodeficiency virus" post="(HIV), lymphocytic choriomeningitis, hepatitis, or herpes viruses (3,4,14,18â€&quot;20,25,28). In"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7186945\results\search\virus\results.xml">
   <result pre="putting the whole world on alertJ Hosp Infect2020104325225332032614 50.TalbotPJEkandeSCashmanNRMounirSStewartJNNeurotropism of" exact="human coronavirus" post="229EAdv Exp Med Biol19933423393468209751 51.MengelingWLBootheADRitchieAECharacteristics of a coronavirus (strain"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7189412\results\search\virus\results.xml">
   <result pre="2011; Zhu etÂ al., 2020). Even though the majority of" exact="human coronavirus" post="infections are mild, the epidemics of two betacoronaviruses (Î²CoV),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190393\results\search\virus\results.xml">
   <result pre="virus, a murine coronavirus, is a close relative of common" exact="human coronavirus" post="HCoV-OC43, which causes a multiple sclerosis-like demyelinating disease in"/>
   <result pre="HCoV-229E, MHV, and IBV [40]. A similar study involving the" exact="human coronavirus" post="HCoV-NL63 likewise demonstrated that HCoV-NL63 exhibited signs of having"/>
   <result pre="evidence of antigenic relatedness between human enteric coronavirus strains and" exact="human coronavirus" post="OC43Microbiologica1984731532210.1016/j.jcv.2010.03.0076083436 29.Recent news from WHO. Bull World Health Organ."/>
   <result pre="WildeAHSnijderEJKikkertMvan HemertMJHost factors in coronavirus replicationCurr Top Microbiol Immunol201841914210.1007/82_2017_2528643204 33.ArdenKENissenMDSlootsTPMackayIMNew" exact="human coronavirus," post="HCoV-NL63, associated with severe lower respiratory tract disease in"/>
   <result pre="tract infections in Korean children, 2000â€&quot;2005Clin Infect Dis20064358559210.1086/50635016886150 37.EbiharaTEndoRMaXIshiguroNKikutaHDetection of" exact="human coronavirus" post="NL63 in young children with bronchiolitisJ Med Virol20057546346510.1002/jmv.2028915648061 38.EsperFWeibelCFergusonDLandryMLKahnJSCoronavirus"/>
   <result pre="of the SARS-associated coronavirusArch Virol200515012010.1007/s00705-004-0413-915480857 41.PyrcKDijkmanRDengLJebbinkMFRossHABerkhoutBvan der HoekLMosaic structure of" exact="human coronavirus" post="NL63, one thousand years of evolutionJ Mol Biol.200636496497310.1016/j.jmb.2006.09.07417054987"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7190742\results\search\virus\results.xml">
   <result pre="research Epidemiology Introduction The global hepatitis C virus (HCV) and" exact="human immunodeficiency virus" post="(HIV) pandemics affect 71 and 36.9 million people, respectively,"/>
   <result pre="sex workers in Calcutta, IndiaArchives of virology20051502117212410.1007/s00705-005-0562-515959835 22.SahniAKPrasadVVSethPGenomic diversity of" exact="human immunodeficiency virus" post="type-1 in IndiaInt J STD AIDS20021311511810.1258/095646202192474911839166 23.KhanIFVajpayeeMPrasadVVSethPGenetic diversity of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194560\results\search\virus\results.xml">
   <result pre="CoV proteases [19,20], Hepatitis C virus RNA-dependent RNA polymerase [21]," exact="dengue virus" post="[22] and Ebola virus [23]. In this work, we"/>
   <result pre="compounds discovered by virtual screening of smallâˆ’ molecule libraries against" exact="dengue virus" post="E proteinACS Chem. Biol.3200876577519053243 23RajU.VaradwajP.K.Flavonoids as multi-target inhibitors for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7194797\results\search\virus\results.xml">
   <result pre=", ciaa310, 10.1093/cid/ciaa310. 28GaoX.ZhouH.WuC.Antibody against nucleocapsid protein predicts susceptibility to" exact="human coronavirus" post="infectionJÂ Infect715201559960226165609 29WangW.XuYGao R.Detection of SARS-CoV-2 in different types"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7196923\results\search\virus\results.xml">
   <result pre="McLellanJ. S., &amp;amp; WardA. B. (2016). Pre-fusion structure of a" exact="human coronavirus" post="spike protein. Nature, 531(7592), 118â€&quot;121. 10.1038/nature1720026935699 KoenigK. L. (2015)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7197622\results\search\virus\results.xml">
   <result pre="therapy has proven effective in improving hyperlipidaemia in patients with" exact="human immunodeficiency virus" post="receiving protease inhibitor treatment10 and in patients with rheumatoid"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7198433\results\search\virus\results.xml">
   <result pre="approach to detect the presence of norovirus, antibiotic-resistant bacteria, the" exact="poliovirus" post="and the measles virus in wastewater [5].Few weeks later"/>
   <result pre="the presence of norovirus, antibiotic-resistant bacteria, the poliovirus and the" exact="measles virus" post="in wastewater [5].Few weeks later COVID-19 virus was detected"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7199731\results\search\virus\results.xml">
   <result pre="remains active. Abstract The recent epidemic outbreak of a novel" exact="human coronavirus" post="called SARS-CoV-2 and causing the respiratory tract disease COVID-19"/>
   <result pre="mouse hepatitis virus ACE2, Angiotensin I converting enzyme 2 HIV," exact="human immunodeficiency virus" post="IVIg, intravenous gammaglobulin PLP, papain-like protease LPV, Lopinavir RTV,"/>
   <result pre="different infectious diseases, such as measles, diarrheal disease, measles-related pneumonia," exact="human immunodeficiency virus" post="(HIV) infection, and malaria, as described by Semba et"/>
   <result pre="deficiency had been reported to intensify the myocardial injury of" exact="coxsackievirus" post="B3 (a kind of RNA viruses) infection in mice"/>
   <result pre="the enzymatic activity of MERS-CoV/3CLpro [98]. Papain-like protease (PLP) of" exact="human coronavirus" post="is a novel viral-encoded deubiquitinase and is an IFN"/>
   <result pre="oxidative stress (Beck, Kolbeck et al., 1994) PUFAa Influenza virus," exact="human immunodeficiency virus" post="Antiâ€�inflammatory and proâ€�inflammatory effects. (Morita, Kuba et al., 2013)"/>
   <result pre="35PatelH.KukolA.Prediction of ligands to universally conserved binding sites of the" exact="influenza a virus" post="nuclear export proteinVirology53720199710331542626 36SrinivasanS.CuiH.GaoZ.LiuM.LuS.MkandawireW.NarykovO.SunM.KorkinD.Structural Genomics of SARS-CoV-2 Indicates Evolutionary"/>
   <result pre="Res. Commun.336200511011716112641 52LoY.-S.LinS.-Y.WangS.-M.WangC.-T.ChiuY.-L.HuangT.-H.Oligomerization of the carboxyl terminal domain of the" exact="human coronavirus" post="229E nucleocapsid proteinFEBS Lett.587201312012723178926 53ChenI.-J.YuannJ.-M.P.ChangY.-M.LinS.-Y.ZhaoJ.PerlmanS.Crystal structure-based exploration of the"/>
   <result pre="the important role of Arg106 in the RNA-binding domain of" exact="human coronavirus" post="OC43 nucleocapsid proteinBiochim. Biophys. Acta Protein Proteonomics1834201310541062 54ChangC-kChenC.-M.M.ChiangM-hHsuY-lHuangT-hTransient oligomerization"/>
   <result pre="Dairy Sci.9720145566557925022687 82BeckM.A.KolbeckP.C.RohrL.H.ShiQ.MorrisV.C.LevanderO.A.Vitamin E deficiency intensifies the myocardial injury of" exact="coxsackievirus" post="B3 infection of miceJ. Nutr.12419943453588120653 83MoritaM.KubaK.IchikawaA.NakayamaM.KatahiraJ.IwamotoR.The lipid mediator protectin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7200052\results\search\virus\results.xml">
   <result pre="in a credit line to the data. Abstract A new" exact="human coronavirus" post="named SARS-CoV-2 was identified in several cases of acute"/>
   <result pre="to other emerging zoonotic RNA viruses. SARS-CoV-2 is a new" exact="human coronavirus" post="identified in patients with acute respiratory syndrome in Wuhan,"/>
   <result pre="coronaviruses in miceSci Transl Med202010.1126/scitranslmed.abb588332253226 23.MendesEAPilgerDRBSantos NastriACSMaltaFMPascoalinoBDSCarneiro Dâ€™AlbuquerqueLAet al.Sofosbuvir inhibits" exact="yellow fever virus" post="in vitro and in patients with acute liver failureAnn"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7202545\results\search\virus\results.xml">
   <result pre="the magnitude and quality of viral-specific CD8+ T-cell responses to" exact="vaccinia virus" post="vaccination in rhesus macaques.Am J Transplant. 2011; 11:613â€&quot;18. 10.1111/j.1600-6143.2010.03407.x21342450"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7203261\results\search\virus\results.xml">
   <result pre="there is still no licensed specific antiviral treatment for the" exact="human coronavirus" post="disease and a vaccine will not be ready soon."/>
   <result pre="there is still no licensed specific antiviral treatment for the" exact="human coronavirus" post="disease and a vaccine will not be ready soon."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7211730\results\search\virus\results.xml">
   <result pre="et al., 2014), but also glomerulonephritis, severe spontaneous colitis, asthma," exact="dengue virus" post="disease (Jain et al., 2013), and swine flu determined"/>
   <result pre="2003). Significantly, selenoproteins regulate immunity in numerous infectious diseases, including" exact="human immunodeficiency virus" post="infection (Avery and Hoffmann, 2018). Under acute infections, such"/>
   <result pre="p56lck is required for triggering NF-ÎºB activation upon interaction of" exact="human immunodeficiency virus" post="type 1 envelope glycoprotein gp120 with cell surface CD4J."/>
   <result pre="Hematol.47201292â€&quot;10410.5045/kjh.2012.47.2.9222783355 IbsK.H.RinkL.Zinc-altered immune functionJ. Nutr.13320031452145610.1093/jn/133.5.1452S JainA.PandeyN.GargR.K.KumarR.IL-17 level in patients with" exact="dengue virus" post="infection &amp;amp; its association with severity of illnessJ. Clin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7214230\results\search\virus\results.xml">
   <result pre="past 18Â years, the beginning of severe acute respiratory syndrome" exact="human coronavirus" post="(SARS-HCoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and now"/>
   <result pre="the advent of the world epidemic, severe acute respiratory syndrome" exact="human coronavirus" post="(SARS-HCoV) in 2002â€&quot;2003 reintroduced the family Coronaviridae [3, 14]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7215134\results\search\virus\results.xml">
   <result pre="in a credit line to the data. Abstract The new" exact="human coronavirus" post="named SARS-CoV-2 is a positive-sense RNA virus for which"/>
   <result pre="to potentially deadly COVID19. Funding http://dx.doi.org/10.13039/100010677H2020 Health 643638BuonaguroLuigi A new" exact="human coronavirus" post="named SARS-CoV-2 was identified in several cases of acute"/>
   <result pre="left behindInt J Antimicrob Agents20195375576010.1016/j.ijantimicag.2018.12.01030605721 14.MendesEAPilgerDRBSantos NastriACSMaltaFMPascoalinoBDSCarneiro D'AlbuquerqueLAet al.Sofosbuvir inhibits" exact="yellow fever virus" post="in vitro and in patients with acute liver failureAnn"/>
   <result pre="and in patients with acute liver failureAnn Hepatol20191881682410.1016/j.aohep.2019.09.00131594756 15.JiangWMuhammadFMaPLiuXLongGSofosbuvir inhibits" exact="hepatitis a virus" post="replication in vitro assessed by a cell-based fluorescent reporter"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7216760\results\search\virus\results.xml">
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseases. ACS Cent. Sci.6 (3), 315â€&quot;331. 10.1021/acscentsci.0c00272.32226821 de HaanC."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7217786\results\search\virus\results.xml">
   <result pre="brief perspective from the front lineJÂ Infect80202037337732109444 34ChafekarA.FieldingB.C.MERS-CoVUnderstanding the latest" exact="human coronavirus" post="threatViruses102018 35JhaveriR.Echoes of 2009 H1N1 influenza pandemic in the"/>
   <result pre="during 2010-2015 in GuangzhouPloS One132018e0191789 79CabecaT.K.GranatoC.BelleiN.Epidemiological and clinical features of" exact="human coronavirus" post="infections among different subsets of patientsInfluenza Other Respir Viruses720131040104723462106"/>
   <result pre="105PeneF.MerlatA.VabretA.RozenbergF.BuzynA.DreyfusF.Coronavirus 229E-related pneumonia in immunocompromised patientsClin Infect Dis37200392993213130404 106EbiharaT.EndoR.MaX.IshiguroN.KikutaH.Detection of" exact="human coronavirus" post="NL63 in young children with bronchiolitisJÂ Med Virol75200546346515648061 107GuarnerJ.Falcon-EscobedoR.Comparison"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7222554\results\search\virus\results.xml">
   <result pre="for rapid and accurate diagnostic test of MERS-CoV: a novel" exact="human coronavirus," post="ahead of Hajj pilgrimage. Iran Red. Crescent. Med. J.18(11),"/>
   <result pre="the spike proteins of severe acute respiratory syndrome coronavirus and" exact="human coronavirus" post="NL63. J. Virol.84(2), 1198â€&quot;1205 (2010).19864379 136.KruseRLTherapeutic strategies in an"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseases. ACS Central Sci.6(3), 315â€&quot;331 (2020)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7228359\results\search\virus\results.xml">
   <result pre="T., &amp;amp; Keppler, O. T. (2005). The Nef protein of" exact="human immunodeficiency virus" post="establishes superinfection immunity by a dual strategy to downregulate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7230702\results\search\virus\results.xml">
   <result pre="effect of RS revealed that RS showed suppressing effects on" exact="human immunodeficiency virus" post="(HIV), human cytomegalovirus (HCMV), and herpes simplex virus types"/>
   <result pre="that RS showed suppressing effects on human immunodeficiency virus (HIV)," exact="human cytomegalovirus" post="(HCMV), and herpes simplex virus types 1 and 2"/>
   <result pre="RS has an antiviral effect on enveloped viruses, such as" exact="measles virus," post="mump virus, influenza A virus, and human corona virus,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7231470\results\search\virus\results.xml">
   <result pre="7231470 pmid: 32314559zr-41-3-213 doi: 10.24272/j.issn.2095-8137.2020.031 : Commentary Zoonotic origins of" exact="human coronavirus" post="2019 (HCoV-19 / SARS-CoV-2): why is this work important?"/>
   <result pre="pandemic of coronavirus disease 2019 (COVID-19), caused by infection with" exact="human coronavirus" post="2019 (HCoV-19 / SARS-CoV-2 / 2019-nCoV), is a global"/>
   <result pre="al., 2020). Caused by another novel coronavirus, known as the" exact="human coronavirus" post="2019 (HCoV-19, also named by various bodies as SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7232622\results\search\virus\results.xml">
   <result pre="therapy users in Malawi: a record linkage study of observational" exact="human immunodeficiency virus" post="cohorts and cancer registry data. Clin Infect Dis. 13DhokoteraT,"/>
   <result pre="HobbinsM, et al.Absence of active hepatitis C virus infection in" exact="human immunodeficiency virus" post="clinics in Zambia and Mozambique. Open Forum Infect Dis2016;3:ofw049."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7233243\results\search\virus\results.xml">
   <result pre="of different viral diseases: for example, anti-retroviral therapy against the" exact="human immunodeficiency virus" post="(HIV), or the pan-genotypic direct-acting antiviral drugs used for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235275\results\search\virus\results.xml">
   <result pre="22.SellersSADoverKLBaileyAGChevesAEasonABPopowitchEBet al.. Burden of respiratory viral infection in persons with" exact="human immunodeficiency virus." post="Influenza Other Respir Viruses. (2020). 10.1111/irv.12734. [Epub ahead of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235449\results\search\virus\results.xml">
   <result pre="symptoms with other endemic mosquito-borne pathogens in the region, including" exact="chikungunya virus," post="dengue virus and malaria, ONNV infections are often un-"/>
   <result pre="other endemic mosquito-borne pathogens in the region, including chikungunya virus," exact="dengue virus" post="and malaria, ONNV infections are often un- or misdiagnosed."/>
   <result pre="endemic infectious diseases with more pronounced, overlapping symptoms, such as" exact="chikungunya virus" post="(CHIKV), dengue virus (DENV) or malaria. ONNV has been"/>
   <result pre="with more pronounced, overlapping symptoms, such as chikungunya virus (CHIKV)," exact="dengue virus" post="(DENV) or malaria. ONNV has been the cause of"/>
   <result pre="previously been performed successfully for different viral pathogens, such as" exact="dengue virus" post="(33), human immunodeficiency virus (34) and zika virus (35)."/>
   <result pre="successfully for different viral pathogens, such as dengue virus (33)," exact="human immunodeficiency virus" post="(34) and zika virus (35). In light of the"/>
   <result pre="such as dengue virus (33), human immunodeficiency virus (34) and" exact="zika virus" post="(35). In light of the underestimated ONNV epidemics that"/>
   <result pre="Dis. (1999) 180:1436â€&quot;43. 10.1086/31507310515801 7.KamYWPokKYEngKETanLKKaurSLeeWWLet al.. Sero-prevalence and cross-reactivity of" exact="chikungunya virus" post="specific anti-E2EP3 antibodies in arbovirus-infected patients. PLoS Negl Trop"/>
   <result pre="56:166â€&quot;72. 10.1016/0035-9203(62)90144-X14038061 9.LaBeaudADBandaTBrichardJMuchiriEMMungaiPLMutukuFMet al.. High rates of o'nyong nyong and" exact="chikungunya virus" post="transmission in coastal kenya. PLoS Negl Trop Dis. (2015)"/>
   <result pre="12.KamY-WLeeWWLSimarmataDHarjantoSTengT-STolouHet al.. Longitudinal analysis of the human antibody response to" exact="chikungunya virus" post="infection: implications for serodiagnosis and vaccine development. J Virol."/>
   <result pre="assays. PLoS ONE. (2011) 6:e28923. 10.1371/journal.pone.002892322205980 14.ChanYTeoTUttATanJJAmrunSNAbu BakarFet al.. Mutating" exact="chikungunya virus" post="non-structural protein produces potent live-attenuated vaccine candidate. EMBO Mol"/>
   <result pre="16.TeoTHLumFMClaserCLullaVLullaAMeritsAet al.. A pathogenic role for CD4+ T cells during" exact="chikungunya virus" post="infection in mice. J Immunol. (2013) 190:259â€&quot;69. 10.4049/jimmunol.120217723209328 17.BechtEMcInnesLHealyJDutertreCAKwokIWHNgLGet"/>
   <result pre="Alliance. (2019) 2:e201900298. 10.26508/lsa.20190029830665948 22.TeoT-HHerZTanJJLLumFLeeWWLChanY-Het al.. Caribbean and la rÃ©union" exact="chikungunya virus" post="isolates differ in their capacity to induce proinflammatory Th1"/>
   <result pre="J Pathol. (2011) 178:32â€&quot;40. 10.1016/j.ajpath.2010.11.01821224040 24.CarissimoGNgLFP. Understanding molecular pathogenesis with" exact="chikungunya virus" post="research tools. Curr Top Microbiol Immunol. (2019) 10.1007/82_2019_15830888547 25.LevineJHSimondsEFBendallSCDavisKLAmirEADTadmorMDet"/>
   <result pre="al.. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls" exact="chikungunya virus" post="arthritis. Sci Transl Med. (2017) 9:eaah3438. 10.1126/scitranslmed.aah343828148840 27.RowellJFGriffinDE. Contribution"/>
   <result pre="10.1126/scitranslmed.aah343828148840 27.RowellJFGriffinDE. Contribution of T cells to mortality in neurovirulent" exact="sindbis virus" post="encephalomyelitis. J Neuroimmunol. (2002) 127:106â€&quot;14. 10.1016/S0165-5728(02)00108-X12044981 28.TeoTChanYLeeWWLLumFAmrunSNHerZet al.Fingolimod treatment"/>
   <result pre="Emerg Infect Dis. (1997) 3:77. 10.3201/eid0301.9701129126450 31.FraserJR. Epidemic polyarthritis and" exact="ross river virus" post="disease. Clin Rheum Dis. (1986) 12:369â€&quot;88. 3026719 32.SuhrbierAJaffar-BandjeeMCGasqueP. Arthritogenic"/>
   <result pre="33.MalakarSSreelathaLDechtawewatTNoisakranSYenchitsomanusPThai ChuJJHet al.. Drug repurposing of quinine as antiviral against" exact="dengue virus" post="infection. Virus Res. (2018) 255:171â€&quot;8. 10.1016/j.virusres.2018.07.01830055216 34.ClouserCLPattersonSEManskyLM. Exploiting drug"/>
   <result pre="Virol. (2010) 84:9301â€&quot;9. 10.1128/JVI.01006-1020610712 35.ChengFMurrayJLRubinDH. Drug repurposing: new treatments for" exact="zika virus" post="infection?Trends Mol Med. (2016) 22:919â€&quot;21. 10.1016/j.molmed.2016.09.00627692879"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235487\results\search\virus\results.xml">
   <result pre="combination therapies that optimally inhibit A549 lung cell infection by" exact="vesicular stomatitis virus" post="within three days of project start. Importantly, a sevenfold"/>
   <result pre="initiated.[8] Treatment options explored to address COVIDâ€�19 have included repurposed" exact="human immunodeficiency virus" post="(HIV) and influenzaâ€�related monotherapies and drug cocktails, trials of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7235633\results\search\virus\results.xml">
   <result pre="antiviral activity was observed in mouse models, including for the" exact="human coronavirus" post="OC439 and influenza A virus H5N1.10 However, in a"/>
   <result pre="Res2020; 30: 269â€&quot;271.32020029 9KeyaertsELiSVijgenL, et al.Antiviral activity of chloroquine against" exact="human coronavirus" post="OC43 infection in newborn mice. Antimicrob Agents Chemother2009; 53:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7236962\results\search\virus\results.xml">
   <result pre="encephalitisVaccine.2009274D80D8519837294 22.MedinaGGarzaroDJBarriosMAugusteAJWeaverSCPujolFHGenetic diversity of venezuelan alphaviruses and circulation of a" exact="venezuelan equine encephalitis" post="virus subtype IAB strain during an interepizootic periodAm J"/>
   <result pre="TrinidadZoonoses Public Health.2015621536024751420 31.Sotomayor-BonillaJAbellaCChavesAÃ�lvarezPRico-ChÃ¡vezOIbÃ¡Ã±ezSPotential sympatric vectors and mammalian hosts of" exact="venezuelan equine encephalitis" post="virus in Southern MexicoJ Wildl Dis201753365766128384059 32.PoddarSHydeJLGormanMJFarzanMDiamondMSThe interferon-stimulated gene"/>
   <result pre="33.LondonWTLevittNHKentSGWongVSeverJLCongenital cerebral and ocular malformations induced in rhesus monkeys by" exact="venezuelan equine encephalitis" post="virusTeratology.197716285296413204 34.ZacksMAPaesslerSEncephalitic alphavirusesVet Microbiol201014028128619775836 35.GuerboisMVolkovaEForresterNLRossiSLFrolovIWeaverSCet al.IRES-driven expression of the"/>
   <result pre="Microbiol201014028128619775836 35.GuerboisMVolkovaEForresterNLRossiSLFrolovIWeaverSCet al.IRES-driven expression of the capsid protein of the" exact="venezuelan equine encephalitis" post="virus TC-83 vaccine strain increases its attenuation and safetyPLoS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7237932\results\search\virus\results.xml">
   <result pre="and SARS-CoV-2 (Zhou etÂ al., 2020) as well as for" exact="human coronavirus" post="NL63. The receptor for the Middle East respiratory syndrome"/>
   <result pre="syndrome (MERS) coronavirus is human dipeptidyl peptidase 4 (DPP4), and" exact="human coronavirus" post="229E uses aminopeptidase N as its receptor. All influenza"/>
   <result pre="with a cough and shortness of breath. Rhinovirus, adenovirus, and" exact="human coronavirus" post="infections are usually limited to the upper respiratory tract."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238163\results\search\virus\results.xml">
   <result pre="Aedes aegypti was suspected to be a vector of the" exact="yellow fever virus" post="by Beauperthuy and later Finlay since the middle of"/>
   <result pre="of mosquitoes currently formally described, less than 30 transmit the" exact="yellow fever virus," post="either naturally or in the laboratory. In other words,"/>
   <result pre="more than 3500 species of mosquitoes do not transmit the" exact="yellow fever virus." post="They are not guilty. There are many reasons for"/>
   <result pre="of Yellow Fever: Once Upon a Time in America The" exact="yellow fever virus" post="circulates in African forests from monkey to monkey, transmitted"/>
   <result pre="urbanisation and able to generate outbreaks. This village or urban" exact="yellow fever virus," post="already adapted to human and Ae. aegypti, was introduced"/>
   <result pre="are involved in the entry and exit of flaviviruses, like" exact="yellow fever virus" post="[33]. Just this intrinsic biology of the mosquito is"/>
   <result pre="Haemagogus, and Sabethes have the capacity to replicate and transmit" exact="yellow fever virus" post="to primates, i.e. (1) possess the receptors for cellular"/>
   <result pre="albopictus, in a pattern similar to the emergence of the" exact="yellow fever virus" post="in Africa from forests to villages [12]. In Laos,"/>
   <result pre="new vectors and a better transmissibility, as happened with the" exact="chikungunya virus" post="and Ae. albopictus [52]. Viruses may also evolve resistance"/>
   <result pre="MottaM.Barreto dos SantosF.VazeilleM.VasconcelosP.F.Lourenco-de-OliveiraR.FaillouxA.B.Potential risk of re-emergence of urban transmission of" exact="yellow fever virus" post="in Brazil facilitated by competent Aedes populationsSci. Rep.20177484810.1038/s41598-017-05186-328687779 24.Moreira-SotoA.TorresM.C.Lima"/>
   <result pre="NogueiraR.M.et al.Evidence for multiple sylvatic transmission cycles during the 2016â€&quot;2017" exact="yellow fever virus" post="outbreak, BrazilClin. Microbiol. Infect.201824101910.1016/j.cmi.2018.01.026 25.LemosP.S.MonteiroH.A.O.CastroF.C.LimaC.P.S.SilvaD.E.A.VasconcelosJ.M.OliveiraL.F.SilvaS.P.CardosoJ.F.Vianez-JÃºniorJ.L.S.G.et al.CaracterizaÃ§Ã£o do genoma mitocondrial"/>
   <result pre="Aedes albopictusEmerg. Microbes Infect.201981265127910.1080/22221751.2019.165778531469046 33.SmithD.R.An update on mosquito cell expressed" exact="dengue virus" post="receptor proteinsInsect Mol. Biol.2012211710.1111/j.1365-2583.2011.01098.x21895818 34.CombesC.Parasitism: The Ecology and Evolution"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238722\results\search\virus\results.xml">
   <result pre="remdesivir, aÂ broad-spectrum antiviral drug, shows the most promise for" exact="human coronavirus" post="infections. It has superior activity against MERS-CoV in vitro,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7238951\results\search\virus\results.xml">
   <result pre="persons who inject drugs and heightened concern about increases in" exact="human immunodeficiency virus" post="(HIV) and HCV infection within communities disproportionately affected by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7239338\results\search\virus\results.xml">
   <result pre="herpes simplex virus, influenza, hepatitis B virus, Varicella zoster virus," exact="human cytomegalovirus," post="respiratory syncytial virus, and human papillomavirus), with antiâ€�HIV and"/>
   <result pre="Zaire ebolavirus, Sudan ebolavirus, TaÃ¯ Forest ebolavirus, and Bundibugyo ebolavirus.14Zaire" exact="ebolavirus" post="is the causative specie of the 2013â€&quot;2016 West Africa"/>
   <result pre="units with Ebola virus Gabon 2001 strain, belonging to Zaire" exact="ebolavirus" post="species. Viral load was detectable in most animals at"/>
   <result pre="387â€&quot;418 (2017).27959626 20Towner, J.S.et alGeneration of eGFP expressing recombinant Zaire" exact="ebolavirus" post="for analysis of early pathogenesis events and highâ€�throughput antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7241406\results\search\virus\results.xml">
   <result pre="source of nosocomial infections?Eye3220181021102729379104 16OYongK.KillerbyM.PanC.Y.Outbreak of epidemic keratoconjunctivitis caused by" exact="human adenovirus" post="type D53 in an eye Care clinic - los"/>
   <result pre="Natl Acad Sci U S A1062009199701997419901337 40LiW.SuiJ.HuangI.C.KuhnJ.H.The S proteins of" exact="human coronavirus" post="NL63 and severe acute respiratory syndrome coronavirus bind overlapping"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7242729\results\search\virus\results.xml">
   <result pre="Canarias (FIISC) (PIFUN11/18). References References 1.ChafekarAFieldingBC. MERS-CoV: understanding the latest" exact="human coronavirus" post="threat. Viruses. (2018) 10:E93. 10.3390/v1002009329495250 2.FlahaultA. Has China faced"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7243793\results\search\virus\results.xml">
   <result pre="of a series of potent and highly selective inhibitors of" exact="human coronavirus" post="papain-like proteasesJ.Â Med. Chem.5720142393241224568342 29GhoshA.K.TakayamaJ.RaoK.V.RatiaK.ChaudhuriR.MulhearnD.C.LeeH.NicholsD.B.BalijiS.BakerS.C.Severe acute respiratory syndrome coronavirus"/>
   <result pre="Chem.202010.2174/0929867327666200114115632 37XiaS.YanL.XuW.AgrawalA.S.AlgaissiA.TsengC.K.WangQ.DuL.TanW.WilsonI.A.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci. Adv.52019eaav458030989115 38FurutaY.TakahashiK.ShirakiK.SakamotoK.SmeeD.F.BarnardD.L.GowenB.B.JulanderJ.G.MorreyJ.D.T-705 (favipiravir) and related compounds: novel broad-spectrum"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7246053\results\search\virus\results.xml">
   <result pre="products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified" exact="vaccinia virus" post="Ankara (MVA)Infect Dis Ther4201549126416214 44Kirk-BayleyJ.SunkaraneniS.ChallacombeS.The use of povidone iodine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7247743\results\search\virus\results.xml">
   <result pre="Various uses including metabolic acidosis. Cetylpyridinium chloride Influenza, hepatitis B," exact="poliovirus" post="1 Targets capsid and is lysosomotropic Yes, GRAS Antiseptic,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7249615\results\search\virus\results.xml">
   <result pre="prefusion conformationScience (New York, NY)202036764831260126310.1126/science.abb2507 13.KirchdoerferRNCottrellCAWangNPallesenJYassineHMTurnerHLet al.Pre-fusion structure of a" exact="human coronavirus" post="spike proteinNature2016531759211812110.1038/nature1720026935699 14.LuRZhaoXLiJNiuPYangBWuHet al.Genomic characterisation and epidemiology of 2019"/>
   <result pre="and COVID-19Antiviral Res202017710476210.1016/j.antiviral.2020.10476232147496 71.KeyaertsELiSVijgenLRysmanEVerbeeckJVan RanstMet al.Antiviral activity of chloroquine against" exact="human coronavirus" post="OC43 infection in newborn miceAntimicrob Agents Chemother20095383416342110.1128/aac.01509-0819506054 72.TanYWYamWKSunJChuJJHAn evaluation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7250111\results\search\virus\results.xml">
   <result pre="These had tested the efficacy of CQ and HCQ in" exact="human immunodeficiency virus" post="(HIV), dengue, chikungunya, hepatitis C and COVID-19 infections. A"/>
   <result pre="evidence and strength of recommendationsBMJ336200892418436948 17SperberK.LouieM.KrausT.PronerJ.SapiraE.LinS.Hydroxychloroquine treatment of patients with" exact="human immunodeficiency virus" post="type 1Clin Ther1719956226368565026 18SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.Comparison of hydroxychloroquine with zidovudine in"/>
   <result pre="18SperberK.ChiangG.ChenH.RossW.ChusidE.GoncharM.Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with" exact="human immunodeficiency virus" post="type 1Clin Ther1919979139239385480 19EngchanilC.KosalaraksaP.LumbiganonP.LulitanondV.PongjunyakulP.ThuennadeeR.Therapeutic potential of chloroquine added to"/>
   <result pre="and chloroquine treatmentVector Borne Zoonotic Dis8200883783918620511 31de LamballerieX.NinoveL.CharrelR.N.Antiviral treatment of" exact="chikungunya virus" post="infectionInfect Disord Drug Targets9200910110419275698 32RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.Paradoxical effect of chloroquine treatment"/>
   <result pre="Disord Drug Targets9200910110419275698 32RoquesP.ThibervilleS.D.Dupuis-MaguiragaL.LumF.M.LabadieK.MartinonF.Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya virus" post="infectionViruses102018 33RavindranV.AliasG.Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252029\results\search\virus\results.xml">
   <result pre="other innate immune cells. IRIS is a phenomenon described in" exact="human immunodeficiency virus" post="(HIV) patients with severe lymphopenia and underlying opportunistic infections,"/>
   <result pre="antiviral activity The combination of two antiviral molecules (lopinavir, a" exact="human immunodeficiency virus" post="type 1 aspartate protease inhibitor, plus ritonavir, an inhibitor"/>
   <result pre="Updated April 6, 2020. Accessed June 9, 2020. https://www.niaid.nih.gov/diseases-conditions/covid-19. 2ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252082\results\search\virus\results.xml">
   <result pre="Acad Sci U S A113502016 Dec 13144081441327911847 27LiC.ZuS.DengY.-Q.Azithromycin protects against" exact="zika virus" post="infection by upregulating virus-induced type I and III interferon"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7252421\results\search\virus\results.xml">
   <result pre="from the chinese center for disease control and preventionJAMA202010.1001/jama.2020.264832275295 4.ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
   <result pre="fibrosisBr J Pharmacol201316947749223488800 25.YeagerCLAshmunRAWilliamsRKCardellichioCBShapiroLHLookATHolmesKVHuman aminopeptidase N is a receptor for" exact="human coronavirus" post="229ENature19923574204221350662 26.TurnerAJHiscoxJAHooperNMACE2: from vasopeptidase to SARS virus receptorTrends Pharmacol"/>
   <result pre="HoekLReplication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by" exact="human coronavirus" post="NL63J Gen Virol2012931924192922718567 32.KubaKImaiYRaoSGaoHGuoFGuanBHuanYYangPZhangYDengWBaoLZhangBLiuGWangZChappellMLiuYZhengDLeibbrandtAWadaTSlutskyASLiuDQinCJiangCPenningerJMA crucial role of angiotensin converting"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256451\results\search\virus\results.xml">
   <result pre="binds to a different receptor, Dipeptidyldipeptidase4 (DPP4) (19), and another" exact="human coronavirus," post="HCoV-229E, uses aminopeptidase N (APN) as its receptor (20)."/>
   <result pre="Proc Natl Acad Sci USA. (2009) 106:19970â€&quot;4. 10.1073/pnas.090883710619901337 16.Abdul-RasoolSFieldingBC. Understanding" exact="human coronavirus" post="HCoV-NL63. Open Virol J. (2010) 4:76â€&quot;84. 10.2174/187435790100401007620700397 17.MathewsonACBishopAYaoYKempFRenJChenHet al.."/>
   <result pre="10.1038/cr.2013.9223835475 20.YeagerCLAshmunRAWilliamsRKCardellichioCBShapiroLHLookATet al.. Human aminopeptidase N is a receptor for" exact="human coronavirus" post="229E. Nature. (1992) 357:420â€&quot;2. 10.1038/357420a01350662 21.WilsonJRBrownNJ. Examining EXAMINE for"/>
   <result pre="Hypertension. (2016) 68:549â€&quot;51. 10.1161/HYPERTENSIONAHA.116.0788427480841 22.WeversBAvan der HoekL. Renin-angiotensin system in" exact="human coronavirus" post="pathogenesis. Future Virol. (2010) 5:145â€&quot;61. 10.2217/fvl.10.432201502 23.ZhangJJDongXCaoYYYuanYDYangYBYanYQet al.Clinical characteristics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7256510\results\search\virus\results.xml">
   <result pre="recommended such as Lopinavir/Ritonavir or otherÂ protease inhibitors (used for" exact="human immunodeficiency virus" post="(HIV)) because of unfavorable pharmacodynamics and negative clinical trial"/>
   <result pre="coronavirus â€&quot; a perspectiveExpert Review of Clinical Immunology2020 111ChannappanavarR.PerlmanS.editors. Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7261908\results\search\virus\results.xml">
   <result pre="not comply with these terms. Abstract Infectious diseases caused by" exact="human immunodeficiency virus" post="(HIV) and other highly pathogenic enveloped viruses, have threatened"/>
   <result pre="important enveloped viruses, including HIV, influenza virus, Zika virus (ZIKV)," exact="dengue virus" post="(DENV), and herpes simplex virus (HSV), and the potential"/>
   <result pre="comprised of a variety of human pathogens, including DENV, ZIKV," exact="yellow fever virus" post="(YFV), West Nile virus (WNV), and so on (Kuno"/>
   <result pre="It was also effective against some other flaviviruses, such as" exact="yellow fever virus" post="(YFV) (Lok et al., 2012). Further studies of its"/>
   <result pre="simplex virus types 1 and 2 (HSV-1 and HSV-2) and" exact="varicella-zoster virus" post="(VZV) are human pathogens, which routinely infect humans (Roizman"/>
   <result pre="necrosis factor (TNF) receptor family, herpesvirus entry mediator (HVEM); the" exact="poliovirus" post="receptor family, including nectin-1 and nectin-2, belonging to the"/>
   <result pre="Chemother.53987â€&quot;996. 10.1128/AAC.00793-0819104014 AlhootM. A.RathinamA. K.WangS. M.ManikamR.SekaranS. D. (2013). Inhibition of" exact="dengue virus" post="entry into target cells using synthetic antiviral peptides.Int. J."/>
   <result pre="A.et al. (2010). Structural optimization and de novo design of" exact="dengue virus" post="entry inhibitory peptides.PLoS Negl. Trop. Dis.4:e72110.1371/journal.pntd.0000721 CuiL.ZouP.ChenE.YaoH.ZhengH.WangQ.et al. (2017)."/>
   <result pre="(2017). Visual and motor deficits in grown-up mice with congenital" exact="zika virus" post="infection.EBioMedicine20193â€&quot;201. 10.1016/j.ebiom.2017.04.02928583742 CulshawA.MongkolsapayaJ.ScreatonG. (2018). The immunology of Zika Virus.F1000Res.7:20310.12688/f1000research.12271.1"/>
   <result pre="concentrations of recombinant soluble CD4 are required to neutralize primary" exact="human immunodeficiency virus" post="type 1 isolates.Proc. Natl. Acad. Sci. U.S.A.876574â€&quot;6578. 10.1073/pnas.87.17.65742395859 DavisonA."/>
   <result pre="with HIV-1.Nat. Med.111170â€&quot;1172. 10.1038/nm131916205738 FerrerM.HarrisonS. C. (1999). Peptide ligands to" exact="human immunodeficiency virus" post="type 1 gp120 identified from phage display libraries.J. Virol.735795â€&quot;5802.10364331"/>
   <result pre="(1998). CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary" exact="human immunodeficiency virus" post="type 1 isolates.J. Virol.723475â€&quot;3478.9525686 GompelsU.MinsonA. (1986). The properties and"/>
   <result pre="Microbe17295â€&quot;300. 10.1016/j.chom.2015.02.01225766291 HrobowskiY. M.GarryR. F.MichaelS. F. (2005). Peptide inhibitors of" exact="dengue virus" post="and West Nile virus infectivity.Virol. J.2:4910.1186/1743-422X-2-49 HuertaV.ChineaG.FleitasN.SarriaM.SanchezJ.ToledoP.et al. (2008)."/>
   <result pre="the interaction of domain III of the envelope protein of" exact="dengue virus" post="with putative receptors from CHO cells.Virus Res.137225â€&quot;234. 10.1016/j.virusres.2008.07.02218723056 HungJ."/>
   <result pre="C.ChangW. (2004). An external loop region of domain III of" exact="dengue virus" post="type 2 envelope protein is involved in serotype-specific binding"/>
   <result pre="JacobsonJ. M.IsraelR. J.LowyI.OstrowN. A.VassilatosL. S.BarishM.et al. (2004). Treatment of advanced" exact="human immunodeficiency virus" post="type 1 disease with the viral entry inhibitor PRO"/>
   <result pre="al. (2000). Single-dose safety, pharmacology, and antiviral activity of the" exact="human immunodeficiency virus" post="(HIV) type 1 entry inhibitor PRO 542 in HIV-infected"/>
   <result pre="University Press). KleinD. E.ChoiJ. L.HarrisonS. C. (2013). Structure of a" exact="dengue virus" post="envelope protein late-stage fusion intermediate.J. Virol.872287â€&quot;2293. 10.1128/JVI.02957-1223236058 KrummenacherC.SupekarV. M.WhitbeckJ."/>
   <result pre="LokS. M.CostinJ. M.HrobowskiY. M.HoffmannA. R.RoweD. K.KukkaroP.et al. (2012). Release of" exact="dengue virus" post="genome induced by a peptide inhibitor.PLoS One7:e5099510.1371/journal.pone.0050995 LuL.PanC.LiY.LuH.HeW.JiangS. (2012)."/>
   <result pre="HIV-1 paradigm.Retrovirology5:11110.1186/1742-4690-5-111 ModisY.OgataS.ClementsD.HarrisonS. C. (2003). A ligand-binding pocket in the" exact="dengue virus" post="envelope glycoprotein.Proc. Natl. Acad. Sci. U.S.A.1006986â€&quot;6991. 10.1073/pnas.083219310012759475 MoirS.ChunT. W.FauciA."/>
   <result pre="S. (1993). Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of" exact="human immunodeficiency virus" post="type 1 (HIV-1) infectivity and their relation to primary"/>
   <result pre="PanC.CaiL.LuH.QiZ.JiangS. (2009). Combinations of the first and next generations of" exact="human immunodeficiency virus" post="(HIV) fusion inhibitors exhibit a highly potent synergistic effect"/>
   <result pre="1 strains.J. Virol.837862â€&quot;7872. 10.1128/JVI.00168-0919493996 PanyaA.BangphoomiK.ChoowongkomonK.YenchitsomanusP. T. (2014). Peptide inhibitors against" exact="dengue virus" post="infection.Chem. Biol. Drug Des.84148â€&quot;157. 10.1111/cbdd.1230924612829 PanyaA.SawasdeeN.JunkingM.SrisawatC.ChoowongkomonK.YenchitsomanusP. T. (2015). A"/>
   <result pre="ectodomain region of DENV membrane (M) protein with activity against" exact="dengue virus" post="infection.Chem. Biol. Drug Des.861093â€&quot;1104. 10.1111/cbdd.1257625891143 ParajuliB.AcharyaK.BachH. C.ParajuliB.ZhangS.SmithA. B.et al."/>
   <result pre="J.475931â€&quot;957. 10.1042/BCJ2017066229343613 ParajuliB.AcharyaK.YuR.NgoB.RashadA. A.AbramsC. F.et al. (2016). Lytic inactivation of" exact="human immunodeficiency virus" post="by dual engagement of gp120 and gp41 domains in"/>
   <result pre="Mol. Biol.16265â€&quot;273. 10.1038/nsmb.156619234466 SullivanN.SunY.BinleyJ.LeeJ.BarbasC. F.IIIParrenP. W.et al. (1998). Determinants of" exact="human immunodeficiency virus" post="type 1 envelope glycoprotein activation by soluble CD4 and"/>
   <result pre="review.Chem. Pharm. Bull.66191â€&quot;206. 10.1248/cpb.c17-0079429491253 TrauneckerA.LukeW.KarjalainenK. (1988). Soluble CD4 molecules neutralize" exact="human immunodeficiency virus" post="type 1.Nature33184â€&quot;86. 10.1038/331084a02829024 TrkolaA.PomalesA. B.YuanH.KorberB.MaddonP. J.AllawayG. P.et al. (1995)."/>
   <result pre="J.AllawayG. P.et al. (1995). Cross-clade neutralization of primary isolates of" exact="human immunodeficiency virus" post="type 1 by human monoclonal antibodies and tetrameric CD4-IgG.J."/>
   <result pre="J. (1994). Peptides corresponding to a predictive alpha-helical domain of" exact="human immunodeficiency virus" post="type 1 gp41 are potent inhibitors of virus infection.Proc."/>
   <result pre="10.1080/13543784.2017.1269170 ZhangX.GeP.YuX.BrannanJ. M.BiG.ZhangQ.et al. (2013). Cryo-EM structure of the mature" exact="dengue virus" post="at 3.5-A resolution.Nat. Struct. Mol. Biol.20105â€&quot;110. 10.1038/nsmb.246323241927"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7263255\results\search\virus\results.xml">
   <result pre="demonstrated activity against many other viruses like the Lassa virus," exact="zika virus," post="Ebola virus, flavivirus, herpes simplex and in food â€&quot;"/>
   <result pre="activity in vitro against a host of other viruses like" exact="hantaan virus," post="chikungunya virus, hepatitis B and C virus, reovirus and"/>
   <result pre="vitro against a host of other viruses like hantaan virus," exact="chikungunya virus," post="hepatitis B and C virus, reovirus and coxsackievirus [97]."/>
   <result pre="virus, chikungunya virus, hepatitis B and C virus, reovirus and" exact="coxsackievirus" post="[97]. ARB has shown activity against SARS-CoV-2 virus and"/>
   <result pre="viral replication of host of viruses including influenza, flavivirus and" exact="dengue virus" post="[169]. The in vitro study of ivermectin anti-viral activity"/>
   <result pre="impair phagocytosis in J774 macrophagesExp. Cell Res.28120028610010.1006/excr.2002.561312441132 132LiC.ZuS.DengY.-Q.LiD.ParvatiyarK.QuanquinN.ShangJ.SunN.SuJ.LiuZ.WangM.AliyariS.R.LiX.-F.WuA.MaF.ShiY.Nielsen-SainesK.JungJ.U.QinF.X.-F.QinC.-F.ChengG.Azithromycin protects against" exact="zika virus" post="infection by upregulating virus-induced Type I and III interferon"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7264535\results\search\virus\results.xml">
   <result pre="JAMA. 2020;323(11):1061â€&quot;1069. 10.1001/jama.2020.1585 10TalbotPJ, EkandÃ©S, CashmanNR, MounirS, StewartJN. Neurotropism of" exact="human coronavirus" post="229E. Adv Exp Med Biol. 1993;342:339â€�346.8209751 11GlassWG, SubbaraoK, MurphyB,"/>
   <result pre="WongAHM, RiniJM, DesforgesM, TalbotPJ. Axonal transport enables neuronâ€�toâ€�neuron propagation of" exact="human coronavirus" post="OC43. J Virol. 2018;92(7):1â€&quot;21. 10.1128/JVI.00404-18 14LiYC, BaiWZ, HiranoN, HayashidaT,"/>
   <result pre="nerve is one route of transneural invasion for intranasally inoculated" exact="influenza a virus" post="in mice. Vet Pathol. 2004;41:101â€�107.15017022 28ChaseyD, AlexanderDJ. Morphogenesis of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7266578\results\search\virus\results.xml">
   <result pre="ligands activate a vitamin D mediated autophagic response that inhibits" exact="human immunodeficiency virus" post="type 1PLoS Pathog82012e1003017 22PalaciosC.GonzalezL.Is vitamin D deficiency a major"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267115\results\search\virus\results.xml">
   <result pre="26EichenbergerEM, SoaveR, ZappettiD, et al. Incidence, significance, and persistence of" exact="human coronavirus" post="infection in hematopoietic stem cell transplant recipients. Bone Marrow"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267399\results\search\virus\results.xml">
   <result pre="9(1), 221â€&quot;236. 10.1080/22221751.2020.171990231987001 Channappanavar, R., &amp;amp; Perlman, S. (2017). Pathogenic" exact="human coronavirus" post="infections: Causes and consequences of cytokine storm and immunopathology."/>
   <result pre="development on therapeutic agents and vaccines for COVIDâ€�19 and related" exact="human coronavirus" post="diseases. ACS Central SCI, 6(3), 315â€&quot;331. 10.1021/acscentsci.0c00272 Liu, J.,"/>
   <result pre="C. H. (2004). Small molecules targeting severe acute respiratory syndrome" exact="human coronavirus." post="Proceedings of the National Academy of Sciences of the"/>
   <result pre="(2019). A panâ€�coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spike. Science Advances, 5(4), 1â€&quot;15. 10.1126/sciadv.aav4580 Xia, S., Zhu,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7267883\results\search\virus\results.xml">
   <result pre="epidemics, now known to have resulted from annual importations of" exact="yellow fever virus" post="and its vector, Aedes aegypti mosquitoes from Caribbean trading"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270404\results\search\virus\results.xml">
   <result pre="lymphopenia [sometimes equivalent or more severe than that observed in" exact="human immunodeficiency virus" post="(HIV) infection] is often observed in severely affected patients"/>
   <result pre="Bacille Calmette-Guerin (BCG) can heterologously protect against virus infections [e.g.," exact="yellow fever virus" post="(94), probably by tapping on trained immunity mechanisms (95,"/>
   <result pre="at OSF (100). References References 1.ChafekarAFieldingBC. MERS-CoV: understanding the latest" exact="human coronavirus" post="threat. Viruses. (2018) 10:93. 10.20944/preprints201711.0198.v229495250 2.PeirisJSYuenKYOsterhausADStohrK. The severe acute"/>
   <result pre="117:7001â€&quot;3. 10.1073/pnas.200258911732165541 26.LuGHuYWangQQiJGaoFLiYet al.. Molecular basis of binding between novel" exact="human coronavirus" post="MERS-CoV and its receptor CD26. Nature. (2013) 500:227â€&quot;31. 10.1038/nature1232823831647"/>
   <result pre="understanding SARS pathogenesis. J Pathol. (2004) 203:631â€&quot;7. 10.1002/path.157015141377 32.ChannappanavarRPerlmanS. Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
   <result pre="Middle east respiratory syndrome ARDS acute respiratory disease syndrome HIV" exact="human immunodeficiency virus" post="S Spike E envelop M matrix N nucleocapsid HA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7270517\results\search\virus\results.xml">
   <result pre="amino acid sequence homology existing between macro-domains of SARS-CoV-2 and" exact="rubella virus" post="and 20% homology between fusion protein of measles virus"/>
   <result pre="and rubella virus and 20% homology between fusion protein of" exact="measles virus" post="and spike protein of SARS-CoV-2. This report is the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7273044\results\search\virus\results.xml">
   <result pre="effective in animal models of mice on viruses such as" exact="human coronavirus" post="OC43, enterovirus EVâ€�A71, Zika virus, and influenza A H5N1"/>
   <result pre="S., Zachariah, M., &amp;amp; Harris, E. (2002). Mycophenolic acid inhibits" exact="dengue virus" post="infection by preventing replication of viral RNA. Virology, 304(2),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7277397\results\search\virus\results.xml">
   <result pre="of human coronaviruses being associated with MS. The first major" exact="human coronavirus" post="outbreak caused by the Î²-coronavirus SARS-CoV originated in Guangdong"/>
   <result pre="angiotensin-converting enzyme 2; CoV, coronavirus; FIP, feline infectious peritonitis; HCoV," exact="human coronavirus;" post="MERS, Middle East respiratory syndrome; NA, neuraminidase; nABs, neutralizing"/>
   <result pre="ECoV, equine coronavirus; MERS-CoV, Middle East respiratory syndrome-coronavirus; MVA, Modified" exact="vaccinia virus" post="Ankara; P19 TBSV, gene silencing suppressor P19 protein from"/>
   <result pre="Woodchuck hepatitis virus; nABs, neutralizing antibodies; NPs, nanoparticles; S377-588, RV," exact="rabies virus;" post="SARS-CoV, severe acute respiratory syndrome-coronavirus, TCoV, turkey coronavirus; TGEV,"/>
   <result pre="with highly virulent PEDV strains. In another study, the modified" exact="vaccinia virus" post="Ankara (MVA) strain was utilized for the expression of"/>
   <result pre="G and polymerase L genes in a highly attenuated safe" exact="rabies virus" post="(RV) vector [153]. A single injection with the RV-SARS-CoV"/>
   <result pre="associated with acute respiratory distress syndrome in humansmBio20123e00473-1210.1128/mBio.00473-1223170002 31.ChiboD.BirchC.Analysis of" exact="human coronavirus" post="229E spike and nucleoprotein genes demonstrates genetic drift between"/>
   <result pre="distinct strainsJ. Gen. Virol.2006871203120810.1099/vir.0.81662-016603522 32.VijgenL.KeyaertsE.LemeyP.MoesE.LiS.VandammeA.M.Van RanstM.Circulation of genetically distinct contemporary" exact="human coronavirus" post="OC43 strainsVirology2005337859210.1016/j.virol.2005.04.01015914223 33.MeyerB.MullerM.A.CormanV.M.ReuskenC.B.RitzD.GodekeG.J.LattweinE.KalliesS.SiemensA.van BeekJ.et al.Antibodies against MERS coronavirus in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278221\results\search\virus\results.xml">
   <result pre="been shown to have antiviral activities to different viruses including" exact="dengue virus," post="chikungunya virus, Ebola virus, etc. Any effect found has"/>
   <result pre="to have antiviral activities to different viruses including dengue virus," exact="chikungunya virus," post="Ebola virus, etc. Any effect found has been limited"/>
   <result pre="COVID-19 in Ningbo cityChin. J. Epidemiol.2020410 22.LoeffelholzMJTangYWLaboratory diagnosis of emerging" exact="human coronavirus" post="infectionsâ€&quot;the state of the artEmerg. Microbes Infect.2020974775632196430 23.HeYWangZLiFShiYPublic health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278986\results\search\virus\results.xml">
   <result pre="profile after infection with viruses such as Enterovirus A71 and" exact="coxsackievirus" post="and found that 47 lipid species/classes such as arachidonic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278987\results\search\virus\results.xml">
   <result pre="demonstrated PLP2 inhibitory properties and positive antiviral results against the" exact="human coronavirus" post="NL63 in cells [75]. Therefore, we suggest that further"/>
   <result pre="Virol.200478136001361210.1128/JVI.78.24.13600-13612.200415564471 27.ZhouY.HeC.WangL.GeB.Post-translational regulation of antiviral innate signalingEur. J. Immunol.2017471414142610.1002/eji.20174695928744851 28.ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: Causes and consequences of cytokine storm and immunopathologySemin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7278991\results\search\virus\results.xml">
   <result pre="lungsJ. Virol.2014884711472010.1128/JVI.02081-1324522912 30.RobinsonD.P.HuberS.A.MoussawiM.RobertsB.TeuscherC.WatkinsR.ArnoldA.P.KleinS.L.Sex chromosome complement contributes to sex differences in" exact="coxsackievirus" post="B3 but not influenza A virus pathogenesisBiol. Sex Differ.20112810.1186/2042-6410-2-821806829"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7280997\results\search\virus\results.xml">
   <result pre="March 2020) 60.ShamH.L.KempfD.J.MollaA.MarshK.C.KumarG.N.ChenC.-M.KatiW.StewartK.LalR.HsuA.et al.ABT-378, a Highly potent inhibitor of the" exact="human immunodeficiency virus" post="proteaseAntimicrob. Agents Chemother.1998423218322410.1128/AAC.42.12.32189835517 61.LeonisG.CzyÅ¼nikowskaÅ».MegariotisG.ReisH.PapadopoulosM.G.Computational studies of darunavir into HIV-1"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281209\results\search\virus\results.xml">
   <result pre="viruses. Representative enveloped viruses (herpes simplex virus 1, HSV-1; HSV-2;" exact="human cytomegalovirus," post="HCMV; measles virus; mumps virus; IFV; human immunodeficiency virus,"/>
   <result pre="viruses (herpes simplex virus 1, HSV-1; HSV-2; human cytomegalovirus, HCMV;" exact="measles virus;" post="mumps virus; IFV; human immunodeficiency virus, HIV; and human"/>
   <result pre="simplex virus 1, HSV-1; HSV-2; human cytomegalovirus, HCMV; measles virus;" exact="mumps virus;" post="IFV; human immunodeficiency virus, HIV; and human coronavirus) and"/>
   <result pre="HSV-1; HSV-2; human cytomegalovirus, HCMV; measles virus; mumps virus; IFV;" exact="human immunodeficiency virus," post="HIV; and human coronavirus) and non-enveloped viruses (adenovirus, poliovirus,"/>
   <result pre="showed potent antiviral activities against enveloped viruses (HSV-1, HSV-2, HCMV," exact="measles virus," post="mump virus, IFV, HIV, and human coronavirus) based on"/>
   <result pre="the proliferation of enveloped viruses including IFV, HSV-1, HSV-2, HCMV," exact="measles virus," post="mumps virus, HIV, and human coronavirus (Table 1). RS"/>
   <result pre="of enveloped viruses including IFV, HSV-1, HSV-2, HCMV, measles virus," exact="mumps virus," post="HIV, and human coronavirus (Table 1). RS showed high"/>
   <result pre="IFV, HSV-1, HSV-2, HCMV, measles virus, mumps virus, HIV, and" exact="human coronavirus" post="(Table 1). RS showed high selective toxicity against IFV"/>
   <result pre="broad spectrum of enveloped viruses, such as HSV-1, HSV-2, HCMV," exact="measles virus," post="mump virus, IFV, HIV, and human coronavirus. Although we"/>
   <result pre="HSV-1, HSV-2, HCMV, measles virus, mump virus, IFV, HIV, and" exact="human coronavirus." post="Although we have not tested on other types of"/>
   <result pre="with 10% FBS. HSV-1 (HF strain), HSV-2 (UW 268 strain)," exact="measles virus" post="(Toyoshima strain), mumps virus (EY strain), poliovirus type 3"/>
   <result pre="(HF strain), HSV-2 (UW 268 strain), measles virus (Toyoshima strain)," exact="mumps virus" post="(EY strain), poliovirus type 3 (Sabin strain), and coxsackievirus"/>
   <result pre="268 strain), measles virus (Toyoshima strain), mumps virus (EY strain)," exact="poliovirus" post="type 3 (Sabin strain), and coxsackievirus type B-1 (Conn-5"/>
   <result pre="mumps virus (EY strain), poliovirus type 3 (Sabin strain), and" exact="coxsackievirus" post="type B-1 (Conn-5 strain) were kindly donated by the"/>
   <result pre="Human cytomegalovirus (Towne strain) (HCMV) obtained from Kanazawa University and" exact="human coronavirus" post="(229E strain) obtained from the ATCC were grown on"/>
   <result pre="cells. Adenovirus (type 2) from Toyama Institute of Health and" exact="human rhinovirus" post="type 14 (1059 strain) from Maruishi-Pharm Co. (Osaka, Japan)"/>
   <result pre="assays, the plaque yield reduction assay was employed except for" exact="human coronavirus," post="adenovirus, and HIV. Cell monolayers in 48-well plates were"/>
   <result pre="plaque assay after 1 day of incubation for HSV-1, HSV-2," exact="measles virus," post="mumps virus, poliovirus, coxsackie virus, and IFV, and after"/>
   <result pre="after 1 day of incubation for HSV-1, HSV-2, measles virus," exact="mumps virus," post="poliovirus, coxsackie virus, and IFV, and after 5 days"/>
   <result pre="receptor, CD4Glycobiology1998813113710.1093/glycob/8.2.1319451022 25.MoulardM.Lortat-JacobH.MondorI.RocaG.WyattR.SodroskiJ.ZhaoL.OlsonW.KwongP.D.SattentauQ.J.Selective interactions of polyanions with basic surfaces on" exact="human immunodeficiency virus" post="type 1 gp120J. Virol.2000741948196010.1128/JVI.74.4.1948-1960.200010644368 26.VivesR.R.ImbertyA.SattentauQ.J.Lortat-JacobH.Heparan sulfate targets the HIV-1"/>
   <result pre="50 Î¼m. marinedrugs-18-00254-t001_Table 1Table 1 Antiviral activity of RS. HCMV:" exact="human cytomegalovirus" post="measles virus; HIV: human immunodeficiency virus; HSV-1: herpes simplex"/>
   <result pre="marinedrugs-18-00254-t001_Table 1Table 1 Antiviral activity of RS. HCMV: human cytomegalovirus" exact="measles virus;" post="HIV: human immunodeficiency virus; HSV-1: herpes simplex virus 1;"/>
   <result pre="Antiviral activity of RS. HCMV: human cytomegalovirus measles virus; HIV:" exact="human immunodeficiency virus;" post="HSV-1: herpes simplex virus 1; HSV-2: herpes simplex virus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7281404\results\search\virus\results.xml">
   <result pre="pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the newly evolving" exact="human coronavirus" post="infection that causes COVID-19, and it first appeared in"/>
   <result pre="have been repurposed as antiviral and immune-modulating therapies. Previous high-morbidity" exact="human coronavirus" post="epidemics such as the 2003 SARS-CoV and the 2012"/>
   <result pre="specific viral replication steps, restricts HIV. [102], influenza virus [103]," exact="dengue virus" post="(DENV), [104], West Nile virus (WNV) infection, Japanese encephalitis"/>
   <result pre="Ivermectin in sub-nanomolar range EC50 inhibits the replication of the" exact="yellow fever virus" post="[113]. Ivermectin is also able to inhibit other flavivirus"/>
   <result pre="treatment of SLE and lupus nephritisNat. Rev. Nephrol.2011771872910.1038/nrneph.2011.15022009248 102.TsaiW.P.NaraP.L.KungH.F.OroszlanS.Inhibition of" exact="human immunodeficiency virus" post="infectivity by chloroquineAIDS Res. Hum. Retroviruses1990648148910.1089/aid.1990.6.4811692728 103.OoiE.E.ChewJ.S.LohJ.P.ChuaR.C.In vitro inhibition"/>
   <result pre="by chloroquineAIDS Res. Hum. Retroviruses1990648148910.1089/aid.1990.6.4811692728 103.OoiE.E.ChewJ.S.LohJ.P.ChuaR.C.In vitro inhibition of human" exact="influenza a virus" post="replication by chloroquineVirol. J.200633910.1186/1743-422X-3-3916729896 104.FariasK.J.MachadoP.R.Da FonsecaB.A.Chloroquine inhibits dengue virus"/>
   <result pre="influenza a virus replication by chloroquineVirol. J.200633910.1186/1743-422X-3-3916729896 104.FariasK.J.MachadoP.R.Da FonsecaB.A.Chloroquine inhibits" exact="dengue virus" post="type 2 replication in Vero cells but not in"/>
   <result pre="in C6/36 cellsScientificWorldJournal2013201328273410.1155/2013/28273423431254 105.DelvecchioR.HigaL.M.PezzutoP.ValadaoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.AliotaM.T.et al.Chloroquine, an endocytosis blocking agent, inhibits" exact="zika virus" post="infection in different cell modelsViruses2016832210.3390/v8120322 106.JangC.H.ChoiJ.H.ByunM.S.JueD.M.Chloroquine inhibits production of"/>
   <result pre="agents: Producing organism and fermentationAntimicrob. Agents Chemother.19791536136710.1128/AAC.15.3.361464561 114.TayM.Y.FraserJ.E.ChanW.K.MorelandN.J.RathoreA.P.WangC.VasudevanS.G.JansD.A.Nuclear localization of" exact="dengue virus" post="(DENV) 1-4 non-structural protein 5; protection against all 4"/>
   <result pre="concise review for the clinicianPostgrad. Med.201712949349910.1080/00325481.2017.128567728116959 124.LiC.ZuS.DengY.-Q.LiD.ParvatiyarK.QuanquinN.ShangJ.SunN.SuJ.LiuZ.et al.Azithromycin protects against" exact="zika virus" post="infection by upregulating virus-induced type I and III interferon"/>
   <result pre="HoekL.Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by" exact="human coronavirus" post="NL63J. Gen. Virol.2012931924192910.1099/vir.0.043919-022718567 132.McIntyreM.CaffeS.E.MichalakR.A.ReidJ.L.Losartan, an orally active angiotensin (AT1)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7284455\results\search\virus\results.xml">
   <result pre="a feature observed in other viral infections like Ebola and" exact="human immunodeficiency virus." post="A case of acute haemorrhagic necrotizing encephalopathy in a"/>
   <result pre="Adv Exp Med Biol2014; 807: 75â€&quot;96.24619619 17ChafekarAFieldingBCMERS-CoV: understanding the latest" exact="human coronavirus" post="threat. Viruses2018; 10: pii: E93.29495250 18SaadMOmraniASBaigK, et al.Clinical aspects"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286219\results\search\virus\results.xml">
   <result pre="a promising future, such as mRNA vaccines against influenza viruses," exact="rabies virus," post="HIV, Ebola virus, and Zika virus (Demoulins et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7286259\results\search\virus\results.xml">
   <result pre="been no vaccines or drugs available for the treatment of" exact="human coronavirus" post="infections to date. In the present study, we have"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7287466\results\search\virus\results.xml">
   <result pre="77:217]Int J Surg762020717632112977 8DubÃ©M.Le CoupanecA.WongA.H.M.RiniJ.M.DesforgesM.TalbotP.J.Axonal transport enables neuron-to-neuron propagation of" exact="human coronavirus" post="OC43J Virol92172018e00404-18. Published 2018 Aug 16 9Ryu, Wang-Shick. Molecular"/>
   <result pre="East respiratory syndrome corona virus (MERS-CoV)Infection434201549550125600929 23ChafekarAasiyahFieldingBurtramMERS-CoV: understanding the latest" exact="human coronavirus" post="threatViruses102201893 24KimJ.E.HeoJ.H.KimH.O.SongS.H.ParkS.S.ParkT.H.Neurological complications during treatment of middle east respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7289747\results\search\virus\results.xml">
   <result pre="cellular immunity but also considerably reduced the titer of challenging" exact="vaccinia virus" post="against the cells expressing N protein [43]. In addition"/>
   <result pre="engineered to express SARS-CoV proteins in them. Adenovirus and modified" exact="vaccinia virus" post="Ankara (MVA) are the two most common viral vectors"/>
   <result pre="form as happened in the case of oral vaccine of" exact="poliovirus" post="[106]. From the safety point of view, it is"/>
   <result pre="18BonaviaA.ZelusB.D.WentworthD.E.TalbotP.J.HolmesK.V.Identification of a receptor-binding domain of the spike glycoprotein of" exact="human coronavirus" post="HCoV-229EJ. Virol.77420032530253812551991 19QinC.WangJ.WeiQ.SheM.MarascoW.A.JiangH.TuX.ZhuH.RenL.GaoH.GuoL.An animal model of SARS produced by"/>
   <result pre="33MacGregorR.R.BoyerJ.D.UgenK.E.LacyK.E.GluckmanS.J.BagarazziM.L.ChattergoonM.A.BaineY.HigginsT.J.CiccarelliR.B.ConeyL.R.First human trial of a DNA-based vaccine for treatment of" exact="human immunodeficiency virus" post="type 1 infection: safety and host responseJ. Infect. Dis.17811998921009652427"/>
   <result pre="for developing SARS diagnostics and vaccinesJ. Immunol.173620044050405715356154 62WeingartlH.CzubM.CzubS.NeufeldJ.MarszalP.GrenJ.SmithG.JonesS.ProulxR.DeschambaultY.GrudeskiE.Immunization with modified" exact="vaccinia virus" post="Ankara-based recombinant vaccine against severe acute respiratory syndrome is"/>
   <result pre="63BishtH.RobertsA.VogelL.BukreyevA.CollinsP.L.MurphyB.R.SubbaraoK.MossB.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia virus" post="protectively immunizes miceProc. Natl. Acad. Sci.1011720046641664615096611 64LiJ.UlitzkyL.SilbersteinE.TaylorD.R.ViscidiR.Immunogenicity and protection"/>
   <result pre="â€¦SutterG.Middle East respiratory syndrome coronavirus spike protein delivered by modified" exact="vaccinia virus" post="Ankara efficiently induces virus-neutralizing antibodiesJournal of virology87212013119501195423986586 96VolzAKupkeA.SongF.JanyS.FuxR.Shams-EldinH. â€¦SutterG.Protective"/>
   <result pre="virus-neutralizing antibodiesJournal of virology87212013119501195423986586 96VolzAKupkeA.SongF.JanyS.FuxR.Shams-EldinH. â€¦SutterG.Protective efficacy of recombinant modified" exact="vaccinia virus" post="Ankara delivering Middle East respiratory syndrome coronavirus spike glycoproteinJournal"/>
   <result pre="the middle east respiratory syndrome coronavirus nucleocapsid protein delivered by" exact="vaccinia virus" post="MVA in miceViruses10122018718 100LiuR.WangJ.ShaoY.WangX.ZhangH.ShuaiL.BuZ.A recombinant VSV-vectored MERS-CoV vaccine induces"/>
   <result pre="vaccine reversion in the field: a comprehensive analysis of Sabin-like" exact="poliovirus" post="isolates in NigeriaJ. Virol.901201531733126468545 107DeDiegoM.L.Ã�lvarezE.AlmazÃ¡nF.RejasM.T.LamirandeE.RobertsA.ShiehW.J.ZakiS.R.SubbaraoK.EnjuanesL.A severe acute respiratory syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291183\results\search\virus\results.xml">
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent. Sci.2020631533110.1021/acscentsci.0c0027232226821 Liu L, Wei Q, Lin Q,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7291595\results\search\virus\results.xml">
   <result pre="LiaoM , QiWThe continuous evolution and dissemination of 2019 novel" exact="human coronavirus." post="J. Infect. (2020) (Epub ahead of print). 23.ChanJF ,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7293492\results\search\virus\results.xml">
   <result pre="causing an outbreak of pneumoniaClin. Chem.66202054955532031583 5.CormanV.Detection of a novel" exact="human coronavirus" post="by real-time reverse-transcription polymerase chain reactionEurosurveillance1720122028523041020 6.KupferschmidtK.â€˜A completely new"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7294848\results\search\virus\results.xml">
   <result pre="possible treatments. Among those, lopinavir, originally used for treatment of" exact="human immunodeficiency virus," post="was identified to have potential antiviral activity against SARS-CoV-2."/>
   <result pre="N.CottrellC. A.WangN.PallesenJ.YassineH. M.TurnerH. L.et al.. (2016). Pre-fusion structure of a" exact="human coronavirus" post="spike protein. Nature531, 118â€&quot;121. 10.1038/nature1720026935699 KramkowskiK.MogielnickiA.BuczkoW. (2006). The physiological"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7295552\results\search\virus\results.xml">
   <result pre="Gag-Pol polyprotein precursors into individual functional proteins required for infectious" exact="human immunodeficiency virus" post="(HIV). This results in the formation of immature, noninfectious"/>
   <result pre="PAPR powered air-purifying respirator CP convalescent plasma VQ ventilation-perfusion HIV" exact="human immunodeficiency virus" post="References References 1Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html."/>
   <result pre="antigensVaccine20112929-304862486810.1016/j.vaccine.2011.03.09121481324 42BourinbaiarASFruhstorferECThe effect of histamine type 2 receptor antagonists on" exact="human immunodeficiency virus" post="(HIV) replication: identification of a new class of antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7297930\results\search\virus\results.xml">
   <result pre="polymerase of SARS-CoV-2; in vitro? Influenza viruses, West Nile virus," exact="yellow fever virus," post="foot-and-mouth disease virus NCT04303299 (THDMS-COVID-19); NCT04310228; ChiCTR2000029600 (plus IFN-Î±)"/>
   <result pre="coronavirus 2, RNA ribonucleic acid, RSV respiratory syncytial virus, HIV" exact="human immunodeficiency virus," post="HPV human papillomavirus, AVB atrioventricular block #Clinical trials summarized"/>
   <result pre="alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and" exact="dengue virus." post="Biochem J. 2012;443(3):851â€&quot;6. 45.Caly L, Druce JD, Catton MG,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7298161\results\search\virus\results.xml">
   <result pre="A and B [52] and can effectively inhibit Ebola virus," exact="yellow fever virus" post="[53], etc. In vitro experiments have shown that favipiravir"/>
   <result pre="in 2012) and seasonal epidemics caused by influenza viruses and" exact="dengue virus." post="Fighting against current epidemics also provides an opportunity to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7300441\results\search\virus\results.xml">
   <result pre="M., â€¦ Kyes, R. C. (2006). Considering humanâ€�primate transmission of" exact="measles virus" post="through the prism of risk analysis. American Journal of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7301903\results\search\virus\results.xml">
   <result pre="on the ability of feline calicivirus (a norovirus surrogate) and" exact="poliovirus" post="to infect cell cultures. J. Appl. Microbiol.95, 1026â€&quot;1033. 10.1046/j.1365-2672.2003.02071.x.14633031"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7302922\results\search\virus\results.xml">
   <result pre="Union in 2001 [43, 44]. It is a type of" exact="human immunodeficiency virus" post="(HIV) protease inhibitor that can block the cleavage of"/>
   <result pre="against almost all RNA viruses, such as West Nile virus," exact="yellow fever virus," post="enterovirus, and Ebola virus [69â€&quot;72]. On February 15, 2020,"/>
   <result pre="that hydroxychloroquine also has therapeutic effect against Ebola virus and" exact="dengue virus" post="in in vitro studies [95]. Recently, it has been"/>
   <result pre="Pharm Sin B20177663063729159022 40.ZouWWangJLiuYEffect of traditional Chinese medicine for treating" exact="human immunodeficiency virus" post="infections and acquired immune deficiency syndrome: boosting immune and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7303804\results\search\virus\results.xml">
   <result pre="infected person dying from the disease. It was the fifth" exact="human coronavirus," post="but it was the first to kill humans [2]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305479\results\search\virus\results.xml">
   <result pre="influenza A virus (IVA); type 3 parainfluenza virus (PIV-3); and" exact="human respiratory syncytial virus" post="(RSV). Related known compounds were also analyzed: 5-(perylen-3-ylethynyl)-2â€²-deoxy-uridine; 5-(perylen-3-ylethynyl)-arabino-uridine;"/>
   <result pre="(I)â€&quot;(IV), antiviral activity was tested in vitro against influenza A," exact="human parainfluenza" post="type 3, and respiratory syncytial virus. Data on their"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7305759\results\search\virus\results.xml">
   <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract The rapid and global spread of a new" exact="human coronavirus" post="(SARS-CoV-2) has produced an immediate urgency to discover promising"/>
   <result pre="benefit of lopinavir/ritonavir combination therapy against COVID-19. Lopinavir is a" exact="human immunodeficiency virus" post="type 1 (HIV-1) protease inhibitor, and in a fixed-dose"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306310\results\search\virus\results.xml">
   <result pre="full recovery and necessitated a non-reactivity of the sample for" exact="human immunodeficiency virus" post="(HIV), hepatitis B virus (HBV), hepatitis C virus (HCV),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7306893\results\search\virus\results.xml">
   <result pre="of CPÂ [6]. Moreover, PI has been used against the" exact="chikungunya virus" post="(CHIKV) as well. This is a reemerged arbovirus responsible"/>
   <result pre="GrandadamM, VisseC, GangneuxN, BagotS, ProstJ-F, LecuitM. Prophylaxis and therapy for" exact="chikungunya virus" post="infection. The Journal of Infectious Diseases. 2009. doi:10.1086/600381. [4]GeXY,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7307812\results\search\virus\results.xml">
   <result pre="virus in human fibroblasts and to block the spread of" exact="vaccinia virus" post="and tanapox virus to neighboring cells. Nitric oxide from"/>
   <result pre="studyKorean J Crit Care Med32154163201710.4266/kjccm.2016.0097631723629 116WeversBAvan der HoekLRenin-angiotensin system in" exact="human coronavirus" post="pathogenesisFuture Virol5145161201010.2217/fvl.10.432201502 117ChappellMCAngiotensin-(17) and the regulation of anti-fibrotic signaling"/>
   <result pre="on ACE inhibitorsLancet35920882089200210.1016/S0140-6736(02)08914-612086766 121YeagerCLAshmunRAWilliamsRKCardellichioCBShapiroLHLookATHolmesKVHuman aminopeptidase N is a receptor for" exact="human coronavirus" post="229ENature357420422199210.1038/357420a01350662 122MorrisSMJrArginine: Master and commander in innate immune responsesSci"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309305\results\search\virus\results.xml">
   <result pre="Hence, discovering broad-spectrum inhibitors that can reduce the symptoms of" exact="human coronavirus" post="infection remains a formidable subject of study. Considering the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7309518\results\search\virus\results.xml">
   <result pre="direct evidence that sialic acids play a critical role in" exact="human coronavirus" post="infection.15 It has been just shown that the attachment"/>
   <result pre="Ann Neurol1991;29:474â€&quot;481.1859178 30.DalakasMC, RakocevicG, ShatunovA, et al.Inclusion body myositis with" exact="human immunodeficiency virus" post="infection: four cases with clonal expansion of viral-specific T"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7310596\results\search\virus\results.xml">
   <result pre="Immunol2005287315515609508 9.BelkaidYRouseBTNatural regulatory T cells in infectious diseaseNat Immunol20056435336015785761 10.ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313527\results\search\virus\results.xml">
   <result pre="was shown to inhibit polyprotein processing in cells infected with" exact="human rhinovirus" post="and coxsackievirus B3 (Krenn et al., 2009). Replication of"/>
   <result pre="inhibit polyprotein processing in cells infected with human rhinovirus and" exact="coxsackievirus" post="B3 (Krenn et al., 2009). Replication of other viruses"/>
   <result pre="2009). Replication of other viruses such as HIV, HSV, and" exact="vaccinia virus" post="as well as SARS-CoVs were also known to be"/>
   <result pre="of their replication and pathogenesisMethods Mol. Biol.1282201512310.1007/978-1-4939-2438-7_125720466 ForniD.CaglianiR.ClericiM.SironiM.Molecular evolution of" exact="human coronavirus" post="genomesTrends Microbiol.252017354810.1016/j.tim.2016.09.00127743750 FosterM.SammanS.Zinc and regulation of inflammatory cytokines: implications"/>
   <result pre="vaccinationJ. Clin. Virol.1192019445210.1016/j.jcv.2019.08.00931491709 JiangP.MizushimaN.Autophagy and human diseasesCell Res.242014697910.1038/cr.2013.16124323045 KatzE.MargalithE.Inhibition of" exact="vaccinia virus" post="maturation by zinc chlorideAntimicrob. Agents Chemother.19198121321710.1128/aac.19.2.2137347557 KaushikN.SubramaniC.AnangS.MuthumohanR.ShalimarNayakB.Ranjith-KumarC.T.SurjitM.Zinc salts block"/>
   <result pre="virus maturation by zinc chlorideAntimicrob. Agents Chemother.19198121321710.1128/aac.19.2.2137347557 KaushikN.SubramaniC.AnangS.MuthumohanR.ShalimarNayakB.Ranjith-KumarC.T.SurjitM.Zinc salts block" exact="hepatitis e virus" post="replication by inhibiting the activity of viral RNA-dependent RNA"/>
   <result pre="RNA-dependent RNA polymeraseJ. Virol.20179110.1128/JVI.00754-17 KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of chloroquine against" exact="human coronavirus" post="OC43 infection in newborn miceAntimicrob. Agents Chemother.5320093416342110.1128/AAC.01509-0819506054 KiralanM.Volatile compounds"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7313828\results\search\virus\results.xml">
   <result pre="treatment causes shorter duration of shedding and symptoms [13]. For" exact="human immunodeficiency virus" post="(HIV), early treatment confers mortality benefits and lowers community"/>
   <result pre="Med2020; 382(19):1787â€&quot;99. 18.MayerBT, KrantzEM, WaldA, et al.Estimating the risk of" exact="human herpesvirus 6" post="and cytomegalovirus transmission to Ugandan infants from viral shedding"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315394\results\search\virus\results.xml">
   <result pre="pathogens, such as hand, foot, and mouth disease (HFMD) virus," exact="human immunodeficiency virus" post="(HIV), bovine coronavirus, or MERS-CoV [49â€&quot;52]. Currently, RPA has"/>
   <result pre="three general approaches to develop potential antiviral treatments of the" exact="human coronavirus." post="Firstly, standard assays may be used to evaluate existing"/>
   <result pre="that an MTHFD1 inhibitor, carolacton, restricts replication of influenza virus," exact="mumps virus," post="Melaka virus, Zika virus, and, most importantly, 2019-nCoV [190]."/>
   <result pre="hepatitis B virus, herpes simplex virus, respiratory syncytial virus, and" exact="monkeypox virus" post="[206]. The broad antiviral properties of silver nanoparticles and"/>
   <result pre="on COVID-192020https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 4WooP. C.LauS. K.YipC. C.HuangY.YuenK. Y.More and more coronaviruses:" exact="human coronavirus" post="HKU1Viruses200911577110.3390/v101005721994538 5WooP. C.LauS. K.LamC. S.et al.Discovery of seven novel"/>
   <result pre="a reverse transcription recombinase-aided amplification assay for the detection of" exact="coxsackievirus" post="A10 and coxsackievirus A6 RNAArchives of Virology201816361455146110.1007/s00705-018-3734-929429036 53CongL.RanF. A.CoxD.et"/>
   <result pre="recombinase-aided amplification assay for the detection of coxsackievirus A10 and" exact="coxsackievirus" post="A6 RNAArchives of Virology201816361455146110.1007/s00705-018-3734-929429036 53CongL.RanF. A.CoxD.et al.Multiplex genome engineering"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Central Science20206331533110.1021/acscentsci.0c0027232226821 148ZiebuhrJ.SnijderE. J.GorbalenyaA. E.Virus-encoded proteinases and proteolytic"/>
   <result pre="Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against" exact="human coronavirus" post="NL63Virus Research2019273, article 19776710.1016/j.virusres.2019.197767 228NieL.-x.WuY.-l.DaiZ.MaS.-c.Antiviral activity of Isatidis Radix"/>
   <result pre="hepatitis C virus; HFMD: hand, foot, and mouth disease; HIV:" exact="human immunodeficiency virus;" post="IL-6: interleukin 6; INF-Î±: interferon-alpha; MAPK: mitogen-activated protein kinase;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315836\results\search\virus\results.xml">
   <result pre="J.; BerkhoutB.; JebbinkM. F.; DijkmanR.; RottierP.; van der HoekL.Inhibition of" exact="human coronavirus" post="NL63 infection at early stages of the replication cycle."/>
   <result pre="YangB.; LuL.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spike. Sci. Adv.2019, 5, eaav458010.1126/sciadv.aav4580.30989115 XiaS.; ZhuY.; LiuM.; LanQ.;"/>
   <result pre="antibodies and screen for viral entry inhibitors against the novel" exact="human coronavirus" post="MERS-CoV. Virol. J.2013, 10, 26610.1186/1743-422X-10-266.23978242 KadamR. U.; WilsonI. A.Structural"/>
   <result pre="MossB.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated" exact="vaccinia virus" post="protectively immunizes mice. Proc. Natl. Acad. Sci. U. S."/>
   <result pre="YuJ.; GaoH.; TuX.; GettieA.; FarzanM.; YuenK. Y.; HoD. D.Recombinant modified" exact="vaccinia virus" post="ankara expressing the spike glycoprotein of severe acute respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7315944\results\search\virus\results.xml">
   <result pre="and other data-holding records of infected SARS-CoV, SARS-Cov-2, influenza, and" exact="human immunodeficiency virus" post="(HIV)) using Deep Neural Network on the eighty old"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7318922\results\search\virus\results.xml">
   <result pre="2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infectionsViruses1222020E19432050635 StockmanL.J.BellamyR.GarnerP.SARS: systematic review of treatment effectsPLoS Med32006e34316968120 Tammaro"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319607\results\search\virus\results.xml">
   <result pre="childrenJ Clin Microbiol4620082368237318495857 7YeagerC.L.AshmumR.A.WilliamsR.K.Human aminopeptidase N is a receptor for" exact="human coronavirus" post="229ENature35719924204221350662 8Shirato K, Kanou K, Kawase M, Matsuyama S."/>
   <result pre="K, Kanou K, Kawase M, Matsuyama S. Clinical isolates of" exact="human coronavirus" post="229E bypass the endosome for cell entry. J Virol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319644\results\search\virus\results.xml">
   <result pre="in MERS-CoV infected patientsJ Infect735201646847510.1016/j.jinf.2016.08.00527519621 52XuL.LiuJ.LuM.YangD.ZhengX.Liver damage during highly pathogenic" exact="human coronavirus" post="infectionsLiver Int0020201710.1111/liv.14435 53ZhangJ.J.DongX.CaoY.Y.YuanY.D.YangY.B.YanY.Q.Clinical characteristics of 140 patients infected by"/>
   <result pre="Cell Mol Immunol2032004322324 56JossetL.MenacheryV.D.GrajinskiL.E.AgnihothramS.SovaP.CarterV.S.Cell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
   <result pre="experimental validation of the discovery of inhibitors targeted towards the" exact="human coronavirus" post="nucleocapsid proteinMol Biosyst1212016596610.1039/C5MB00582E26542199 117DayerM.R.Taleb-GassabiS.DayerM.R.S.LopinavirA Potent Drug against Coronavirus Infection:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7319650\results\search\virus\results.xml">
   <result pre="drug repurposingACS Infect. Dis.1July 10 (7)201531732610.1021/acsinfecdis.5b0003027622822 81RoyJ.PaquetteJ.S.FortinJ.F.TremblayM.J.The immunosuppressant rapamycin represses" exact="human immunodeficiency virus" post="type 1 replicationAntimicrob. Agents Chemother.46November(11)20023447345512384349 82ZhangM.XieM.LiS.GaoY.XueS.HuangH.ChenK.LiuF.ChenL.Electrophysiologic studies on the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7320840\results\search\virus\results.xml">
   <result pre="for vaccines and therapeuticsAntivir Res201613316517727468951 42.KremplCSchultzeBHerrlerGAnalysis of cellular receptors for" exact="human coronavirus" post="OC43Adv Exp Med Biol19953803713748830510 43.Schwegmann-WesselsCBauerSWinterCEnjuanesLLaudeHHerrlerGThe sialic acid binding activity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7325419\results\search\virus\results.xml">
   <result pre="of all time such as Yellow fever virus (YFV) and" exact="dengue virus" post="(DENV), which resulted in millions of fatalities worldwide (6,"/>
   <result pre="22, 27). In addition to the extensive history of epidemics," exact="chikungunya virus" post="(CHIKV) and Zika virus (ZIKV) caused serious outbreaks in"/>
   <result pre="vector studies on six mosquito and one tick species with" exact="chikungunya virus." post="Trans R Soc Trop Med Hyg. (1981) 75:15â€&quot;9. 10.1016/0035-9203(81)90005-56115488"/>
   <result pre="10.1016/j.cell.2009.11.04220064373 28.Diaz-GonzÃ¡lezEEKautzTFDorantes-DelgadoAMalo-GarcÃ­aIRLaguna-AguilarMLangsjoenRMet al.. First report of Aedes aegypti transmission of" exact="chikungunya virus" post="in the Americas. Am J Trop Med Hyg. (2015)"/>
   <result pre="12:541. 10.1186/s13071-019-3794-z31727179 41.SharpTMLorenziOTorres-VelÃ¡squezBAcevedoVPÃ©rez-PadillaJRiveraAet al.. Autocidal gravid ovitraps protect humans from" exact="chikungunya virus" post="infection by reducing Aedes aegypti mosquito populations. PLoS Negl"/>
   <result pre="II, randomized, safety and immunogenicity study of a re-derived, live-attenuated" exact="dengue virus" post="vaccine in healthy adults. Am J Trop Med Hyg."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7331567\results\search\virus\results.xml">
   <result pre="to various approved drugs, for example, against chronic infections with" exact="human immunodeficiency virus" post="(HIV) or hepatitis C virus (HCV), which employ aspartyl"/>
   <result pre="SARS-CoV-2.107 It is likely that SARS-CoV-2 is not the last" exact="human coronavirus" post="emerging from animals. It is therefore important to closely"/>
   <result pre="of coronavirusesAdv Virus Res66200619329210.1016/S0065-3527(06)66005-316877062 31ZiebuhrJ.HeusippG.SiddellS.G.Biosynthesis, purification, and characterization of the" exact="human coronavirus" post="229E 3C-like proteinaseJ Virol7151997399239979094676 32KhailanyR.A.SafdarM.OzaslanM.Genomic characterization of a novel"/>
   <result pre="research on highly pathogenic human coronavirusesAntiviral Res1001201328629510.1016/j.antiviral.2013.08.01524012996 51WongG.BiY.-H.WangQ.-H.ChenX.-W.ZhangZ.-G.YaoY.-G.Zoonotic origins of" exact="human coronavirus" post="2019 (HCoV-19/SARS-CoV-2): why is this work important?Zool Res413202021321910.24272/j.issn.2095-8137.2020.03132314559 52ZhangC.HuangS.ZhengF.DaiY.Controversial"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332457\results\search\virus\results.xml">
   <result pre="surface receptor angiotensin-converting enzyme II (ACE2). With the exception of" exact="human coronavirus" post="(hCoV) NL63, the seven other hCoVs have other host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332875\results\search\virus\results.xml">
   <result pre="1 Zidovudine 72187 Antiviral drug used for the treatment of" exact="human immunodeficiency virus" post="(HIV) infections Nucleoside reverse transcriptase inhibitor (NRTI) with activity"/>
   <result pre="H. (2013). Oligomerization of the carboxyl terminal domain of the" exact="human coronavirus" post="229E nucleocapsid protein. FEBS Letters, 587(2), 120â€&quot;127. 10.1016/j.febslet.2012.11.01623178926 Madhavi"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332877\results\search\virus\results.xml">
   <result pre="Docking studies towards exploring antiviral compounds against envelope protein of" exact="yellow fever virus." post="Interdisciplinary Sciences, Computational Life Sciences, 3(1), 64â€&quot;77. 10.1007/s12539-011-0064-y VilarS.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7332961\results\search\virus\results.xml">
   <result pre="Virol.93:e02062-1810.1128/JVI.02062-2018 AlipertiG.SchlesingerM. J. (1978). Evidence for an autoprotease activity of" exact="sindbis virus" post="capsid protein.Virology90366â€&quot;369. 10.1016/0042-6822(78)90321-5726255 Alva-UrciaC.Aguilar-LuisM. A.Palomares-ReyesC.Silva-CasoW.Suarez-OgnioL.WeilgP.et al. (2017). Emerging and"/>
   <result pre="the unfolded protein response.PLoS Biol.4:e42310.1371/journal.pbio.0040423 BernardE.SolignatM.GayB.ChazalN.HiggsS.DevauxC.et al. (2010). Endocytosis of" exact="chikungunya virus" post="into mammalian cells: role of clathrin and early endosomal"/>
   <result pre="Evol. Biol.20:3110.1186/s12862-020-1596-1598 BonifayT.PrinceC.NeyraC.DemarM.RoussetD.KallelH.et al. (2018). Atypical and severe manifestations of" exact="chikungunya virus" post="infection in French Guiana: a hospital-based study.PLoS One13:e020740610.1371/journal.pone.0207406 BrightonS."/>
   <result pre="monocyte chemotactic protein synthesis, protects against bone loss induced by" exact="chikungunya virus" post="infection.J. Virol.89581â€&quot;593. 10.1128/JVI.02034-1425339772 ChenW.FooS. S.ZaidA.TengT. S.HerreroL. J.WolfS.et al. (2017)."/>
   <result pre="pathway in viral infection.EMBO J.174585â€&quot;4593. 10.1093/emboj/17.16.45859707418 DialloM.ThonnonJ.Traore-LamizanaM.FontenilleD. (1999). Vectors of" exact="chikungunya virus" post="in Senegal: current data and transmission cycles.Am. J. Trop."/>
   <result pre="10.1099/vir.0.071845-025395592 GardnerC. L.HritzJ.SunC.VanlandinghamD. L.SongT. Y.GhedinE.et al. (2014). Deliberate attenuation of" exact="chikungunya virus" post="by adaptation to heparan sulfate-dependent infectivity: a model for"/>
   <result pre="Infect.71413â€&quot;421. 10.1016/j.jinf.2015.06.00626092350 GÃ©rardinP.BarauG.MichaultA.BintnerM.RandrianaivoH.ChokerG.et al. (2008). Multidisciplinary prospective study of mother-to-child" exact="chikungunya virus" post="infections on the island of La Reunion.PLoS Med.5:6010.1371/journal.pone.000060 GÃ©rardinP.CoudercT.BintnerM.TournebizeP.RenouilM.LÃ©mantJ.et"/>
   <result pre="France.Emerg. Infect. Dis.17:91010.3201/eid1705.101873 GreenA. M.BeattyP. R.HadjilaouA.HarrisE. (2014). Innate immunity to" exact="dengue virus" post="infection and subversion of antiviral responses.J. Mol. Biol.4261148â€&quot;1160. 10.1016/j.jmb.2013.11.02324316047"/>
   <result pre="responses.J. Mol. Biol.4261148â€&quot;1160. 10.1016/j.jmb.2013.11.02324316047 HalsteadS. B.UdomsakdiS.ScanlonJ. E.RohitayodhinS. (1969). Dengue and" exact="chikungunya virus" post="infection in man in Thailand, 1962-1964. V. Epidemiologic observations"/>
   <result pre="in the induction of ER stress and downstream events in" exact="chikungunya virus" post="infection.Microb. Pathog.101104â€&quot;118. 10.1016/j.micpath.201627863885 KielianM.Chanel-VosC.LiaoM. (2010). Alphavirus entry and membrane"/>
   <result pre="muscle cells.PLoS Negl. Trop. Dis.13:e000761010.1371/journal.pntd.0007610 LemantJ.BoissonV.WinerA.ThibaultL.AndrÃ©H.TixierF.et al. (2008). Serious acute" exact="chikungunya virus" post="infection requiring intensive care during the Reunion Island outbreak"/>
   <result pre="Virol.728586â€&quot;8596. 10.1128/jvi.72.11.8586-8596.19989765397 LitzbaN.SchuffeneckerI.ZellerH.DrostenC.EmmerichP.CharrelR.et al. (2008). Evaluation of the first commercial" exact="chikungunya virus" post="indirect immunofluorescence test.J. Virol. Methods149175â€&quot;179. 10.1016/j.jviromet.2008.01.00418294706 LiuC. Y.KaufmanR. J."/>
   <result pre="M.et al. (2019). FHL1 is a major host factor for" exact="chikungunya virus" post="infection.Nature574259â€&quot;263. 10.1038/s41586-019-1578-431554973 MehtaR.GerardinP.de BritoC. A. A.SoaresC. N.FerreiraM. L. B.SolomonT."/>
   <result pre="Anopheles gambiae infectivity.J. Virol.804992â€&quot;4997. 10.1128/JVI.80.10.4992-4997.200616641290 NasciR. S. (2014). Movement of" exact="chikungunya virus" post="into the Western hemisphere.Emerg. Infect. Dis.201394â€&quot;1395. 10.3201/eid2008.14033325061832 NavecaF. G.ClaroI.GiovanettiM.de"/>
   <result pre="disease.Indian J. Dermatol.54128â€&quot;131. 10.4103/0019-5154.5318620101307 QueyriauxB.SimonF.GrandadamM.MichelR.TolouH.BoutinJ. P. (2008). Clinical burden of" exact="chikungunya virus" post="infection.Lancet Infect. Dis.82â€&quot;3. 10.1016/S1473-3099(07)70294-318156079 RadoshitzkyS. R.PegoraroG.ChÃ®X. O. D.NgL.ChiangC. Y.JozwickL.et"/>
   <result pre="phosphorylation.Virol. J.10:3610.1186/1743-422X-10-36 RenaultP.SoletJ. L.SissokoD.BalleydierE.LarrieuS.FilleulL.et al. (2007). A major epidemic of" exact="chikungunya virus" post="infection on Reunion Island, France, 2005-2006.Am. J. Trop. Med."/>
   <result pre="Trop. Med. Hyg.77727â€&quot;731. 10.4269/ajtmh.2007.77.72717978079 RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA. C.PanningM.et al. (2007). Infection with" exact="chikungunya virus" post="in Italy: an outbreak in a temperate region.Lancet3701840â€&quot;1846. 10.1016/S0140-6736(07)61779-618061059"/>
   <result pre="characteristics.BMC Res. Notes11:17510.1186/s13104-018-3290-0 SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.et al. (2010). Type I IFN controls" exact="chikungunya virus" post="via its action on nonhematopoietic cells.J. Exp. Med.207429â€&quot;442. 10.1084/jem.2009085120123960"/>
   <result pre="(2018). Vector competence of Italian Aedes albopictus populations for the" exact="chikungunya virus" post="(E1-226V).PLoS Negl. Trop. Dis.12:e000643510.1371/journal.pntd.0006435 SharpT. M.RothN. M.TorresJ.RyffK. R.PÃ©rez RodrÃ­guezN."/>
   <result pre="10.1086/60549619663604 SuhanaO.NazniW. A.ApandiY.FarahH.LeeH. L.Sofian-AzirunM. (2019). Insight into the origin of" exact="chikungunya virus" post="in Malaysian non-human primates via sequence analysis.Heliyon5:e0268210.1016/j.heliyon.2019.e02682 SuhrbierA.Jaffar-BandjeeM. C.GasqueP."/>
   <result pre="U.S.A.1087872â€&quot;7877. 10.1073/pnas.101834410821518887 TsetsarkinK. A.ChenR.YunR.RossiS. L. (2014). Multi-peaked adaptive landscape for" exact="chikungunya virus" post="evolution predicts continued fitness optimization in Aedes albopictus mosquitoes.Nat."/>
   <result pre="(2009). Epistatic roles of E2 glycoprotein mutations in adaption of" exact="chikungunya virus" post="to Aedes albopictus and Ae. aegypti mosquitoes.PLoS One31:e683510.1371/journal.pone.0006835 TsetsarkinK."/>
   <result pre="One31:e683510.1371/journal.pone.0006835 TsetsarkinK. A.VanlandinghamD. L.McGeeC. E.HiggsS. (2007). A single mutation in" exact="chikungunya virus" post="affects vector specificity and epidemic potential.PLoS Pathog.3:e20110.1371/journal.ppat.0030201 TsetsarkinK. A.WeaverS."/>
   <result pre="A.AdamsA. P.GarciaT. I.SallA. A.et al. (2010). Genome-scale phylogenetic analyses of" exact="chikungunya virus" post="reveal independent emergences of recent epidemics and various evolutionary"/>
   <result pre="receptor protein.J. Med. Virol.841757â€&quot;1770. 10.1002/jmv.2340322997079 XavierJ.GiovanettiM.FonsecaV.ThÃ©zÃ©J.GrÃ¤fT.FabriA.et al. (2019). Circulation of" exact="chikungunya virus" post="East/Central/South African lineage in Rio de Janeiro, Brazil.PLoS One14:e021787110.1371/journal.pone.0217871"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7334131\results\search\virus\results.xml">
   <result pre="such as varicella zoster [9], cytomegalovirus [10], parvovirus [11], and" exact="human immunodeficiency virus" post="have been associated with stroke. Various hypotheses have been"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7334951\results\search\virus\results.xml">
   <result pre="(COVID-19) pandemic and the lack of approved treatments for any" exact="human coronavirus" post="(CoV) infection highlight the urgent need to develop strategies"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335243\results\search\virus\results.xml">
   <result pre="a guanine analog among approved nucleoside analogs used to treat" exact="hepatitis c virus" post="and respiratory syncytial virus infections and has been harnessed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7335248\results\search\virus\results.xml">
   <result pre="single-stranded RNA genome, and includes four serotypes (DENV-1-4). 100â€&quot;400 million" exact="dengue virus" post="infections are estimated each year. Dengue affects in particular"/>
   <result pre="of polyphenols, including resveratrol, for their potential beneficial effects against" exact="dengue virus." post="Unfortunately, resveratrol did not exhibit antiviral activity for U937-DC-SIGN"/>
   <result pre="Macaranga barteri (Euphorbiaceae) [95]. The pure compounds were tested against" exact="echovirus" post="7, 13 and 19 serotypes and were inactive against"/>
   <result pre="echovirus 7, 13 and 19 serotypes and were inactive against" exact="echovirus" post="E13, while a good activity was reported on E19."/>
   <result pre="Trop. Dis.82014e302510.1371/journal.pntd.0003025 62ZandiK.TeohB.T.SamS.S.WongP.F.MustafaM.AbubakarS.Antiviral activity of four types of bioflavonoid against" exact="dengue virus" post="type-2Virol. J.8201111110.1186/1743-422X-8-56021205327 63ZandiK.LimT.H.RahimN.A.ShuM.H.TeohB.T.SamS.S.DanlamiM.B.TanK.K.AbubakarS.Extract of Scutellaria baicalensis inhibits dengue virus"/>
   <result pre="against dengue virus type-2Virol. J.8201111110.1186/1743-422X-8-56021205327 63ZandiK.LimT.H.RahimN.A.ShuM.H.TeohB.T.SamS.S.DanlamiM.B.TanK.K.AbubakarS.Extract of Scutellaria baicalensis inhibits" exact="dengue virus" post="replicationBMC Compl. Alternative Med.13201310.1186/1472-6882-13-91 64Jasso-MirandaC.Herrera-CamachoI.Flores-MendozaL.K.DominguezF.Antiviral and immunomodulatory effects of"/>
   <result pre="64Jasso-MirandaC.Herrera-CamachoI.Flores-MendozaL.K.DominguezF.Antiviral and immunomodulatory effects of polyphenols on macrophages infected with" exact="dengue virus" post="serotypes 2 and 3 enhanced or not with antibodies,"/>
   <result pre="RNA triphosphatase, and unwinding activities of the helicase domain of" exact="dengue virus" post="NS3 proteinFEBS Lett.583200969169610.1016/j.febslet.2009.01.00819166847 68PandeV.RamosM.J.Nuclear factor kappa B: a potential"/>
   <result pre="malibatoJ.Â Nat. Prod.61199835135310.1021/np970519h9544565 76CardinA.D.SmithP.L.HydeL.BlankenshipD.T.BowlinT.L.SchroederK.StaudermanK.A.TaylorD.L.TymsA.S.Stilbene disulfonic acids: CD4 antagonists that block" exact="human immunodeficiency virus" post="type-1 growth at multiple stages of the virus life"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7336121\results\search\virus\results.xml">
   <result pre="neutralizing mAbs against various viruses such as H5N1 influenza virus," exact="human immunodeficiency virus" post="(HIV), herpes simplex virus (HSV), cytomegalovirus (CMV), hepatitis C"/>
   <result pre="hepatitis C virus (HCV), Ebola virus, Marburg virus, SARS virus," exact="dengue virus," post="rabies virus, Hendra virus, Nipah virus, yellow fever virus,"/>
   <result pre="virus (HCV), Ebola virus, Marburg virus, SARS virus, dengue virus," exact="rabies virus," post="Hendra virus, Nipah virus, yellow fever virus, and West"/>
   <result pre="SARS virus, dengue virus, rabies virus, Hendra virus, Nipah virus," exact="yellow fever virus," post="and West Nile virus have been described in the"/>
   <result pre="experiments, it was recognized that anti-Mxra8 monoclonal antibody can blocked" exact="chikungunya virus" post="infection in different cell types, including primary human synovial"/>
   <result pre="[81]. Fab of 2F4, a mouse monoclonal antibody against the" exact="measles virus," post="prevents viral entry via two cellular receptors, SLAM and"/>
   <result pre="cervical exfoliated cellsJ. Virol. Methods2572018334129614248 28FatimaA.WangH.KangK.XiaL.WangY.YeW.Development of VHH antibodies against" exact="dengue virus" post="type 2 NS1 and comparison with monoclonal antibodies for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338124\results\search\virus\results.xml">
   <result pre="viruses and laboratory testing methodsAntivi Ther20121715917310.3851/IMP2067 9.WeinstockDMGubarevaLVZuccottiGProlonged shedding of multidrug-resistant" exact="influenza a virus" post="in an immunocompromised patientNew Engl J Med200334886786810.1056/NEJM20030227348092312606750 10.ChoiJHKimMSLeeJYLeeNJKwonDKangMGet al.Development"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7338588\results\search\virus\results.xml">
   <result pre="in the TLR3 pathway and RNA metabolism (9, 11, 12)," exact="varicella-zoster virus" post="and defective innate RNA POL III signaling (13â€&quot;15), severe"/>
   <result pre="disease (COVID-19) outbreak. J Autoimmun. (2020) 109:102433. 10.1016/j.jaut.2020.10243332113704 3.ChannappanavarRPerlmanS. Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
   <result pre="polymerase III genes and defective DNA sensing in adults with" exact="varicella-zoster virus" post="CNS infection. Genes Immun. (2019) 20:214â€&quot;23. 10.1038/s41435-018-0027-y29728610 15.Carter-TimofteMEHansenAFMardahlMFribourgSRapaportFZhangS-Yet al.."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339094\results\search\virus\results.xml">
   <result pre="pathogens such as herpes viruses [cytomegalovirus (CMV), Epstein-Barr virus (EBV)," exact="varicella-zoster virus" post="(VZV), herpes simplex 1 and 2 (HSV1-2) and herpesvirus-6]"/>
   <result pre="principlesInt J Infect Dis201762869310.1016/j.ijid.2017.07.01128739424 33.JacobsSEet al.Clinical and molecular epidemiology of" exact="human rhinovirus" post="infections in patients with hematologic malignancyJ Clin Virol201571515810.1016/j.jcv.2015.07.30926370315 34.FisherBTet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7339606\results\search\virus\results.xml">
   <result pre="the recent 2019 novel coronavirus (SARS-CoV-2) in light of Past" exact="human coronavirus" post="outbreaksPathogens.20209186 13.NguyenTMZhangYPandolfiPPVirus against virus: a potential treatment for 2019-nCov"/>
   <result pre="fever virus L segmentVirology2004321232815033561 38.LiangBLiZJenniSRahmehAAMorinBMGrantTGrigorieffNHarrisonSCWhelanSPStructure of the L protein of" exact="vesicular stomatitis virus" post="from electron cryomicroscopyCell201516231432726144317 39.GerlachPMaletHCusackSRegueraJStructural insights into bunyavirus replication and"/>
   <result pre="fragment at 2.8 Ã… resolutionJ Mol Biol.1998284109511119837729 64.Jacobo-MolinaADingJNanniRGClarkADLuXTantilloCWilliamsRLKamerGFerrisALClarkPCrystal structure of" exact="human immunodeficiency virus" post="type 1 reverse transcriptase complexed with double-stranded DNA at"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7340244\results\search\virus\results.xml">
   <result pre="previous bocavirus infection heralding KD.42 Metagenomic sequencing and PCR detected" exact="torque teno virus" post="7 in only 2/11 (18%) patients with KD prospectively"/>
   <result pre="specimens, although 2 were corresponding to their vaccinal history (oral" exact="poliovirus" post="and measles/mumps/rubella vaccine) and 2 to bocavirus and rhinovirus,"/>
   <result pre="Epstein-Barr virus infectionJ Infect Dis1990162121510.1093/infdis/162.5.12152172398 34KuijpersTWHerweijerTJScholvinckLet al.Kawasaki disease associated with" exact="measles virus" post="infection in a monozygotic twinPediatr Infect Dis J200019350310.1097/00006454-200004000-0001810783028 35ShingadiaDBoseABooyRCould"/>
   <result pre="year prospective study&quot;Pathol Biol (Paris)201462365810.1016/j.patbio.2014.06.00225193448 43ThissenJBIsshikiMJaingCet al.A novel variant of" exact="torque teno virus" post="7 identified in patients with Kawasaki diseasePLoS One20181312e020968310.1371/journal.pone.020968330592753 44MaggioMCFabianoCCorselloGKawasaki"/>
   <result pre="Kawasaki diseaseJ Formos Med Assoc20141131485410.1016/j.jfma.2013.12.00824495555 48EsperFShapiroEDWeibelCet al.Association between a novel" exact="human coronavirus" post="and Kawasaki diseaseJ Infect Dis200519149950210.1086/42829115655771 49DominguezSRAndersonMSGlodÃ©MPet al.Blinded case-control study"/>
   <result pre="Infect Dis200519149950210.1086/42829115655771 49DominguezSRAndersonMSGlodÃ©MPet al.Blinded case-control study of the relationship between" exact="human coronavirus" post="NL63 and Kawasaki syndromeJ Infect Dis200619416970110.1086/50950917109341 50ShiratoKImadaYKawaseMet al.Possible involvement"/>
   <result pre="Kawasaki syndromeJ Infect Dis200619416970110.1086/50950917109341 50ShiratoKImadaYKawaseMet al.Possible involvement of infection with" exact="human coronavirus" post="229E, but not NL63, in Kawasaki diseaseJ Med Virol20148621465310.1002/jmv.2395024760654"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343578\results\search\virus\results.xml">
   <result pre="human CD26Emerg Microbes Infect2020960160432178593 33.LuGHuYWangQQiJGaoFLiYZhangYZhangWYuanYBaoJZhangBShiYYanJGaoGFMolecular basis of binding between novel" exact="human coronavirus" post="MERS-CoV and its receptor CD26Nature.201350022723123831647 34.Onder G, Rezza G,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7343716\results\search\virus\results.xml">
   <result pre="Front Microbiol. (2018) 9:2126. 10.3389/fmicb.2018.0212630258421 4.ArunkumarGChandniRMouryaDTSinghSKSadanandanRSudanPet al.. Outbreak investigation of" exact="nipah virus" post="disease in Kerala, India, 2018. J Infect Dis. (2019)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344048\results\search\virus\results.xml">
   <result pre="anti-malarial molecules. Importantly, Artemisinin has demonstrated broad anti-viral activity against" exact="human cytomegalovirus," post="herpes simplex virus type 1, Epstein-Barr virus, hepatitis B"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344049\results\search\virus\results.xml">
   <result pre="well as has antiviral activity on the hepatitis A virus," exact="coxsackievirus" post="B3, enterovirus 71, and human rhinovirus 3 [21]. Ginsenoside"/>
   <result pre="on the hepatitis A virus, coxsackievirus B3, enterovirus 71, and" exact="human rhinovirus" post="3 [21]. Ginsenoside Rg3 attenuates hepatitis B virus DNA"/>
   <result pre="mitochondrial dynamics [23]. Glycyrrhizic acid is effective against infection of" exact="coxsackievirus" post="A16 and enterovirus 71 while Glycyrrhizin has an inhibition"/>
   <result pre="the SARS-associated virus [24]. Radix Glycyrrhizae restricts infection of the" exact="human respiratory syncytial virus" post="through preventing viral attachment, internalization, and by stimulating the"/>
   <result pre="that IFN-Î± and IFN-Î² both have protective effects during acute" exact="chikungunya virus" post="(CHIKV) infection, but the mechanisms are different. IFN-Î± inhibits"/>
   <result pre="IFN-Î± responsiveness to promote HCV eradication. IL-23 promotes host resistance" exact="vaccinia virus" post="infection via the IL-23/IL-17 axis. IL-23 produced by myeloid"/>
   <result pre="activity to control HIV [58]. IL-15 is up-regulated during primary" exact="human immunodeficiency virus" post="(HIV) infection, which renders primary human CD4+ cells more"/>
   <result pre="in many virus infections, including HBV, rotavirus, HIV, influenza virus," exact="dengue virus," post="and HSV-2 [60]. IL-22 induces the proliferation of liver"/>
   <result pre="peptide 1 (HNP1)Â with the in vitroÂ significant effects against" exact="vesicular stomatitis virus." post="Due to high viral mutation probability traditional vaccines are"/>
   <result pre="Wuhan, ChinaLancet.20203951022349750631986264 12.ChenLLiuWZhangQXuKYeGWuWet al.RNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg"/>
   <result pre="J Clin Exp Med2015810189631897126770521 21.SongJHChoiHJSongHHHongEHLeeBROhSRet al.Antiviral activity of ginsenosides against" exact="coxsackievirus" post="B3, enterovirus 71, and human rhinovirus 3J Ginseng Res201438317317925378991"/>
   <result pre="al.Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and" exact="human rhinovirus" post="3J Ginseng Res201438317317925378991 22.KangLJChoiYJLeeSGStimulation of TRAF6/TAK1 degradation and inhibition"/>
   <result pre="25.Feng YehCWangKCChiangLCShiehDEYenMHSanChang JWater extract of licorice had anti-viral activity against" exact="human respiratory syncytial virus" post="in human respiratory tract cell linesJ Ethnopharmacol2013148246647323643542 26.ChenXWangZYangZWangJXuYTanRXet al.Houttuynia"/>
   <result pre="43.CookLELockeMCYoungARMonteKHedbergMLShimakRMet al.Distinct roles of interferon alpha and beta in controlling" exact="chikungunya virus" post="replication and modulating neutrophil-mediated inflammationJ Virol2019941 44.MordsteinMNeugebauerEDittVJessenBRiegerTFalconeVet al.Lambda interferon"/>
   <result pre="97.XiaSYanLXuWAgrawalASAlgaissiATsengCTKet al.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci Adv.2019544580 98.ColemanCMSiskJMMingoRMNelsonEAWhiteJMFriemanMBAbelson kinase inhibitors are potent inhibitors of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344768\results\search\virus\results.xml">
   <result pre="perspectives: What animal coronaviruses have taught usRes. Vet. Sci.2020131212310.1016/j.rvsc.2020.04.00932278960 55.DecaroN.LorussoA.Novel" exact="human coronavirus" post="(SARS-CoV-2): A lesson from animal coronavirusesVet. Microbiol.202024410869310.1016/j.vetmic.2020.10869332402329 56.ChangT.W.Recurrent viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7344926\results\search\virus\results.xml">
   <result pre="to use antimalarial drugs in controlling other viral infections, including" exact="human immunodeficiency virus" post="(HIV) and hepatitis C. For example, the antimalarial drug,"/>
   <result pre="replication. This phenomenon was observed in many viruses, including the" exact="yellow fever virus," post="zika virus, and coronaviruses [33]. ADE can adversely impact"/>
   <result pre="was observed in many viruses, including the yellow fever virus," exact="zika virus," post="and coronaviruses [33]. ADE can adversely impact the process"/>
   <result pre="an inhibitor of hepatitis C virusHepatology201358869710.1002/hep.2627323348596 14.NeelyM.KalyesubulaI.BagendaD.MyersC.OlnessK.Effect of chloroquine on" exact="human immunodeficiency virus" post="(HIV) vertical transmissionAfr. Health Sci.20033616712913796 15.Clinical Trial Launches to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345039\results\search\virus\results.xml">
   <result pre="deemed important in veterinary responses; however, since the outbreak of" exact="human coronavirus" post="(HCoV) causing severe acute respiratory syndrome (SARS-CoV) in 2003,"/>
   <result pre="in vitro [65]. Lopinavir/ritonavir, a medication used to treat the" exact="human immunodeficiency virus" post="(HIV), is also found to exhibit anti-SARS-CoV activity in"/>
   <result pre="of Virus-Host InteractionsDiseases2016410.3390/diseases403002628933406 14.YeagerC.L.AshmunR.A.WilliamsR.K.CardellichioC.B.ShapiroL.H.LookA.T.HolmesK.V.Human aminopeptidase N is a receptor for" exact="human coronavirus" post="229ENature199235742042210.1038/357420a01350662 15.LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.SomasundaranM.SullivanJ.L.LuzuriagaK.GreenoughT.C.et al.Angiotensin-converting enzyme 2 is a functional receptor"/>
   <result pre="functional receptor for the SARS coronavirusNature200342645045410.1038/nature0214514647384 16.LiW.SuiJ.HuangI.C.KuhnJ.H.RadoshitzkyS.R.MarascoW.A.ChoeH.FarzanM.The S proteins of" exact="human coronavirus" post="NL63 and severe acute respiratory syndrome coronavirus bind overlapping"/>
   <result pre="a Receptor-Destroying EnzymeJ. Virol.2015897202721310.1128/JVI.00854-1525926653 20.ButlerN.PeweL.TrandemK.PerlmanS.Murine encephalitis caused by HCoV-OC43, a" exact="human coronavirus" post="with broad species specificity, is partly immune-mediatedVirology200634741042110.1016/j.virol.2005.11.04416413043 21.WrappD.WangN.CorbettK.S.GoldsmithJ.A.HsiehC.L.AbionaO.GrahamB.S.McLellanJ.S.Cryo-EM structure"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7345743\results\search\virus\results.xml">
   <result pre="repertoire for certain applications in canine medicine. In horses, the" exact="western equine encephalitis" post="virus (WEEV) and the Venezuelan equine encephalitis virus (VEEV)"/>
   <result pre="a naÃ¯ve llama antibody repertoire resulted in the screening of" exact="rabies virus" post="glycoprotein specific VHH, which later led to the generation"/>
   <result pre="and respiratory syndrome virus in pigs [65] VHH Camelid Whole" exact="rabies virus" post="in dogs [66] scFv Human * gD protein of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7346995\results\search\virus\results.xml">
   <result pre="respiratory syndrome, coronavirus infections and asthmaPediatr Allergy Immunol20041520620915209951 16GreenbergSBUpdate on" exact="human rhinovirus" post="and coronavirus infectionsSemin Respir Crit Care Med20163755557127486736 17PapadopoulosNGChristodoulouIRohdeGAgacheIAlmqvistCBrunoAet al.Viruses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7349555\results\search\virus\results.xml">
   <result pre="the spike proteins of severe acute respiratory syndrome coronavirus and" exact="human coronavirus" post="NL63J. Virol.2010841198120510.1128/JVI.01248-0919864379 25.TikellisC.ThomasM.C.Angiotensin-Converting Enzyme 2 (ACE2) Is a Key"/>
   <result pre="leads to re-admission after pneumonia resolvedInt. J. Infect. Dis.202010.1016/j.ijid.2020.04.06332353545 34.ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: Causes and consequences of cytokine storm and immunopathologySemin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7350360\results\search\virus\results.xml">
   <result pre="Severe Respiratory FailureCell Host Microbe2020271910.1016/j.chom.2020.04.00931951820 22.XuL.LiuJ.LuM.YangD.ZhengX.Liver injury during highly pathogenic" exact="human coronavirus" post="infectionsLiver Int.202040998100410.1111/liv.1443532170806 23.ZhangC.ShiL.WangF.-S.Liver injury in COVID-19: Management and challengesLancet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7351566\results\search\virus\results.xml">
   <result pre="of a rapidly changing epidemiology and the potential re-emergence of" exact="yellow fever virus" post="(YFV). Furthermore, the first-ever importation of YFV into Asia"/>
   <result pre="the world [1]. YF is caused by the etiological agent," exact="yellow fever virus" post="(YFV), which belongs to the flavivirus genus of arboviruses."/>
   <result pre="YFV spread to the Americas [14]. Unlike flaviviruses such as" exact="dengue virus" post="(DENV), YFV is highly stable with slow epidemic and"/>
   <result pre="feverRev Med Virol201323530531810.1002/rmv.175223873723 5.JohanssonMAVasconcelosPFStaplesJEThe whole iceberg: estimating the incidence of" exact="yellow fever virus" post="infection from the number of severe casesTrans R Soc"/>
   <result pre="10.CarringtonCVAugusteAJEvolutionary and ecological factors underlying the tempo and distribution of" exact="yellow fever virus" post="activityInfect Genet Evol20131319821010.1016/j.meegid.2012.08.01522981999 11.FernandesNCunhaMSGuerraJMRessioRACirqueiraCDSIgleziasSDet al.Outbreak of yellow fever among"/>
   <result pre="Santo, Brazil, 2017Emerg Infect Dis201723122038204110.3201/eid2312.17068529148378 12.SilvaNIOSacchettoLde RezendeIMTrindadeGSLaBeaudADde ThoisyBet al.Recent sylvatic" exact="yellow fever virus" post="transmission in Brazil: the news from an old diseaseVirol"/>
   <result pre="from an old diseaseVirol J2020171910.1186/s12985-019-1277-731973727 13.MutebiJPWangHLiLBryantJEBarrettADPhylogenetic and evolutionary relationships among" exact="yellow fever virus" post="isolates in AfricaJ Virol200175156999700810.1128/JVI.75.15.6999-7008.200111435580 14.BryantJEHolmesECBarrettADOut of Africa: a molecular"/>
   <result pre="14.BryantJEHolmesECBarrettADOut of Africa: a molecular perspective on the introduction of" exact="yellow fever virus" post="into the AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 15.ChenCJiangDNiMLiJChenZLiuJYeHWongGLiWZhangYWangBBiYChenDZhangPZhaoXKongYShiWduPXiaoGMaJGaoGFCuiJZhangFLiuWBoXLiAZengHLiuDPhylogenomic analysis unravels evolution of"/>
   <result pre="virus into the AmericasPLoS Pathog200735e7510.1371/journal.ppat.003007517511518 15.ChenCJiangDNiMLiJChenZLiuJYeHWongGLiWZhangYWangBBiYChenDZhangPZhaoXKongYShiWduPXiaoGMaJGaoGFCuiJZhangFLiuWBoXLiAZengHLiuDPhylogenomic analysis unravels evolution of" exact="yellow fever virus" post="within hostsPLoS Negl Trop Dis2018129e000673810.1371/journal.pntd.000673830188905 16.KumDBMishraNVranckenBThibautHJWilder-SmithALemeyPNeytsJDallmeierKLimited evolution of the"/>
   <result pre="virus within hostsPLoS Negl Trop Dis2018129e000673810.1371/journal.pntd.000673830188905 16.KumDBMishraNVranckenBThibautHJWilder-SmithALemeyPNeytsJDallmeierKLimited evolution of the" exact="yellow fever virus" post="17d in a mouse infection modelEmerg Microbes Infect2019811734174610.1080/22221751.2019.169439431797751 17.FigueiredoPOSilvaATSOliveiraJSMarinhoPERochaFTDomingosGPPobletePCPOliveiraLBSDuarteDCBonjardimCAAbrahÃ£oJSKroonEGDrumondBPOliveiraDBTrindadeGSDetection"/>
   <result pre="mouse infection modelEmerg Microbes Infect2019811734174610.1080/22221751.2019.169439431797751 17.FigueiredoPOSilvaATSOliveiraJSMarinhoPERochaFTDomingosGPPobletePCPOliveiraLBSDuarteDCBonjardimCAAbrahÃ£oJSKroonEGDrumondBPOliveiraDBTrindadeGSDetection and molecular characterization of" exact="yellow fever virus," post="2017Brazil Ecohealth201815486487010.1007/s10393-018-1364-z30117000 18.RezendeIMSacchettoLMunhoz de MelloEAlvesPAIaniFCMAdelinoTERet al.Persistence of Yellow fever"/>
   <result pre="fever transmission across AfricaPLoS Negl Trop Dis2018123e000628410.1371/journal.pntd.000628429543798 27.KraemerMUGFariaNRReinerRCJrGoldingNNikolayBStasseSJohanssonMASaljeHFayeOWintGRWNiedrigMShearerFMHillSCThompsonRNBisanzioDTaveiraNNaxHHPradelskiBSRNsoesieEOMurphyNRBogochIIKhanKBrownsteinJSTatemAJde OliveiraTSmithDLSallAAPybusOGHaySICauchemezSSpread of" exact="yellow fever virus" post="outbreak in Angola and the Democratic Republic of the"/>
   <result pre="2018Front Microbiol201910107910.3389/fmicb.2019.0107931178835 32.FariaNRKraemerMUGHillSCde Jesus GoesJAguiarRSIaniFCMet al.Genomic and epidemiological monitoring of" exact="yellow fever virus" post="transmission potentialScience.2018361640589489910.1126/science.aat711530139911 33.CunhaMDPDuarte-NetoANPourSZOrtiz-BaezASCernyJPereiraBBSet al.Origin of the Sao Paulo yellow"/>
   <result pre="Cruz201811310e18027810.1590/0074-0276018027830427974 35.Couto-LimaDMadecYBersotMICamposSSMottaMASantosFBDet al.Potential risk of re-emergence of urban transmission of" exact="yellow fever virus" post="in Brazil facilitated by competent Aedes populationsSci Rep201771484810.1038/s41598-017-05186-328687779 36.NavaAShimabukuroJSChmuraAALuzSLBThe"/>
   <result pre="Amanna IJ, et al. Persistence of neutralizing antibody responses among" exact="yellow fever virus" post="17D Vaccinees living in a nonendemic setting. J Infect"/>
   <result pre="deficient adenovectors encoding YF-17D antigens induces long-lasting protection from severe" exact="yellow fever virus" post="infection in micePLoS Negl Trop Dis2016102e000446410.1371/journal.pntd.000446426886513 88.MacielMJrCruz FdaSCordeiroMTda MottaMACassemiroKMMaia"/>
   <result pre="Trop Dis201594e000369310.1371/journal.pntd.000369325875109 89.JulanderJGTestoriMCheminayCVolkmannAImmunogenicity and protection after vaccination with a modified" exact="vaccinia virus" post="Ankara-vectored yellow fever vaccine in the hamster modelFront Immunol20189175610.3389/fimmu.2018.0175630116244"/>
   <result pre="replicationSci Rep201774092010.1038/srep4092028098253 96.XuHTColby-GerminarioSPHassounahSAFogartyCOsmanNPalanisamyNHanYOliveiraMQuanYWainbergMAEvaluation of Sofosbuvir (beta-D-2â€²-deoxy-2â€²-alpha-fluoro-2â€²-beta-C-methyluridine) as an inhibitor of" exact="dengue virus" post="replicationSci Rep201771634510.1038/s41598-017-06612-228740124 97.JulanderJGBantiaSTaubenheimBRMinningDMKotianPMorreyJDSmeeDFSheridanWPBabuYSBCX4430, a novel nucleoside analog, effectively treats"/>
   <result pre="in vivoPLoS Negl Trop Dis2019131e000707210.1371/journal.pntd.000707230699122 99.MendesEAPilgerDRBSantos NastriACSMaltaFMPascoalinoBDSCarneiro D'AlbuquerqueLAet al.Sofosbuvir inhibits" exact="yellow fever virus" post="in vitro and in patients with acute liver failureAnn"/>
   <result pre="of a human neutralizing and protective monoclonal antibody targeting the" exact="yellow fever virus" post="envelope. Cell Rep. 2019;26(2):438â€&quot;46 e5. 10.1016/j.celrep.2018.12.065."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7352498\results\search\virus\results.xml">
   <result pre="many new infectious disease agents, especially viruses, have appeared, with" exact="human immunodeficiency virus" post="(HIV) and acute respiratory infections being the leading causes"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7354743\results\search\virus\results.xml">
   <result pre="that no medically proven predecessor exists for any type of" exact="human coronavirus." post="Only a small number of SARS-CoV vaccines made it"/>
   <result pre="for some other RNA viruses, this is not so. The" exact="human immunodeficiency virus," post="types 1 and 2 (HIV-1 and HIV-2), is an"/>
   <result pre="simian immunodeficiency viruses (SIV) naturally infected African primates [29]. The" exact="human immunodeficiency virus" post="(HIV), which consists of two identical negative-sense single-stranded RNA"/>
   <result pre="most frequently studied organisms known to cause cytokine storms is" exact="influenza a virus," post="particularly the pandemic subtypes. It has been shown that"/>
   <result pre="vaccines against a large number of pathogens, including influenza virus," exact="measles virus," post="lymphocytic choriomeningitis virus, orthopoxviruses, and other viruses [71]. At"/>
   <result pre="al.Neutralization activity in a geographically diverse East London cohort of" exact="human immunodeficiency virus" post="type 1-infected patients: Clade C infection results in a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356537\results\search\virus\results.xml">
   <result pre="Research Database; ERR: excess relative risk; HMPV: human metapneumovirus; HPIV:" exact="human parainfluenza" post="virus; ICD: international classification of diseases; MERS: Middle East"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356583\results\search\virus\results.xml">
   <result pre="disease 2019 (COVID-19) with myocardial injury and mortalityJAMA Cardiol.202010.1001/jamacardio.2020.1105 26.ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: Causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356825\results\search\virus\results.xml">
   <result pre="classified into two groups: flaviviruses and alphaviruses. These include the" exact="dengue virus" post="(DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV),"/>
   <result pre="virus (WNV), and Zika virus (ZIKV) which are flaviviruses, and" exact="chikungunya virus" post="(CHIKV) which is an alphavirus (refer to Table 1)"/>
   <result pre="include DENV, JEV, WNV, ZIKV, and many others such as" exact="yellow fever virus" post="and hepatitis C virus (HCV). 2.1. Dengue Virus (DENV)"/>
   <result pre="serotypes, DEN-1 to -4. According to the World Health Organization," exact="dengue virus" post="(DENV) is considered to be the most widespread arbovirus"/>
   <result pre="antiviral activity against several enveloped viruses including PR8 influenza virus," exact="vaccinia virus," post="pseudorabies virus, Newcastle disease virus [98], HCV [120], and"/>
   <result pre="virus, pseudorabies virus, Newcastle disease virus [98], HCV [120], and" exact="human immunodeficiency virus" post="(HIV) [121]. In contrast, the non-enveloped enterovirus-A71 (EV-A71) remained"/>
   <result pre="Dengue and Chikungunya VirusesMolecules20172250510.3390/molecules22030505 24.BradyO.J.GethingP.W.BhattS.MessinaJ.P.BrownsteinJ.S.HoenA.G.MoyesC.L.FarlowA.W.ScottT.W.HayS.I.Refining the global spatial limits of" exact="dengue virus" post="transmission by evidence-based consensusPLoS Negl. Trop. Dis.20126e176010.1371/journal.pntd.000176022880140 25.BhattS.GethingP.W.BradyO.J.MessinaJ.P.FarlowA.W.MoyesC.L.DrakeJ.M.BrownsteinJ.S.HoenA.G.SankohO.et al.The"/>
   <result pre="baicalein with antiviral activity against dengue virusSci. Rep.20144545210.1038/srep0545224965553 97.BalasubramanianA.PilankattaR.TeramotoT.SajithA.M.NwuliaE.KulkarniA.PadmanabhanR.Inhibition of" exact="dengue virus" post="by curcuminoidsAntivir. Res.2019162717810.1016/j.antiviral.2018.12.00230529358 98.ChenT.-Y.ChenD.-Y.WenH.-W.OuJ.-L.ChiouS.-S.ChenJ.-M.WongM.-L.HsuW.-L.Inhibition of enveloped viruses infectivity by"/>
   <result pre="enveloped viruses infectivity by curcuminPLoS ONE20138e6248210.1371/journal.pone.006248223658730 99.MounceB.C.CesaroT.CarrauL.ValletT.VignuzziM.Curcumin inhibits Zika and" exact="chikungunya virus" post="infection by inhibiting cell bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 100.WeberC.SlivaK.Von RheinC.KÃ¼mmererB.M.SchnierleB.S.The green"/>
   <result pre="bindingAntivir. Res.201714214815710.1016/j.antiviral.2017.03.01428343845 100.WeberC.SlivaK.Von RheinC.KÃ¼mmererB.M.SchnierleB.S.The green tea catechin, epigallocatechin gallate inhibits" exact="chikungunya virus" post="infectionAntivir. Res.20151131310.1016/j.antiviral.2014.11.00125446334 101.CarneiroB.M.BatistaM.N.BragaA.C.S.NogueiraM.L.RahalP.The green tea molecule EGCG inhibits Zika"/>
   <result pre="RNA-Binding CharacteristicsPLoS ONE20127e3025910.1371/journal.pone.003025922276167 106.FrabasileS.KoishiA.C.KuczeraD.SilveiraG.F.VerriW.A.Jr.Duarte Dos SantosC.N.BordignonJ.The citrus flavanone naringenin impairs" exact="dengue virus" post="replication in human cellsSci. Rep.201774186410.1038/srep4186428157234 107.LeeJ.L.LoeM.W.C.LeeR.C.H.ChuJ.J.H.Antiviral activity of pinocembrin"/>
   <result pre="replicationAntivir. Res.2019167132410.1016/j.antiviral.2019.04.00330959074 108.ZandiK.TeohB.-T.SamS.-S.WongP.-F.MustafaM.R.AbubakarS.Antiviral activity of four types of bioflavonoid against" exact="dengue virus" post="type-2Virol. J.2011856010.1186/1743-422X-8-56022201648 109.MalakarS.SreelathaL.DechtawewatT.NoisakranS.YenchitsomanusP.-T.ChuJ.J.H.LimjindapornT.Drug repurposing of quinine as antiviral against"/>
   <result pre="virus type-2Virol. J.2011856010.1186/1743-422X-8-56022201648 109.MalakarS.SreelathaL.DechtawewatT.NoisakranS.YenchitsomanusP.-T.ChuJ.J.H.LimjindapornT.Drug repurposing of quinine as antiviral against" exact="dengue virus" post="infectionVirus Res.201825517117810.1016/j.virusres.2018.07.01830055216 110.MohdA.ZainalN.TanK.-K.AbubakarS.Resveratrol affects Zika virus replication in vitroSci."/>
   <result pre="Res.201917110458910.1016/j.antiviral.2019.10458931421165 112.EllanK.ThayanR.RamanJ.HidariK.I.P.J.IsmailN.SabaratnamV.Anti-viral activity of culinary and medicinal mushroom extracts against" exact="dengue virus" post="serotype 2: An in-vitro studyBMC Complement. Altern. Med.20191926010.1186/s12906-019-2629-y31533688 113.ClainE.HaddadJ.G.KoishiA.C.SinigagliaL.RachidiW.DesprÃ¨sP.Duarte"/>
   <result pre="hepatitis C virus genotypes into human liver cellsGut2014631137114910.1136/gutjnl-2012-30429923903236 121.MazumderA.RaghavanK.WeinsteinJ.KohnK.W.PommierY.Inhibition of" exact="human immunodeficiency virus" post="type-1 integrase by curcuminBiochem. Pharmacol.1995491165117010.1016/0006-2952(95)98514-A7748198 122.CallandN.AlbeckaA.BelouzardS.WychowskiC.DuverlieG.DescampsV.HoberD.DubuissonJ.RouillÃ©Y.SÃ©ronK.(âˆ’)-Epigallocatechin-3-gallate is a new"/>
   <result pre="123.YamaguchiK.HondaM.IkigaiH.HaraY.ShimamuraT.Inhibitory effects of (âˆ’)-epigallocatechin gallate on the life cycle of" exact="human immunodeficiency virus" post="type 1 (HIV-1)Antivir. Res.200253193410.1016/S0166-3542(01)00189-911684313 124.WeisburgJ.H.WeissmanD.B.SedaghatT.BabichH.In Vitro Cytotoxicity of Epigallocatechin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7356962\results\search\virus\results.xml">
   <result pre="periodic cold or mild human digestive infections [3]. A new" exact="human coronavirus" post="(CoV) became notably popular in spring 2003 because of"/>
   <result pre="of medicinal plants or isolated compounds on different strains of" exact="human coronavirus." post="Among these, four extracts exhibited moderate to potent inhibition"/>
   <result pre="of CoV that infects humans and animals and together with" exact="human coronavirus" post="OC43 is one of the common-cold viruses [17]. Such"/>
   <result pre="the treatment of SARSPhytother. Res.20041859259410.1002/ptr.148515305324 17.ChengP.W.NgL.T.ChiangL.C.LinC.C.Antiviral effects of saikosaponins on" exact="human coronavirus" post="229E in vitroClin. Experim. Pharmacol. Physiol.20063361261610.1111/j.1440-1681.2006.04415.x 18.HoeverG.BaltinaL.MichaelisM.KondratenkoR.BaltinaL.TolstikovG.A.CinatlJ.Antiviral Activity of"/>
   <result pre="Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against" exact="human coronavirus" post="NL63Virus. Res.201927319776710.1016/j.virusres.2019.19776731560964 59.Oâ€™KeefeB.R.GiomarelliB.BarnardD.L.ShenoyS.R.ChanP.K.McMahonJ.B.McCrayP.B.Broad-spectrum in vitro activity and in vivo"/>
   <result pre="B: Trends and developmentsCurr. Opinion. Pharmacol.2008853254010.1016/j.coph.2008.09.008 109.AsresK.BucarF.KartnigT.WitvrouwM.PannecouqueC.De ClercqE.Antiviral activity against" exact="human immunodeficiency virus" post="type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7357070\results\search\virus\results.xml">
   <result pre="studies aimed at the identification of the molecular mechanisms of" exact="human immunodeficiency virus" post="type 1 (HIV-1) infection and the development of novel"/>
   <result pre="within the global population. For several centuries, measles, poliomyelitis, rotavirus," exact="human immunodeficiency virus," post="and different respiratory viruses, including influenza, parainfluenza, adenoviruses, and"/>
   <result pre="Clinical Manifestations and Pathophysiological InsightsJ. Stroke Cerebrovasc. Dis.20202910494110.1016/j.jstrokecerebrovasdis.2020.104941 49.YoshiiH.KamiyamaH.GotoK.OishiK.KatunumaN.TanakaY.HayashiH.MatsuyamaT.SatoH.YamamotoN.et al.CD4-independent" exact="human immunodeficiency virus" post="infection involves participation of endocytosis and cathepsin BPLoS ONE20116e1935210.1371/journal.pone.001935221541353"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7358456\results\search\virus\results.xml">
   <result pre="effective way to control most of intracellular infections (29). The" exact="human immunodeficiency virus" post="(HIV), the pathogen well-known for evading immune responses, is"/>
   <result pre="Antiviral effects of trehalose on other disease-related viruses, such as" exact="human cytomegalovirus" post="(HCMV) and varicella-zoster virus (VZV), have been demonstrated in"/>
   <result pre="on other disease-related viruses, such as human cytomegalovirus (HCMV) and" exact="varicella-zoster virus" post="(VZV), have been demonstrated in vitro (Table 1). Its"/>
   <result pre="treated with trehalose, but autophagy induction impaired antiviral function against" exact="human rhinovirus" post="(HRV) infection (36) (Table 1). Table 1 Summary of"/>
   <result pre="92:e02015-17. 10.1128/JVI.02015-1729237845 34.BelzileJPSabalzaMCraigMClarkEMorelloCSSpectorDH. Trehalose, an mTOR-independent inducer of autophagy, inhibits" exact="human cytomegalovirus" post="infection in multiple cell types. J Virol. (2016) 90:1259â€&quot;77."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360125\results\search\virus\results.xml">
   <result pre="N Y Acad Sci20091173161962610.1111/j.1749-6632.2009.04759.x19758207 48.Acosta-AmpudiaYMonsalveDMCastillo-MedinaLFet al.Autoimmune neurological conditions associated with" exact="zika virus" post="infectionFront Mol Neurosci201810.3389/fnmol.2018.0011629695953 49.TanayAChikungunya virus and autoimmunityCurr Opin Rheumatol201729438939310.1097/BOR.000000000000039628376065"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7360901\results\search\virus\results.xml">
   <result pre="In the late autumn of 2019, aÂ new potentially lethal" exact="human coronavirus" post="designated severe acute respiratory syndrome coronavirusÂ 2 (SARS-CoV-2) emerged"/>
   <result pre="responses by applying live vaccines directed against, for example, tuberculosis," exact="poliovirus" post="or measles virus may reduce the susceptibility to SARS-CoVâ€‘2"/>
   <result pre="applying live vaccines directed against, for example, tuberculosis, poliovirus or" exact="measles virus" post="may reduce the susceptibility to SARS-CoVâ€‘2 infections and the"/>
   <result pre="death after feline infectious peritonitis virus challenge due to recombinant" exact="vaccinia virus" post="immunizationJ Virol199064140714092154621 62.DiamondMSPiersonTCThe challenges of vaccine development against aÂ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361534\results\search\virus\results.xml">
   <result pre="from the tobacco mosaic virus (1892), footâ€�mouth disease virus (1898)," exact="yellow fever virus" post="(1901) followed by a deadly virus created influenza epidemic"/>
   <result pre="transmission (Copyright permission @ 2016 Elsevier Ltd.30). Human coronaviruses The" exact="human coronavirus" post="first emerged in 1965 and was obtained from human"/>
   <result pre="virus and it was isolated from horseshoe bats.50 The fourth" exact="human coronavirus" post="strain, HCoVâ€�NL63 was identified by Hoek and coâ€�workers52 in"/>
   <result pre="problems in children due to HCoVâ€�NL63.30 In 2004 again, fifth" exact="human coronavirus" post="strain, HCoVâ€�HKU1 was isolated by Patrick and coâ€�workers53 from"/>
   <result pre="step to determine the host range for a coronavirus. Some" exact="human coronavirus" post="has receptors like angiotensinâ€�converting enzyme 2 (ACE2) for SARSâ€�CoV"/>
   <result pre="well known for the detection of various viruses such as" exact="dengue virus," post="influenza virus, bovine viral diarrhea coronavirus, etc.93 Recently, Seo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7361641\results\search\virus\results.xml">
   <result pre="have already proven effective for other viral diseases such as" exact="human immunodeficiency virus" post="(HIV) and malaria. Drug repurposing could be a rational"/>
   <result pre="the recent 2019 novel coronavirus (SARSâ€�CoVâ€�2) in light of past" exact="human coronavirus" post="outbreaks. Pathogens, 9(3), E18610.3390/pathogens903018632143502 BÃ¡ezâ€�Santos, Y. M., St John,"/>
   <result pre="Z., Koerhuis, D., &amp;amp; Veesler, D. (2019). Structural basis for" exact="human coronavirus" post="attachment to sialic acid receptors. Nature Structural &amp;amp; Molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362761\results\search\virus\results.xml">
   <result pre="therapeutics fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction The novel" exact="human coronavirus" post="(SARS-CoV-2) seems emerged in December 2019 in Wuhan, China"/>
   <result pre="the recent 2019 novel coronavirus (SARS-CoV-2) in light of past" exact="human coronavirus" post="outbreaks. Pathogens. (2020) 9:186. 10.3390/pathogens903018632143502 29.Rodriguez-PalaciosACominelliFBassonAPizarroTIlicS. Textile masks and"/>
   <result pre="295:4773â€&quot;9. 10.1074/jbc.AC120.01305632094225 46.KeyaertsELiSVijgenLRysmanEVerbeeckJVan RanstMet al.. Antiviral activity of chloroquine against" exact="human coronavirus" post="OC43 infection in newborn mice. Antimicrob Agents Chemother. (2009)"/>
   <result pre="de Chimie. (2018) 69:305â€&quot;9. 10.37358/RC.18.2.6095 106.MaQHuangWZhaoJYangZ. Liu Shen Wan inhibits" exact="influenza a virus" post="and excessive virus-induced inflammatory response via suppression of TLR4/NF-kappaB"/>
   <result pre="10.1016/S0140-6736(03)13615-X12814717 111.WuCYJanJTMaSHKuoCJJuanHFChengYSet al.. Small molecules targeting severe acute respiratory syndrome" exact="human coronavirus." post="Proc Natl Acad Sci USA. (2004) 101:10012â€&quot;7. 10.1073/pnas.040359610115226499 112.HoeverGBaltinaLMichaelisMKondratenkoRBaltinaLTolstikovGAet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362831\results\search\virus\results.xml">
   <result pre="are single-stranded, positive-sense RNA viruses that include Zika virus (ZIKV)," exact="dengue virus" post="(DENV), yellow fever virus (YFV), and West Nile virus"/>
   <result pre="RNA viruses that include Zika virus (ZIKV), dengue virus (DENV)," exact="yellow fever virus" post="(YFV), and West Nile virus (WNV), which still represent"/>
   <result pre="polioviruses, and hand, foot and mouth disease commonly caused by" exact="coxsackievirus" post="A16 or enterovirus 71 (EV71) [26,27]. Hepatitis E Virus"/>
   <result pre="MERS-CoV in cells [6,7]. Silvestrol also blocked the replication of" exact="poliovirus" post="type 1, but at higher concentrations with an EC50"/>
   <result pre="inhibits the translation of mRNAs harboring 5â€²-UTRs derived from the" exact="human coronavirus" post="HCoV-229E associated with common cold symptoms and the highly"/>
   <result pre="eIF4A inhibitor silvestrol against corona- and picornavirusesAntivir. Res.1502018123129 8HenssL.ScholzT.GruenwellerA.SchnierleB.S.Silvestrol inhibits" exact="chikungunya virus" post="replicationViruses102018592 9GlitscherM.HimmelsbachK.WoytinekK.JohneR.ReuterA.SpiricJ.SchwabenL.GruenwellerA.HildtE.Inhibition of hepatitis E virus spread by the"/>
   <result pre="(HEV) replication inÂ vitro and inÂ vivoAntivir. Res.1572018151158 11ElgnerF.SabinoC.BasicM.PloenD.GruenwellerA.HildtE.Inhibition of" exact="zika virus" post="replication by silvestrolViruses102018149/1-14914 12SlaineP.D.KleerM.SmithN.K.KhaperskyyD.A.McCormickC.Stress granule-inducing eukaryotic translation initiation factor"/>
   <result pre="silvestrolViruses102018149/1-14914 12SlaineP.D.KleerM.SmithN.K.KhaperskyyD.A.McCormickC.Stress granule-inducing eukaryotic translation initiation factor 4A inhibitors block" exact="influenza a virus" post="replicationViruses92017388/1-38815 13MuellerC.ObermannW.SchulteF.W.Lange-GruenwellerK.OestereichL.ElgnerF.GlitscherM.HildtE.SinghK.WendelH.-G.HartmannR.K.ZiebuhrJ.GruenwellerA.Comparison of broad-spectrum antiviral activities of the synthetic"/>
   <result pre="and the eIF4A-inhibitor silvestrolAntivir. Res.1752020104706 14WintachaiP.ThuaudF.BasmadjianC.RoytrakulS.UbolS.DesaubryL.SmithD.R.Assessment of flavaglines as potential" exact="chikungunya virus" post="entry inhibitorsMicrobiol. Immunol.592015129141 15LiuS.WangW.BrownL.E.QiuC.LajkiewiczN.ZhaoT.ZhouJ.PorcoJ.A.Jr.WangT.T.AÂ novel class of small molecule"/>
   <result pre="cellsVirology4062010149161 44ClydeK.KyleJ.L.HarrisE.Recent advances in deciphering viral and host determinants of" exact="dengue virus" post="replication and pathogenesisJ.Â Virol.80200611418 45SharmaA.VasanthapuramR.VenkataswamyM.M.DesaiA.Prohibitin 1/2 mediates Dengue-3 entry"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362842\results\search\virus\results.xml">
   <result pre="structure of the 2019-nCoV spike in the prefusion conformationScience36720201260126332075877 13ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362851\results\search\virus\results.xml">
   <result pre="Abstract Severe Acute Respiratory Distress Syndrome caused by a novel" exact="human coronavirus" post="SARS-CoV-2 named COVID-19 and declared as a pandemic. This"/>
   <result pre="Key Indexing Terms Coronavirus SARS-CoV-2 COVID-19 SARS Introduction A novel" exact="human coronavirus" post="named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged"/>
   <result pre="3DijkmanRJebbinkMFDeijsMReplication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by" exact="human coronavirus" post="NL63J Gen Virol9320121924192910.1099/vir.0.043919-022718567 4TikellisCThomasMCAngiotensin-Converting Enzyme 2 (ACE2) Is a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7362854\results\search\virus\results.xml">
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent. Sci.63202031533132226821 42WuC.LiuY.YangY.ZhangP.ZhongW.WangY.Analysis of therapeutic targets for SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7364167\results\search\virus\results.xml">
   <result pre="However, CyPA is closely related to viral infections, such as" exact="human immunodeficiency virus" post="(HIV), hepatitis B virus (HBV), hepatitis C virus (HCV),"/>
   <result pre="non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during" exact="human coronavirus" post="229E replicationAntiviral Res173202010462031634494 36NigroP.PompilioG.CapogrossiM.C.Cyclophilin A: a key player for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7367788\results\search\virus\results.xml">
   <result pre="time in the twenty-first century when a new, highly pathogenic" exact="human coronavirus" post="outbreak has led to an epidemic. The COVID-19 epidemic"/>
   <result pre="Lopinavir and Ritonavir These protease inhibitors are widely used for" exact="human immunodeficiency virus" post="(HIV) and have also shown potential antiviral activity against"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent Sci2020631533132226821 12.ThorlundKDronLParkJHsuGForrestJIMillsEJA real-time dashboard of clinical trials"/>
   <result pre="S protein efficiently binds angiotensin-converting enzyme 2J Biol Chem20042793197320114670965 53.ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7368942\results\search\virus\results.xml">
   <result pre="animal model study with the BALB/c mouse strain infected with" exact="dengue virus" post="type 2 identified elevated levels of TNF-Î± within the"/>
   <result pre="Virginia, Risaralda, ColombiaF1000Research20165p. 36010.12688/f1000research.8235.2 4BonifayT.PrinceC.NeyraC.et al.Atypical and severe manifestations of" exact="chikungunya virus" post="infection in French Guiana: a hospital-based studyPLoS One2018131210.1371/journal.pone.0207406 5Antunes"/>
   <result pre="in BrazilRevista da Sociedade Brasileira de Medicina Tropical201750558558910.1590/0037-8682-0479-201629160503 6EconomopoulouA.DominguezM.HelynckB.et al.Atypical" exact="chikungunya virus" post="infections: clinical manifestations, mortality and risk factors for severe"/>
   <result pre="on rÃ©unionEpidemiology and Infection2009137453454110.1017/S095026880800116718694529 7RenaultP.de ValkH.BalleydierE.et al.A major epidemic of" exact="chikungunya virus" post="infection on rÃ©union island, France, 2005-2006The American Journal of"/>
   <result pre="&amp;amp; Hepatology201812111101110810.1080/17474124.2018.153098330277409 11AtrasheuskayaA.PetzelbauerP.FredekingT. M.IgnatyevG.Anti-TNF antibody treatment reduces mortality in experimental" exact="dengue virus" post="infectionFEMS Immunology &amp;amp; Medical Microbiology2003351334210.1111/j.1574-695X.2003.tb00646.x12589955 12DelignyC.de BandtM.DehlingerV.et al.Dengue fever"/>
   <result pre="B.TanabeE. L. L.SantosE. C.et al.Cellular and molecular immune response to" exact="chikungunya virus" post="infectionFrontiers in Cellular and Infection Microbiology20188p. 34510.3389/fcimb.2018.00345 19VenugopalanA.GhorpadeR. P.ChopraA.Cytokines"/>
   <result pre="in acute chikungunyaPLoS One201491010.1371/journal.pone.0111305 20CunhaR. V.TrintaK. S.MontalbanoC. A.et al.Seroprevalence of" exact="chikungunya virus" post="in a rural community in BrazilPLoS Neglected Tropical Diseases201711110.1371/journal.pntd.0005319"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7369591\results\search\virus\results.xml">
   <result pre="hypertension and/or diabetes (P=.4712 and P=.7704). Lopinavir/Ritonavir Lopinavir/ritonavir inhibit the" exact="human immunodeficiency virus" post="type 1 protease and are used in the treatment"/>
   <result pre="type 1 protease and are used in the treatment of" exact="human immunodeficiency virus" post="infection and AIDS. Reports of the potentially successful use"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent Sci63202031533132226821 116Eli Lilly and Company. Lilly Begins"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7374000\results\search\virus\results.xml">
   <result pre="amniotic fluid embolism [62]. Rhabdomyolysis can be caused by the" exact="measles virus," post="influenza viruses, and coronaviruses [63,64], and substances produced by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7375387\results\search\virus\results.xml">
   <result pre="constitute an excellent model to study infection with the novel" exact="human coronavirus" post="SARS-CoV-2. We observed efficient replication of the virus in"/>
   <result pre="of the time to the most recent ancestor suggests that" exact="human coronavirus" post="NL63 (HCoV-NL63) is the oldest species in humans, followed"/>
   <result pre="zoonotic transmission, however, resulted in the emergence of a novel" exact="human coronavirus" post="which seems to carry an optimal set of features"/>
   <result pre="fully differentiated epithelium cultures to study infection with the novel" exact="human coronavirus" post="SARS-CoV-2. We observed efficient replication of the virus in"/>
   <result pre="lines in terms of their ability to support replication of" exact="human coronavirus" post="HKU1 (HCoV-HKU1) and also as a model to study"/>
   <result pre="DijkmanR, DengL, JebbinkMF, RossHA, BerkhoutB, van der HoekL2006Mosaic structure of" exact="human coronavirus" post="NL63, one thousand years of evolution. J Mol Biol364:964â€&quot;973."/>
   <result pre="BerkhoutRJ, WolthersKC, Wertheim-van DillenPM, KaandorpJ, SpaargarenJ, BerkhoutB2004Identification of a new" exact="human coronavirus." post="Nat Med10:368â€&quot;373. doi:10.1038/nm1024.15034574 4.ForniD, CaglianiR, ClericiM, SironiM2017Molecular evolution of"/>
   <result pre="coronavirus. Nat Med10:368â€&quot;373. doi:10.1038/nm1024.15034574 4.ForniD, CaglianiR, ClericiM, SironiM2017Molecular evolution of" exact="human coronavirus" post="genomes. Trends Microbiol25:35â€&quot;48. doi:10.1016/j.tim.2016.09.001.27743750 5.RamadanN, ShaibH2019Middle East respiratory syndrome"/>
   <result pre="SzczepanskiA, ZarebskiM, HoangA, BerniakK, WojarskiJ, ZeglenS, BasterZ, RajfurZ, PyrcK2017Entry of" exact="human coronavirus" post="NL63 into the cell. J Virol92:e01933-17. doi:10.1128/JVI.01933-17. 14.ShiratoK, KanouK,"/>
   <result pre="cell. J Virol92:e01933-17. doi:10.1128/JVI.01933-17. 14.ShiratoK, KanouK, KawaseM, MatsuyamaS2017Clinical isolates of" exact="human coronavirus" post="229E bypass the endosome for cell entry. J Virol91:e01387-16."/>
   <result pre="DemingD, DonaldsonE, VabretA, BaricR, van der HoekL, PicklesR2010Culturing the unculturable:" exact="human coronavirus" post="HKU1 infects, replicates, and produces progeny virions in human"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7377207\results\search\virus\results.xml">
   <result pre="Nidoviruses 2001 (pp. 193â€&quot;198). Springer, Boston, MA.doi: 10.1007/978-1-4615-1325-4_31. 51.KonoMTatsumiKImaiAMSaitoKKuriyamaTShirasawaHInhibition of" exact="human coronavirus" post="229E infection in human epithelial lung cells (L132) by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7388682\results\search\virus\results.xml">
   <result pre=", BarrasAet al.Functional carbon quantum dots as medical countermeasures to" exact="human coronavirus." post="ACS Appl. Mater. Interfaces11(46), 42964â€&quot;42974 (2019).31633330 13.collab: Centers for"/>
   <result pre="al.Dipeptidyl peptidase 4 is a functional receptor for the emerging" exact="human coronavirus" post="â€&quot; EMC. Nature495(7440), 251â€&quot;254 (2013).23486063 22.LiW , MooreMJ ,"/>
   <result pre="JanJT , MaSHet al.Small molecules targeting severe acute respiratory syndrome" exact="human coronavirus." post="Proc. Natl Acad. Sci. USA101(27), 10012 (2004).15226499 99.ChuCM ,"/>
   <result pre="capsid protein expressed from a baculovirus system compared with a" exact="vaccinia virus" post="system. Biotechnol. Appl. Biochem.32(1), 27â€&quot;33 (2000).10918035 130.ToddTJ , ZhenZ"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7391235\results\search\virus\results.xml">
   <result pre="14.DubÃ©, M. et al. Axonal transport enables neuron-to-neuron propagation of" exact="human coronavirus" post="OC43. J Virol.92. 10.1128/jvi.00404-18. (2018). 15.LiFReceptor recognition and cross-species"/>
   <result pre="Cashman, N. R., Mouni, S., Stewart, J. N. Neurotropism of" exact="human coronavirus" post="229E. In: Advances in Experimental Medicine and Biology. 342,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7392210\results\search\virus\results.xml">
   <result pre="21 July 2020. 44ShamH.L.ABT-378, a highly potent inhibitor of the" exact="human immunodeficiency virus" post="proteaseAntimicrob. Agents Chemother.421998321832249835517 45ChuC.M.Role of lopinavir/ritonavir in the treatment"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396637\results\search\virus\results.xml">
   <result pre="EVs and viral infection has also been extensively investigated, including" exact="human immunodeficiency virus" post="(HIV), hepatitis B virus (HBV), Hepatitis C virus (HCV),"/>
   <result pre="1791â€&quot;1800. 10.1007/s00125-017-4331-228601907 ChenX.LiuS.GorayaM. U.MaaroufM.HuangS.ChenJ. L. (2018). Host immune response to" exact="influenza a virus" post="infection. Front. Immunol.9:32010.3389/fimmu.2018.0032029556226 CocucciE.MeldolesiJ. (2015). Ectosomes and exosomes: shedding"/>
   <result pre="255â€&quot;289. 10.1146/annurev-cellbio-101512-12232625288114 ConeA. S.YorkS. B.MeckesD. G.Jr. (2019). Extracellular vesicles in" exact="epstein-barr virus" post="pathogenesis. Curr. Clin. Microbiol. Rep.6, 121â€&quot;131. 10.1007/s40588-019-00123-632051811 CyprykW.LoreyM.PuustinenA.NymanT. A.MatikainenS."/>
   <result pre="bioinformatic characterization of extracellular vesicles released from human macrophages upon" exact="influenza a virus" post="infection. J. Proteome. Res.16, 217â€&quot;227. 10.1021/acs.jproteome.6b0059627723984 DasK.PrasadR.RoyS.MukherjeeA.SenP. (2018). The"/>
   <result pre="and bioinformatic characterization of mouse mast cells (P815) upon different" exact="influenza a virus" post="(H1N1, H5N1, and H7N2) infections. Front. Genet.10:595. 10.3389/fgene.2019.0059531281330 HutchinsonE."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7396720\results\search\virus\results.xml">
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent Sci202063153132226821 4.SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for coronavirus disease 2019"/>
   <result pre="receptor bindingLancet20203955657432007145 6.ChenLLiuWZhangQXuKYeGWuWet al.RNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg"/>
   <result pre="of the SARS-CoV-2 spike glycoproteinCell202018128192 e28632155444 17.BertramSDijkmanRHabjanMHeurichAGiererSGlowackaIet al.TMPRSS2 activates the" exact="human coronavirus" post="229E for cathepsin-independent host cell entry and is expressed"/>
   <result pre="22.XiaSYanLXuWAgrawalASAlgaissiATsengCKet al.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci Adv20195eaav458030989115 23.MilletJKWhittakerGRPhysiological and molecular triggers for SARS-CoV membrane"/>
   <result pre="structural studies of SARS coronavirusJ Virol202094e001272031996437 40.TortoriciMAWallsACLangYWangCLiZKoerhuisDet al.Structural basis for" exact="human coronavirus" post="attachment to sialic acid receptorsNat Struct Mol Biol201926481931160783 41.CoutardBValleCde"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7398440\results\search\virus\results.xml">
   <result pre="KochC, et al.: Full-length sequence and mosaic structure of a" exact="human immunodeficiency virus" post="type 1 isolate from Thailand. J Virol1996;70:5935â€&quot;59438709215 2.GaoF, RobertsonDL,"/>
   <result pre="Thailand. J Virol1996;70:5935â€&quot;59438709215 2.GaoF, RobertsonDL, MorrisonSG, et al.: The heterosexual" exact="human immunodeficiency virus" post="type 1 epidemic in Thailand is caused by an"/>
   <result pre="et al.: Testing the hypothesis of a recombinant origin of" exact="human immunodeficiency virus" post="type 1 subtype E. J Virol2000;74:10752â€&quot;1076511044120 4.MurphyE, KorberB, Georges-CourbotMC,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7400054\results\search\virus\results.xml">
   <result pre="within the central nervous systemPLoS Pathog.201511e100526110.1371/journal.ppat.100526126545254 37.KirchdoerferR.N.CottrellC.A.WangN.PallesenJ.YassineH.M.TurnerH.L.CorbettK.S.GrahamB.S.McLellanJ.S.WardA.B.Pre-fusion structure of a" exact="human coronavirus" post="spike proteinNature201653111812110.1038/nature1720026935699 38.WallsA.C.TortoriciM.A.SnijderJ.XiongX.BoschB.J.ReyF.A.VeeslerD.Tectonic conformational changes of a coronavirus spike"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7400365\results\search\virus\results.xml">
   <result pre="Int. AIDS Soc.201821115 15.SimmonsB.SaleemJ.HillA.RileyR.D.CookeG.S.Risk of late relapse or reinfection with" exact="hepatitis c virus" post="after achieving a sustained virological response: A systematic review"/>
   <result pre="TURQUOISE-I Part 2Open Forum Infect. Dis.20174ofx15410.1093/ofid/ofx15428948180 26.SarrazinC.IsakovV.SvarovskaiaE.S.HedskogC.MartinR.ChodavarapuK.BrainardD.M.MillerM.D.MoH.MolinaJ.M.et al.Late relapse versus" exact="hepatitis c virus" post="reinfection in patients with sustained virologic response after sofosbuvir-based"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402116\results\search\virus\results.xml">
   <result pre="cytoprotection. This has been seen in other viral illness like" exact="human immunodeficiency virus" post="(HIV), Ebola, and SARS/MERS. There are a number of"/>
   <result pre="profile, used extensively in triple negative breast cancer and in" exact="human immunodeficiency virus" post="(HIV) treatment [137,138]. There is a granulocyte-macrophage colony-stimulating factor"/>
   <result pre="interest. Abbreviations ACE angiotensin converting enzyme HO heme oxygenase HIV" exact="human immunodeficiency virus" post="SARS acute respiratory distress syndrome MERS middle East respiratory"/>
   <result pre="AZT: Protective role of heme and IL-1Exp. Hematol.1993212632687678812 147.LevereR.D.GongY.F.KappasA.BucherD.J.WormserG.P.AbrahamN.G.Heme inhibits" exact="human immunodeficiency virus" post="1 replication in cell cultures and enhances the antiviral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402395\results\search\virus\results.xml">
   <result pre="still be prone to a second infection. Coronavirus Virology A" exact="human coronavirus" post="was isolated for the first time from the nasal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7402641\results\search\virus\results.xml">
   <result pre="replicationAntiviral Res2019167354430974126 ChenLLiuWZhangQXuKYeGWuWSunZLiuFWuKZhongBet al.RNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg"/>
   <result pre="system suitable for high-throughput screening of compounds able to inhibit" exact="ebolavirus" post="replication and/or transcriptionAntimicrob Agents Chemother201054300720421407 JordanPCStevensSKDevalJNucleosides for the treatment"/>
   <result pre="refinement of macromolecular crystal structuresActa Crystallogr Sect D20116735536721460454 QingMZouGWangQ-YXuHYDongHYuanZShiP-YCharacterization of" exact="dengue virus" post="resistance to brequinar in cell cultureAntimicrob Agents Chemother2010543686369520606073 RavehADelektaPCDobryCJPengWSchultzPJBlakelyPKTaiAWMatainahoTIraniDNShermanDHDiscovery"/>
   <result pre="during recovery from SARSRespir Res200564215888207 WangQYBushellSQingMXuHYBonaviaANunesSZhouJPohMKFlorez de SessionsPNiyomrattanakitPet al.Inhibition of" exact="dengue virus" post="through suppression of host pyrimidine biosynthesisJ Virol2011856548655621507975 WangMCaoRZhangLYangXLiuJXuMShiZHuZZhongWXiaoGRemdesivir and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403001\results\search\virus\results.xml">
   <result pre="the recent 2019 novel coronavirus (SARS-CoV-2) in light of past" exact="human coronavirus" post="outbreaksPathogens92020186 11ChanJ.F.W.KokK.H.ZhuZ.ChuH.ToK.K.-W.YuanS.YuenK.-Y.Genomic characterization of the 2019 novel human-pathogenic coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7403098\results\search\virus\results.xml">
   <result pre="2016) and H1N1 type influenza virus (Singh et al., 2017)," exact="human immunodeficiency virus" post="(HIV), human papillomavirus (HPV) (Huang et al., 2015), and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404079\results\search\virus\results.xml">
   <result pre="including herpesviruses, human immunodeficiency viruses (HIV), human T-lymphotropic virus (HTLV)," exact="human adenovirus" post="(HAdV), influenza A virus and Dengue virus (DENV) [38]."/>
   <result pre="7.JossetLMenacheryVDGralinskiLEAgnihothramSSovaPCarter VS, et alCell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
   <result pre="76.PoppeMWittigSJuridaLBartkuhnMWilhelmJMÃ¼llerHet al.The NF-ÎºB-dependent and -independent transcriptome and chromatin landscapes of" exact="human coronavirus" post="229E-infected cellsPLoS Pathog.201713e100628628355270 77.Chiusano ML. The modelling of COVID19"/>
   <result pre="medical treatments. v2. ArXiv200311614 Q-Bio. Available at: http://arxiv.org/abs/2003.11614 (2020). 78.ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404132\results\search\virus\results.xml">
   <result pre="76.XiaS.YanL.XuW.AgrawalA.S.AlgaissiA.TsengC.-T.K.WangQ.DuL.TanW.WilsonI.A.et al.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci. Adv.20195eaav458010.1126/sciadv.aav458030989115 77.GrahamR.L.DonaldsonE.F.BaricR.S.A decade after SARS: Strategies for controlling"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404531\results\search\virus\results.xml">
   <result pre="communities in determining appropriate study design. Like in the recombinant" exact="vesicular stomatitis virus" post="vaccine trial, the ring vaccination design found appropriate for"/>
   <result pre="Design. American Journal of Public Health. 106(3): 432â€�5. The recombinant" exact="vesicular stomatitis virus" post="vaccine trial was found morally appropriate for West Africa"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7404911\results\search\virus\results.xml">
   <result pre="It also has high mortality and low cure rates of" exact="human immunodeficiency virus" post="(HIV)-positive TB patients. This study aimed to analyse, under"/>
   <result pre="Guide. GHD online. https://www.ghdonline.org/drtb/discussion/practical-guidance-for-pediatric-mdr-tb-management/?ref=profile_detail. Accessed 2012. 5.BarnesPFBlochABDavidsonPTSniderDETuberculosis in patients with" exact="human immunodeficiency virus" post="infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of human immunodeficiency virus"/>
   <result pre="with human immunodeficiency virus infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of" exact="human immunodeficiency virus" post="infection on the epidemiology, clinical features, management, and control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405170\results\search\virus\results.xml">
   <result pre="used in dental operatories, Escherichia coli, Staphylococcus aureus, human papillomavirus," exact="human immunodeficiency virus," post="and hepatitis B virus have been detected in surgical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405322\results\search\virus\results.xml">
   <result pre="to Mycobacterium tuberculosis (MTB). 2 CASE PRESENTATION A 2â€�year 5â€�monthâ€�old" exact="human immunodeficiency virus" post="(HIV)â€�negative boy presented to his local hospital with fever,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405402\results\search\virus\results.xml">
   <result pre="drug target explored against the influenza virus, rhinoviruses, hepatitis A," exact="poliovirus" post="and enteroviruses (Yamauchi &amp;amp; Greber,Â 2016). In accordance with"/>
   <result pre="HIVâ€�2 (Wu etÂ al.,Â 1995), HIVâ€�1 (Li etÂ al.,Â 2009)," exact="dengue virus" post="type 2 (DENV2) (Qin etÂ al.,Â 2005), HBV (Seo"/>
   <result pre="Y. (2011). Receptor tyrosine kinase inhibitors block multiple steps of" exact="influenza a virus" post="replication. Journal of Virology, 85, 2818â€&quot;2827. 10.1128/JVI.01969-1021209112 Landrieu, I.,"/>
   <result pre="A. H., &amp;amp; White, J. M. (2009). Î±5 Î²1â€�Integrin controls" exact="ebolavirus" post="entry by regulating endosomal cathepsins. Proceedings of the National"/>
   <result pre="G., â€¦ Kappes, J. C. (1995). Targeting foreign proteins to" exact="human immunodeficiency virus" post="particles via fusion with Vpr and Vpx. Journal of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405653\results\search\virus\results.xml">
   <result pre="Commons Attribution License Abstract Abstract Since the emergence of the" exact="chikungunya virus" post="in Brazil in 2014, more than 700,000 cases have"/>
   <result pre="Musculoskeletal pain Arbovirus Management fig-count: table-count: equation-count: ref-count: INTRODUCTION The" exact="chikungunya virus" post="(CHIKV) is an arbovirus of the family Togaviridae, genus"/>
   <result pre="core antigen), hepatitis C (antibody to hepatitis C virus) and" exact="human immunodeficiency virus," post="the Mantoux test, and chest x-ray. Physiotherapeutic treatment is"/>
   <result pre="in BrazilPLoS Negl Trop Dis201711111110.1371/journal.pntd.0005319 9DiasJPCosta M daCNCamposGSPaixÃ£oESNatividadeMSBarretoFRet al.Seroprevalence of" exact="chikungunya virus" post="after its emergence in BrazilEmerg Infect Dis201824917731773 10PaixÃ£oESRodriguesLCCosta M"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7405836\results\search\virus\results.xml">
   <result pre="responses (176). The recombinant vaccine can be designed by using" exact="rabies virus" post="(RV) as a viral vector. RV can be made"/>
   <result pre="against emerging infectious diseases. The dual vaccine developed from inactivated" exact="rabies virus" post="particles that express the MERS-CoV S1 domain of S"/>
   <result pre="was found to induce immune responses for both MERS-CoV and" exact="rabies virus." post="The vaccinated mice were found to be completely protected"/>
   <result pre="to the influenza virus, hepatitis C virus, Ebola virus, and" exact="dengue virus" post="(206). Producing similar transbodies against intracellular proteins of coronaviruses,"/>
   <result pre="2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infections. Viruses12:194. doi:10.3390/v12020194. 121.LiuY, YangY, ZhangC, HuangF, WangF, YuanJ,"/>
   <result pre="humans and animals against Middle East Respiratory syndrome coronavirus and" exact="rabies virus." post="J Virol91:e02040-16. doi:10.1128/JVI.02040-16.27807241 170.BuchholzUJ, BukreyevA, YangL, LamirandeEW, MurphyBR, SubbaraoK,"/>
   <result pre="SzczepanskiA, ZarebskiM, HoangA, BerniakK, WojarskiJ, ZeglenS, BasterZ, RajfurZ, PyrcK2017Entry of" exact="human coronavirus" post="NL63 into the cell. J Virol92:e01933-17. doi:10.1128/JVI.01933-17. 225.NkengasongJ2020Chinaâ€™s response"/>
   <result pre="N Engl J Med382:1564â€&quot;1567. doi:10.1056/NEJMc2004973.32182409 258.LoeffelholzMJ, TangYW2020Laboratory diagnosis of emerging" exact="human coronavirus" post="infectionsâ€&quot;the state of the art. Emerg Microbes Infect9:1â€&quot;26. doi:10.1080/22221751.2020.1745095.31859589"/>
   <result pre="studies. Viruses12:254. doi:10.3390/v12030254. 295.RamaiahA, ArumugaswamiV2020Insights into cross-species evolution of novel" exact="human coronavirus" post="2019-nCoV and defining immune determinants for vaccine development. bioRxiv10.1101/2020.01.29.925867."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409030\results\search\virus\results.xml">
   <result pre="and are grouped in four genera, as follows: alphacoronavirus (e.g.," exact="human coronavirus" post="NL63 (HCoV-NL63), human coronavirus 229E (HCoV-229E), porcine transmissible gastroenteritis"/>
   <result pre="four genera, as follows: alphacoronavirus (e.g., human coronavirus NL63 (HCoV-NL63)," exact="human coronavirus" post="229E (HCoV-229E), porcine transmissible gastroenteritis coronavirus (TGEV), porcine epidemic"/>
   <result pre="bat coronavirus HKU4, mouse hepatitis coronavirus (MHV), bovine coronavirus (BCoV)," exact="human coronavirus" post="OC43, and human coronavirus Hong University 1 (HCoV-HKU1)), gammacoronavirus"/>
   <result pre="hepatitis coronavirus (MHV), bovine coronavirus (BCoV), human coronavirus OC43, and" exact="human coronavirus" post="Hong University 1 (HCoV-HKU1)), gammacoronavirus (e.g., avian infectious bronchitis"/>
   <result pre="paramyxoviridae (parainfluenza type 3 virus, measles and mumps viruses, and" exact="nipah virus," post="among others) and pneumoviridae (respiratory syncytial virus), and positive"/>
   <result pre="of molecular docking, using a previous co-crystal structure of the" exact="poliovirus" post="RdRp. The study showed that the difference between the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409380\results\search\virus\results.xml">
   <result pre="with magnetic nanoparticles through real-time optomagnetic measurement, which can detect" exact="dengue virus" post="at the femtomolar (fM) level.81 Microfluidic-circular fluorescent probe-mediated isothermal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409838\results\search\virus\results.xml">
   <result pre="C virus His-al (S)-2-amino-3-imidazolyl propanal HIV Human immunodeficiency virus HCoV" exact="human coronavirus" post="M Membrane protein MERS-CoV Middle East respiratory syndrome coronavirus"/>
   <result pre="derivatives, and among these, 47â€&quot;51 exhibited good antiviral properties against" exact="human coronavirus" post="229E (TableÂ 3 ). Fig.Â 13 (A) P1 modifications,"/>
   <result pre="8.4Â Î¼M, respectively, and favourably, 73 could also effectively inhibit" exact="coxsackievirus" post="B3 3CLpro [76]. Po-Huang Liang etÂ al. further synthesized"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7409942\results\search\virus\results.xml">
   <result pre="for the SARS coronavirusNature4266965200345045410.1038/nature0214514647384 24LuG.HuY.WangQ.QiJ.GaoF.LiY.Molecular basis of binding between novel" exact="human coronavirus" post="MERS-CoV and its receptor CD26Nature5007461201322723110.1038/nature1232823831647 25QianZ.TravantyE.A.OkoL.EdeenK.BerglundA.WangJ.Innate immune response of"/>
   <result pre="in vitroCell Res.303202026927110.1038/s41422-020-0282-032020029 87ShamH.L.KempfD.J.MollaA.MarshK.C.KumarG.N.ChenC.M.ABT-378, a highly potent inhibitor of the" exact="human immunodeficiency virus" post="proteaseAntimicrob .Agents Chemother.4212199832183224Epub 1998/12/03. PubMed PMID: 9835517; PubMed Central"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7410516\results\search\virus\results.xml">
   <result pre="a global pandemic. Abstract COVID-19 is a pandemic caused by" exact="human coronavirus" post="(HCoV) SARS-CoV-2, which originated in Wuhan, China, at the"/>
   <result pre="M, Talbot PJ (2018) Axonal transport enables neuron-to-neuron propagation of" exact="human coronavirus" post="OC43. J Virol 92(17):e00404-18. 10.1128/JVI.00404-18 15.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute respiratory syndrome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7411102\results\search\virus\results.xml">
   <result pre="for Disease Control and PreventionJ Am Med Assoc2020201936http://www.ncbi.nlm.nih.gov/pubmed/32091533 8LeeJ.StorchG.A.Characterization of" exact="human coronavirus" post="OC43 and human coronavirus NL63 infections among hospitalized children"/>
   <result pre="PreventionJ Am Med Assoc2020201936http://www.ncbi.nlm.nih.gov/pubmed/32091533 8LeeJ.StorchG.A.Characterization of human coronavirus OC43 and" exact="human coronavirus" post="NL63 infections among hospitalized children &amp;lt;5 years of agePediatr"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7413162\results\search\virus\results.xml">
   <result pre="13ArbourN.CÃ´tÃ©G.LachanceC.TardieuM.CashmanN.R.TalbotP.J.Acute and persistent infection of human neural cell lines by" exact="human coronavirus" post="OC43J Virol.73419993338335010074188 14DubÃ©M.Le CoupanecA.WongA.H.M.RiniJ.M.DesforgesM.TalbotP.J.Axonal transport enables neuron-to-neuron propagation of"/>
   <result pre="coronavirus OC43J Virol.73419993338335010074188 14DubÃ©M.Le CoupanecA.WongA.H.M.RiniJ.M.DesforgesM.TalbotP.J.Axonal transport enables neuron-to-neuron propagation of" exact="human coronavirus" post="OC43J Virol.92172018e00404e0041829925652 15NilssonA.EdnerN.AlbertJ.TernhagA.Fatal encephalitis associated with coronavirus OC43 in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414693\results\search\virus\results.xml">
   <result pre="remains active. The lessons learned from the response to the" exact="human immunodeficiency virus" post="(HIV) epidemic are important to quell the opioid use"/>
   <result pre="â€¢The opioid epidemic is fueling new infectious disease epidemics, including" exact="human immunodeficiency virus" post="(HIV), hepatitis C virus, and serious bacterial infections such"/>
   <result pre="directly related to a surge in infectious diseases such as" exact="human immunodeficiency virus" post="(HIV), hepatitis C virus (HCV), and serious bacterial infections"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7414935\results\search\virus\results.xml">
   <result pre="al. Elucidation of the stability and functional regions of the" exact="human coronavirus" post="OC43 nucleocapsid protein. Protein Sci. 2009;18:2209â€&quot;2218. doi:10.1002/pro.22519691129 14.SanchezCM, IzetaA,"/>
   <result pre="WilliamsRK, et al. Human aminopeptidase N is a receptor for" exact="human coronavirus" post="229E. Nature. 1992;357:420â€&quot;422. doi:10.1038/357420a01350662 30.LiW, MooreMJ, VasilievaN, et al."/>
   <result pre="innate immune response. PLoS One. 2013;8:e70129. doi:10.1371/journal.pone.007012923894604 39.DongC. Advances in" exact="human coronavirus" post="229E. Occup Health. 2014;30:3625â€&quot;3628. 40.ZhangY. Molecular Epidemiology and Phylogenetic"/>
   <result pre="2020;382:727â€&quot;733. doi:10.1056/NEJMoa200101731978945 46.ForniD, CaglianiR, ClericiM, et al. Molecular evolution of" exact="human coronavirus" post="genomes. Trends Microbiol. 2016;25:35â€&quot;48. doi:10.1016/j.tim.2016.09.00127743750 47.WuZ, YangL, RenX, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7416802\results\search\virus\results.xml">
   <result pre="viral antibody Fc receptors in herpes simplex virus (HSV) and" exact="human cytomegalovirus" post="(HCMV) infections and immunityFront Immunol201910211031555298 156.Gunn BM, Yu W-H,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7418792\results\search\virus\results.xml">
   <result pre="emerging coronavirusesPhysiol. Behav.176201713914810.1016/j.physbeh.2017.03.04028363838 33ChenL.LiuW.ZhangQ.XuK.YeG.WuW.SunZ.LiuF.WuK.ZhongB.MeiY.ZhangW.ChenY.LiY.ShiM.LanK.LiuY.RNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg."/>
   <result pre="for murine coronavirus strain A59 complementation groupsVirology177199064665610.1016/0042-6822(90)90530-52164728 62LauS.K.P.LeeP.TsangA.K.L.YipC.C.Y.TseH.LeeR.A.SoL.-Y.LauY.-L.ChanK.-H.WooP.C.Y.YuenK.-Y.Molecular epidemiology of" exact="human coronavirus" post="OC43 reveals evolution of different genotypes over time and"/>
   <result pre="due to natural recombinationJ. Virol.852011113251133710.1128/jvi.05512-1121849456 63PyrcK.DijkmanR.DengL.JebbinkM.F.RossH.A.BerkhoutB.van der HoekL.Mosaic structure of" exact="human coronavirus" post="NL63, one thousand years of evolutionJ. Mol. Biol.364200696497310.1016/j.jmb.2006.09.07417054987 64HonC.-C.LamT.-Y.ShiZ.-L.DrummondA.J.YipC.-W.ZengF.LamP.-Y.LeungF.C.-C.Evidence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7424135\results\search\virus\results.xml">
   <result pre="Genet Evol20208110427232142938 23.ChenLLiuWZhangQXuKYeGWuWet al.RNA based mNGS approach identifies a novel" exact="human coronavirus" post="from two individual pneumonia cases in 2019 Wuhan outbreakEmerg"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426275\results\search\virus\results.xml">
   <result pre="high throughput discovery and mechanistic study of antiviral agents against" exact="yellow fever virus" post="GaoZhaoaZhangLinaMaJuliaaJuradoAndreabHongSeon-HuibGuoJu-TaoaRiceCharles M.bMacDonaldMargaret R.bChangJinhongaâˆ—[a], [b], âˆ—Corresponding author. pmc-release: 2020-8-8ppub: 2020-10epub:"/>
   <result pre="remains active. Abstract Despite the availability of a highly effective" exact="yellow fever virus" post="(YFV) vaccine, outbreaks of yellow fever frequently occur in"/>
   <result pre="Highlights â€¢Lack of antivirals compromises the efforts to control the" exact="yellow fever virus" post="outbreak. â€¢Antibodies of various YFV proteins facilitate study of"/>
   <result pre="1 Introduction Yellow fever is a mosquito-borne disease caused by" exact="yellow fever virus" post="(YFV) infection and frequently associated with a severe form"/>
   <result pre="Ploss, 2018). This outnumbers the estimated death toll of global" exact="dengue virus" post="infection (http://www.who.int/mediacentre/factsheets/fs100/en/). The World Health Organization and its partners"/>
   <result pre="of vaccines and antiviral agents against emerging flaviviruses such as" exact="dengue virus" post="(DENV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV)"/>
   <result pre="in the cells infected with Ebolavirus (Hoenen et al., 2012)," exact="chikungunya virus" post="(Reid et al., 2015) or coronavirus (Hagemeijer et al.,"/>
   <result pre="YFV. References References AdungoF.YuF.KamauD.InoueS.HayasakaD.Posadas-HerreraG.SangR.MwauM.MoritaK.Development and characterization of monoclonal antibodies to" exact="yellow fever virus" post="and application in antigen detection and IgM capture enzyme-linked"/>
   <result pre="hepatitis C virus proteins for viral assemblyCells82019 BredenbeekP.J.KooiE.A.LindenbachB.HuijkmanN.RiceC.M.SpaanW.J.A stable full-length" exact="yellow fever virus" post="cDNA clone and the role of conserved RNA elements"/>
   <result pre="polyfunctional immune responsesJ. Exp. Med.20520083119313119047440 GuoF.WuS.JulanderJ.MaJ.ZhangX.KulpJ.CuconatiA.BlockT.M.DuY.GuoJ.T.ChangJ.A novel benzodiazepine compound inhibits" exact="yellow fever virus" post="infection by specifically targeting NS4B proteinJ. Virol.90201615 GuoF.ZhaoX.GillT.ZhouY.CampagnaM.WangL.LiuF.ZhangP.DiPaoloL.DuY.XuX.JiangD.WeiL.CuconatiA.BlockT.M.GuoJ.T.ChangJ.An interferon-beta"/>
   <result pre="using click chemistryJ. Virol.8620125808581622438542 HoenenT.ShabmanR.S.GrosethA.HerwigA.WeberM.SchudtG.DolnikO.BaslerC.F.BeckerS.FeldmannH.Inclusion bodies are a site of" exact="ebolavirus" post="replicationJ. Virol.862012117791178822915810 JaoC.Y.SalicA.Exploring RNA transcription and turnover in vivo"/>
   <result pre="yellow feverAntivir. Res.97201316917923237991 KlittingR.FischerC.DrexlerJ.F.GouldE.A.RoizD.PaupyC.de LamballerieX.What does the future hold for" exact="yellow fever virus?" post="(II)Genes92018 KlittingR.GouldE.A.PaupyC.de LamballerieX.What does the future hold for yellow"/>
   <result pre="fever virus? (II)Genes92018 KlittingR.GouldE.A.PaupyC.de LamballerieX.What does the future hold for" exact="yellow fever virus?" post="(I)Genes92018 KumarA.BuhlerS.SeliskoB.DavidsonA.MulderK.CanardB.MillerS.BartenschlagerR.Nuclear localization of dengue virus nonstructural protein 5"/>
   <result pre="future hold for yellow fever virus? (I)Genes92018 KumarA.BuhlerS.SeliskoB.DavidsonA.MulderK.CanardB.MillerS.BartenschlagerR.Nuclear localization of" exact="dengue virus" post="nonstructural protein 5 does not strictly correlate with efficient"/>
   <result pre="replication and inhibition of type I interferon signalingJ. Virol.8720134545455723408610 LescarJ.SohS.LeeL.T.VasudevanS.G.KangC.LimS.P.The" exact="dengue virus" post="replication complex: from RNA replication to protein-protein interactions to"/>
   <result pre="vitro and in vivoAntivir. Res.150201811212229253498 MillerS.KastnerS.Krijnse-LockerJ.BuhlerS.BartenschlagerR.The non-structural protein 4A of" exact="dengue virus" post="is an integral membrane protein inducing membrane alterations in"/>
   <result pre="Biol. Chem.28120068854886316436383 MonathT.P.VasconcelosP.F.Yellow feverJ. Clin. Virol.64201516017325453327 PatkarC.G.LarsenM.OwstonM.SmithJ.L.KuhnR.J.Identification of inhibitors of" exact="yellow fever virus" post="replication using a replicon-based high-throughput assayAntimicrob. Agents Chemother.5320094103411419651907 PrichardM.N.AseltineK.R.ShipmanC.Jr.MacSynergy"/>
   <result pre="fever vaccine in humansNat. Immunol.10200911612519029902 ReidS.P.TritschS.R.KotaK.ChiangC.Y.DongL.KennyT.BrueggemannE.E.WardM.D.CazaresL.H.BavariS.Sphingosine kinase 2 is a" exact="chikungunya virus" post="host factor co-localized with the viral replication complexEmerg. Microb."/>
   <result pre="a quantitative NS1-capture enzyme-linked immunosorbent assay for early detection of" exact="yellow fever virus" post="infectionSci. Rep.720171622929176643 RiceC.M.LenchesE.M.EddyS.R.ShinS.J.SheetsR.L.StraussJ.H.Nucleotide sequence of yellow fever virus: implications"/>
   <result pre="virus proteinsJ Virol Methods222201511011626086983 WelschS.MillerS.Romero-BreyI.MerzA.BleckC.K.WaltherP.FullerS.D.AntonyC.Krijnse-LockerJ.BartenschlagerR.Composition and three-dimensional architecture of the" exact="dengue virus" post="replication and assembly sitesCell Host Microbe5200936537519380115 YiZ.SperzelL.NurnbergerC.BredenbeekP.J.LubickK.J.BestS.M.StoyanovC.T.LawL.M.YuanZ.RiceC.M.MacDonaldM.R.Identification and characterization"/>
   <result pre="evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of" exact="dengue virus" post="infectionJ. Med. Chem.5520126061607522712544 ZhangJ.H.ChungT.D.OldenburgK.R.A simple statistical parameter for use"/>
   <result pre="switch controls the low pH-triggered rearrangement and maturation of the" exact="dengue virus" post="envelope proteinsNat. Commun.52014387724846574 ZmurkoJ.NeytsJ.DallmeierK.Flaviviral NS4b, chameleon and jack-in-the-box roles"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426442\results\search\virus\results.xml">
   <result pre="not the subcutaneous, route imparted a protective response against the" exact="human coronavirus." post="The infused CD4+ memory T cell, upon re-stimulation, produces"/>
   <result pre="10.4103/1817-1737.18575627512511 76.JossetLMenacheryVDGralinskiLEAgnihothramSSovaPCarterVSet al.. Cell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseases. ACS Cent Sci. (2020) 6:315â€&quot;31. 10.1021/acscentsci.0c0027232226821 135.Ortiz-AlcantaraJBhardwajKPalaninathanSFriemanMBaricRSKaoCCSmall molecule"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426546\results\search\virus\results.xml">
   <result pre="our overall understanding of viral diseases. Coronavirus coronavirus disease 2019" exact="human coronavirus" post="severe acute respiratory syndrome INTRODUCTION In March 2015, Bill"/>
   <result pre="of developing a number of agents to treat or inhibit" exact="human immunodeficiency virus" post="(HIV) infection, as well as anti-hepatitis C virus (HCV)"/>
   <result pre="was reported. Abbreviations CoV coronavirus COVID-19 coronavirus disease 2019 hCoV" exact="human coronavirus" post="SARS severe acute respiratory syndrome. References REFERENCES 1GatesBThe next"/>
   <result pre="of Middle East respiratory syndrome coronavirusN Engl J Med20133694071610.1056/NEJMoa130674223782161 8DecaroNLorussoANovel" exact="human coronavirus" post="(SARS-CoV-2): a lesson from animal coronavirusesVet Microbiol202024410869310.1016/j.vetmic.2020.10869332402329 9CuiJLiFShiZLOrigin and"/>
   <result pre="of pathogenic coronavirusesNat Rev Microbiol2019171819210.1038/s41579-018-0118-930531947 10VijgenLKeyaertsEMoesEet al.Complete genomic sequence of" exact="human coronavirus" post="OC43: molecular clock analysis suggests a relatively recent zoonotic"/>
   <result pre="of a new human coronavirusNat Med2004103687310.1038/nm102415034574 23EsperFShapiroEDWeibelCFergusonDLandryMLKahnJSAssociation between a novel" exact="human coronavirus" post="and Kawasaki diseaseJ Infect Dis200519149950210.1086/42829115655771 24ShimizuCShikeHBakerSCet al.Human coronavirus NL63"/>
   <result pre="acute Kawasaki diseaseJ Infect Dis200519217677110.1086/49717016235175 25LehmannCKlarRLindnerJLindnerPWolfHGerlingSKawasaki disease lacks association with" exact="human coronavirus" post="NL63 and human bocavirusPediatr Infect Dis J200928553410.1097/inf.0b013e31819f41b619504744 26SuSWongGShiWet al.Epidemiology,"/>
   <result pre="al.Epidemiology, genetic recombination, and pathogenesis of coronavirusesTrends Microbiol20162449050210.1016/j.tim.2016.03.00327012512 27GreenbergSBUpdate on" exact="human rhinovirus" post="and coronavirus infectionsSemin Respir Crit Care Med2016375557110.1055/s-0036-158479727486736 28FriedmanNAlterHHindiyehMMendelsonEShemer AvniYMandelboimMHuman"/>
   <result pre="symptoms and summer seasonality of HCoV-HKU1Viruses20181051510.3390/v10100515 29PatrickDMPetricMSkowronskiDMet al.An outbreak of" exact="human coronavirus" post="OC43 infection and serological cross-reactivity with SARS coronavirusCan J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7426550\results\search\virus\results.xml">
   <result pre="the intracellular viral cycle.15 ANIMAL AND HUMAN CORONAVIRUS The first" exact="human coronavirus" post="was described by June Dalziel Almeida in 1966. She"/>
   <result pre="bottom line, infected human hosts. COVID-19, coronavirus disease 2019; HCoV-229E," exact="human coronavirus" post="229E; HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43, human coronavirus"/>
   <result pre="hosts. COVID-19, coronavirus disease 2019; HCoV-229E, human coronavirus 229E; HCoV-NL63," exact="human coronavirus" post="Netherlands 63; HCoV-OC43, human coronavirus OC43; HCoV-HKU1, human coronavirus"/>
   <result pre="HCoV-229E, human coronavirus 229E; HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43," exact="human coronavirus" post="OC43; HCoV-HKU1, human coronavirus Hong Kong U1; MERS, Middle"/>
   <result pre="HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43, human coronavirus OC43; HCoV-HKU1," exact="human coronavirus" post="Hong Kong U1; MERS, Middle East respiratory syndrome; MERS-CoV,"/>
   <result pre="healthcare services, medical equipment, etc. COVID-19, coronavirus disease 2019; HCoV-229E," exact="human coronavirus" post="229E; HCoV-HKU1, human coronavirus Hong Kong U1; HCoV-NL63, human"/>
   <result pre="etc. COVID-19, coronavirus disease 2019; HCoV-229E, human coronavirus 229E; HCoV-HKU1," exact="human coronavirus" post="Hong Kong U1; HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43,"/>
   <result pre="human coronavirus 229E; HCoV-HKU1, human coronavirus Hong Kong U1; HCoV-NL63," exact="human coronavirus" post="Netherlands 63; HCoV-OC43, human coronavirus OC43; MERS-CoV, Middle East"/>
   <result pre="coronavirus Hong Kong U1; HCoV-NL63, human coronavirus Netherlands 63; HCoV-OC43," exact="human coronavirus" post="OC43; MERS-CoV, Middle East respiratory syndrome coronavirus; SARS-CoV-1, severe"/>
   <result pre="cause of most pandemics, with the only exception being the" exact="variola virus," post="which is composed of DNA. Relatively few pandemics were"/>
   <result pre="of vector mosquitos. Other viruses transmitted by Aedes aegypti include" exact="dengue virus," post="Zika virus, and chikungunya virus.34 For close to half"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7428724\results\search\virus\results.xml">
   <result pre="as herpes simplex (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and" exact="varicella-zoster virus" post="(VZV). VZV, for example, is a highly cytolytic, highly"/>
   <result pre="this phenomenon, studied mostly inÂ vitro, has implications for natural" exact="human coronavirus" post="infections or vaccinations (Wan etÂ al., 2020); however, it"/>
   <result pre="pan-encephalitis (SSPE), a fatal human disease associated with persistent natural" exact="measles virus" post="infection complicated by generation of host-edited mutant viruses (Cattaneo"/>
   <result pre="which created a secondary ecologic niche for the emergence of" exact="yellow fever virus" post="and, centuries later, dengue, chikungunya, and Zika, all of"/>
   <result pre="locus mutation in the Aedes aegypti-adapted Indian Ocean strain of" exact="chikungunya virus" post="has newly adapted it, without loss of fitness for"/>
   <result pre="simple viral receptorVirus Res.24220171628870470 CarrollD.DaszakP.WolfeN.D.GaoG.F.MorelC.M.MorzariaS.Pablos-MÃ©ndezA.TomoriO.MazetJ.A.K.The Global Virome ProjectScience359201887287429472471 CattaneoR.SchmidA.RebmannG.BaczkoK.Ter MeulenV.BelliniW.J.RozenblattS.BilleterM.A.Accumulated" exact="measles virus" post="mutations in a case of subacute sclerosing panencephalitis: interrupted"/>
   <result pre="death after feline infectious peritonitis virus challenge due to recombinant" exact="vaccinia virus" post="immunizationJ.Â Virol.641990140714092154621 WanY.ShangJ.SunS.TaiW.ChenJ.GengQ.HeL.ChenY.WuJ.ShiZ.Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429184\results\search\virus\results.xml">
   <result pre="killed &amp;gt;700,000 [4,5]. COVID-19 is the latest and third serious" exact="human coronavirus" post="outbreak in the past 20Â years. Additionally, of course,"/>
   <result pre="of the COVID-19 outbreak: To what extent were the previous" exact="human coronavirus" post="(SARS and MERS) outbreaks studied? Is research on emerging"/>
   <result pre="(SARS and MERS). There are many other strains of the" exact="human coronavirus," post="and 4 of them are known for causing seasonal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429403\results\search\virus\results.xml">
   <result pre="disease 2019 COVID-19 SARS-CoV-2 fig-count: table-count: ref-count: page-count: History The" exact="human coronavirus" post="was first diagnosed in 1965 by Tyrrell and Bynoe"/>
   <result pre="antibodies, including CR3022, m396, and CR3014, have been used against" exact="human coronavirus" post="that can be considered as therapeutic candidates for SARS-CoV-2"/>
   <result pre="combined treatment of Shuanghuanglian and recombinant interferon alpha 2a on" exact="coxsackievirus" post="B3 replication in vitro]. Zhongguo Zhong Yao Za Zhi."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7429453\results\search\virus\results.xml">
   <result pre="it to be effective against respiratory viruses, including the picornavirus" exact="human rhinovirus" post="(RV), where it enhances viral-induced type I and type"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7430223\results\search\virus\results.xml">
   <result pre="14BonaviaA.ZelusB.D.WentworthD.E.TalbotP.J.HolmesK.V.Identification of a receptor-binding domain of the spike glycoprotein of" exact="human coronavirus" post="HCoV-229EJÂ Virol7720032530253810.1128/jvi.77.4.2530-2538.200312551991 15KlimpelG.R.Immune defensesBaronS.Medical microbiology4th ed.1996University of Texas Medical"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7431281\results\search\virus\results.xml">
   <result pre="SARS-CoV-2-related coronaviruses [30, 39â€&quot;41]. However, it was less effective against" exact="ebolavirus" post="infections in humans [42]. Recently, clinical trials of remdesivir"/>
   <result pre="3 mRNA Zydus Cadila ZyCoV-D vaccine Phase 1/2 RNA recombinant" exact="measles virus" post="Mudoch Childreâ€™s Research Institute BCG vaccine Phase 2/3 Live"/>
   <result pre="taken up by Tonix Pharmaceuticals which had earlier developed the" exact="horsepox virus" post="vaccine on a similar plan. University of Alberta, Canada,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432271\results\search\virus\results.xml">
   <result pre="(1.5â€&quot;7.5%), chronic kidney diseases (1â€&quot;3%), cerebrovascular disease (1.5â€&quot;3%), co-infection with" exact="human immunodeficiency virus" post="(HIV) or hepatitis B virus (1â€&quot;2%), malignancy (1â€&quot;3.5%), respiratory"/>
   <result pre="respiratory syncytial virus, SARS-CoV, parainfluenza type 5, poliovirus, rhinovirus 14," exact="coxsackievirus" post="B5, hantavirus, Chikungunya virus, hepatitis B virus (HBV) and"/>
   <result pre="[141]. Another study demonstrated that camostat partially blocked SARS-CoV and" exact="human coronavirus" post="NL63 (HCoV-NL63) infection in HeLa cells expressing the ACE2"/>
   <result pre="influenza A and B viruses, influenza A H5N1 virus, HCV," exact="rabies virus," post="hepatitis A virus, poliovirus, Chikungunya virus, Lassa virus, Dengue"/>
   <result pre="onchocerciasis, which shows anti-viral effects against HIV-1, simian virus SV40," exact="dengue virus" post="(DENV), West Nile Virus, Venezuelan equine encephalitis virus (VEEV)"/>
   <result pre="2009 H1N1 pandemic influenza A, respiratory syncytial virus, Zika viruses," exact="human cytomegalovirus" post="and rabies have confirmed the presence of neutralizing antibodies"/>
   <result pre="SARS-CoV-2 [213]. By screening hybridomas from immunized mice using pseudotyped" exact="vesicular stomatitis virus," post="a chimeric mAb called 47D11 was identified which has"/>
   <result pre="HCV hepatitis B virus, hepatitis C virus HA hemagglutinin HCoV-NL63" exact="human coronavirus" post="NL63 DENV dengue virus VEEV Venezuelan equine encephalitis virus"/>
   <result pre="hepatitis C virus HA hemagglutinin HCoV-NL63 human coronavirus NL63 DENV" exact="dengue virus" post="VEEV Venezuelan equine encephalitis virus IN integrase protein IMP"/>
   <result pre="acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant" exact="vaccinia virus" post="DIsVirology200635136838010.1016/j.virol.2006.03.02016678878 45.BhattacharyaM.SharmaA.R.PatraP.GhoshP.SharmaG.PatraB.C.LeeS.-S.ChakrabortyC.Development of epitope-based peptide vaccine against novel coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7432648\results\search\virus\results.xml">
   <result pre="implemented policies ensure the successful control of pandemics. COVID-19 SARS-CoV-2" exact="human coronavirus" post="pre-existing conditions public health strategy prevention containment control measures"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7434367\results\search\virus\results.xml">
   <result pre="2017). Cetylpyridinium chloride has anti-viral activity against Influenza, hepatitis B," exact="poliovirus" post="1. â€¢Miramistin. Antiseptic with antiviral activity against HIV, influenza,"/>
   <result pre="of herpes simplex virus type 1, respiratory syncytial virus and" exact="echovirus" post="type 11 by peroxidase-generated hypothiocyaniteAntivir. Res.2619951611717605114 MoskwaP.LorentzenD.ExcoffonK.J.ZabnerJ.McCrayP.B.Jr.NauseefW.M.DupuyC.BanfiB.A novel host"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7435512\results\search\virus\results.xml">
   <result pre="ExoN exonuclease FDA Food and Drug Administration HCQ hydroxychloroquine HIV" exact="human immunodeficiency virus" post="IFN interferon IL interleukin M membrane protein mAbs monoclonal"/>
   <result pre="10 Î¼M in Calu3 lung cells. Protease inhibitors used in" exact="human immunodeficiency virus" post="(HIV) therapy, such as lopinavir/ritonavir (a combination known as"/>
   <result pre="inhibit (in the nM to Î¼M range) the entry of" exact="vesicular stomatitis virus" post="pseudotypes carrying the SARSâ€�CoVâ€�2 S protein in different cell"/>
   <result pre="2016;10(5):e0004695.27163257 76DelangL, Segura GuerreroN, TasA, et al. Mutations in the" exact="chikungunya virus" post="nonâ€�structural proteins cause resistance to favipiravir (Tâ€�705), a broadâ€�spectrum"/>
   <result pre="Î±/Î²â€�mediated nuclear import able to inhibit replication of HIVâ€�1 and" exact="dengue virus." post="Biochem J. 2012;443(3):851â€�856.22417684 119LundbergL, PinkhamC, BaerA, et al. Nuclear"/>
   <result pre="Res. 2013;100(3):662â€�672.24161512 120TayMYF, FraserJE, ChanWKK, et al. Nuclear localization of" exact="dengue virus" post="(DENV) 1â€&quot;4 nonâ€�structural protein 5; protection against all 4"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438224\results\search\virus\results.xml">
   <result pre="(SARS-Cov-2) infecting pregnant women: lessons from SARS, MERS, and other" exact="human coronavirus" post="infectionsViruses122202019410.3390/v12020194 ShoreyS.NgE.D.Evaluation of a technology-based peer-support intervention program for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438404\results\search\virus\results.xml">
   <result pre="viral entry inhibition against several enveloped viruses, such as the" exact="human immunodeficiency virus" post="(HIV). GRFT is capable of binding to terminal mannoses"/>
   <result pre="then optimized synthetically, generating mucroporin-M1, which was able to inhibit" exact="measles virus" post="(MeV), SARS-CoV, and influenza H5N1. Specifically, mucroporin M-1 affected"/>
   <result pre="Singapore491â€&quot;3. HuangI.-C.BoschB. J.LiF.LiW.LeeK. H.GhiranS.et al. (2006). SARS coronavirus, but not" exact="human coronavirus" post="NL63, utilizes cathepsin L to infect ACE2-expressing cells.J. Biol."/>
   <result pre="Agents Chemother.583354â€&quot;3359. 10.1128/AAC.02794-1324687509 PyrcK.BoschB. J.BerkhoutB.JebbinkM. F.DijkmanR.RottierP.et al. (2006). Inhibition of" exact="human coronavirus" post="NL63 infection at early stages of the replication cycle.Antimicrob."/>
   <result pre="RoquesP.ThibervilleS.-D.Dupuis-MaguiragaL.LumF.-M.LabadieK.MartinonF.et al. (2018). Paradoxical effect of chloroquine treatment in enhancing" exact="chikungunya virus" post="infection.Viruses10:268. 10.3390/v1005026829772762 RossignolJ.-F. (2014). Nitazoxanide: a first-in-class broad-spectrum antiviral"/>
   <result pre="E.ChanW. K. K.MorelandN. J.RathoreA. P.WangC.et al. (2013). Nuclear localization of" exact="dengue virus" post="(DENV) 1â€&quot;4 non-structural protein 5; protection against all 4"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7438974\results\search\virus\results.xml">
   <result pre="6Botelho-SouzaL.F.VasconcelosM.P.A.Dos SantosA.O.SalcedoJ.M.V.VieiraD.S.Hepatitis delta: virological and clinical aspectsVirol J14201717728903779 7FattovichG.GiustinaG.ChristensenE.PantalenaM.ZagniI.RealdiG.Influence of" exact="hepatitis delta virus" post="infection on morbidity and mortality in compensated cirrhosis type"/>
   <result pre="and outcomesJÂ Hepatol63201558659225962883 9Le GalF.BrichlerS.SahliR.ChevretS.GordienE.First international external quality assessment for" exact="hepatitis delta virus" post="RNA quantification in plasmaHepatology6420161483149427530084 10KohC.HellerT.GlennJ.S.Pathogenesis of and new therapies"/>
   <result pre="and meta-analysisLancet Glob Health52017e992e100328911765 12BrichlerS.Le GalF.Neri-PintoF.MansourW.RoulotD.LapercheS.Serological and molecular diagnosis of" exact="hepatitis delta virus" post="infection: results of a French national quality control studyJÂ"/>
   <result pre="novel quantitative microarray antibody capture assay identifies an extremely high" exact="hepatitis delta virus" post="prevalence among hepatitis B virus-infected mongoliansHepatology6620171739174927880976 27collab: World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7439087\results\search\virus\results.xml">
   <result pre="of reyanning mixture in evaluating combining disease with syndrome of" exact="human coronavirus" post="pneumonia with pestilence attacking lung syndromeChina J. Chin. Materia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441012\results\search\virus\results.xml">
   <result pre="that remain foundational to modern surgery. HIV/AIDS Background Infection with" exact="human immunodeficiency virus" post="(HIV), a Lentivirus, can cause acquired immunodeficiency syndrome (AIDS),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7441399\results\search\virus\results.xml">
   <result pre="Epstein-Barr, Japanese encephalitis, Coxsackie, West Nile, Western equine encephalomyelitis, and" exact="human immunodeficiency virus," post="mostly due to induction of neuroinflammation and/or hypoxic brain"/>
   <result pre="nerve is one route of transneural invasion for intranasally inoculated" exact="influenza a virus" post="in miceVet. Pathol.20044110110715017022 158.JonesJFEpstein-Barr virus and the chronic fatigue"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443229\results\search\virus\results.xml">
   <result pre="10% mortality rate [6]. More recently, in 2012, a new" exact="human coronavirus," post="designated as Middle East respiratory syndrome-coronavirus (MERS-CoV), was identified,"/>
   <result pre="[7]. Over the last few months, a new strain of" exact="human coronavirus," post="SARS-CoV-2 (also known as 2019-nCoV), has caught the world's"/>
   <result pre="lipocalin that promoted a neuroprotective effect against encephalitis induced by" exact="human coronavirus" post="OC43â€&quot;in mice. This protective effect occurred through the reduction"/>
   <result pre="B activation in intact cellsThe Journal of Experimental Medicine199217551181119410.1084/jem.175.5.11811314883 27ChannappanavarR.PerlmanS.Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySeminars"/>
   <result pre="SOCS1 and SOCS3Journal of Virology20158952672268310.1128/JVI.03529-1425520513 30BogdenJ. D.BakerH.FrankO.et al.Micronutrient status and" exact="human immunodeficiency virus" post="(HIV) infectionAnnals of the New York Academy of Sciences1990587118919510.1111/j.1749-6632.1990.tb00146.x2360760"/>
   <result pre="deathInternational Journal of Cell Biology201420141610.1155/2014/46745224899897 33WuY.-H.TsengC.-P.ChengM.-L.HoH.-Y.ShihS.-R.ChiuD. T.-Y.Glucose-6-phosphate dehydrogenase deficiency enhances" exact="human coronavirus" post="229E infectionThe Journal of Infectious Diseases2008197681281610.1086/52837718269318 34TanW.AboulhosnJ.The cardiovascular burden"/>
   <result pre="pathwaysVeterinary Microbiology201923211210.1016/j.vetmic.2019.03.02831030832 41Do CarmoS.JacomyH.TalbotP. J.RassartE.Neuroprotective effect of apolipoprotein D against" exact="human coronavirus" post="OC43-induced encephalitis in miceThe Journal of Neuroscience20082841103301033810.1523/JNEUROSCI.2644-08.200818842892 42GanforninaM. D.Do"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7443335\results\search\virus\results.xml">
   <result pre="as an effective anti-viral agent against HIV-1, H1N1, H3N2, H5N1," exact="dengue virus," post="bovine viral diarrhea virus and Foot-and-mouth disease virus [74]."/>
   <result pre="investigated only for some pathogenic viruses like influenza, HIV and" exact="rabies virus" post="[74]. As an alternative to synthetic polymers, some natural"/>
   <result pre="already been documented against some viruses including influenza virus, Ebola-virus," exact="zika virus," post="HSV-1, 2 and HIV. Research on the efficacy of"/>
   <result pre="that binds to the same ACE-2 receptor as SARS-CoV-2, namely" exact="human coronavirus" post="NL-63 (hCoV-NL63). The researcher anticipates using this animal model"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7445016\results\search\virus\results.xml">
   <result pre="batsProc Natl Acad Sci U S A2005102140401404516169905 46.ForniDCaglianiRClericiMSironiMMolecular evolution of" exact="human coronavirus" post="genomesTrends Microbiol201725354827743750 47.SuSWongGShiWLiuJLaiACKZhouJLiuWBiYGaoGFEpidemiology, genetic recombination, and pathogenesis of coronavirusesTrends"/>
   <result pre="coronavirus genome expressionJ Gen Virol2003842305231512917450 66.KirchdoerferRNCottrellCAWangNPallesenJYassineHMTurnerHLet al.Pre-fusion structure of a" exact="human coronavirus" post="spike proteinNature201653111812126935699 67.SiuYLTeohKTLoJChanCMKienFet al.The M, E, and N structural"/>
   <result pre="receptor recognition by SARS-CoV-2Nature202058122122410.1038/s41586-020-2179-y32225175 97.LuGHuYWangQQiJGaoFLiYZhangYZhangWYuanYBaoJZhangBShiYYanJGaoGFMolecular basis of binding between novel" exact="human coronavirus" post="MERS-CoV and its receptor CD26Nature201350022723110.1038/nature1232823831647 98.Crystal structure of SARS-CoV-2"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7448857\results\search\virus\results.xml">
   <result pre="have been demonstrated in the mice models of enterovirus and" exact="human immunodeficiency virus" post="(HIV) [7]. Additionally, the mean peak plasma concentration of"/>
   <result pre="10.1016/j.antiviral.2016.12.02228049006 6DenisovaOV, KakkolaL, FengL, et al.Obatoclax, saliphenylhalamide, and gemcitabine inhibit" exact="influenza a virus" post="infection. J Biol Chem. 2012;287:35324â€&quot;32. doi: 10.1074/jbc.M112.39214222910914 7LeeK, KimDE,"/>
   <result pre="Rep. 2018;17:2523â€&quot;2528.29207118 13LiuJ, YangY, XuY, et al.Lycorine reduces mortality of" exact="human enterovirus" post="71-infected mice by inhibiting virus replication. Virol J. 2011;8:483."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449072\results\search\virus\results.xml">
   <result pre="CameroonAIDS Res Hum Retrovir20132911310.1089/aid.2012.019622889147 10.FokamJSalpiniRSantoroMMet al.Performance evaluation of an in-house" exact="human immunodeficiency virus" post="type-1 protease-reverse transcriptase genotyping assay in CameroonArch Virol201115671235124310.1007/s00705-011-0982-321465085 11.Fokam"/>
   <result pre="Monotherapy versus Dolutegravir/Abacavir/lamivudine for Virologically suppressed people living with chronic" exact="human immunodeficiency virus" post="infection: the randomized noninferiority MONotherapy of TiviCAY trialClin Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7449465\results\search\virus\results.xml">
   <result pre="2017;58(2):269â€&quot;80. Epub 2017/12/08. 10.1093/ilar/ilx03029216343 29MunsterVJ, de WitE, FeldmannH. Pneumonia from" exact="human coronavirus" post="in a macaque model. N Engl J Med. 2013;368(16):1560â€&quot;2."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7451056\results\search\virus\results.xml">
   <result pre="recombinant viral particle made from a well-known backbone, like the" exact="human immunodeficiency virus" post="(HIV-1) or the vesicular stomatitis virus (VSV), and envelope"/>
   <result pre="well-known backbone, like the human immunodeficiency virus (HIV-1) or the" exact="vesicular stomatitis virus" post="(VSV), and envelope proteins from the virus to be"/>
   <result pre="inhibition of the feline infectious peritonitis (FIP) coronavirus and the" exact="human coronavirus" post="OC43 (HCoV-OC43) in a cell culture model [13]. This"/>
   <result pre="systemic diseaseBiomed J422019273530987702 35WuY.M.YanJ.OjciusD.M.ChenL.L.GuZ.Y.PanJ.P.Correlation between infections with different genotypes of" exact="human cytomegalovirus" post="and Epstein-Barr virus in subgingival samples and periodontal status"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453465\results\search\virus\results.xml">
   <result pre="been isolated from humans (Figure 1). These include two alpha-CoVs," exact="human coronavirus" post="229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63), and five"/>
   <result pre="1). These include two alpha-CoVs, human coronavirus 229E (HCoV-229E) and" exact="human coronavirus" post="NL63 (HCoV-NL63), and five beta-CoVs: human coronavirus OC43 (HCoV-OC43),"/>
   <result pre="229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63), and five beta-CoVs:" exact="human coronavirus" post="OC43 (HCoV-OC43), human coronavirus HKU1 (HCoV-HKU1), SARS-CoV-1, MERS-CoV, and"/>
   <result pre="coronavirus NL63 (HCoV-NL63), and five beta-CoVs: human coronavirus OC43 (HCoV-OC43)," exact="human coronavirus" post="HKU1 (HCoV-HKU1), SARS-CoV-1, MERS-CoV, and SARS-CoV-2. SARS-CoV-1, MERS-CoV, and"/>
   <result pre="or underlying conditions such as lung disease, diabetes mellitus, and" exact="human immunodeficiency virus" post="infection.22 Figure 3. Development of the (a) SARS-CoV-1, (b)"/>
   <result pre="(SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other" exact="human coronavirus" post="infections. Viruses2020; 12: 194. doi:10.3390/v12020194. 14WangNShangJJiangS, et al.Subunit vaccines"/>
   <result pre="Adv Virus Res2016; 96: 165â€&quot;192.27712623 17ForniDCaglianiRClericiM, et al.Molecular evolution of" exact="human coronavirus" post="genomes.Trends Microbiol2017; 25: 35â€&quot;48. Epub 2016/10/25. eng.27743750 18SongZXuYBaoL, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7453598\results\search\virus\results.xml">
   <result pre="letters has been found in all the members of the" exact="human coronavirus" post="family that have been studied since 2004. Therefore, this"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7454523\results\search\virus\results.xml">
   <result pre="JossetL, MenacheryVD, GralinskiLEet al.Cell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7457942\results\search\virus\results.xml">
   <result pre="exhibited broad-spectrum inhibitory activities against different types of viruses, including" exact="human immunodeficiency virus" post="(HIV), and hepatitis C virus (HCV) [66]. Compound 66"/>
   <result pre="obvious antivirus activity with 50% inhibition at 50Â Î¼M against" exact="dengue virus" post="serotype 2 productions by standard plaque assay, equivalent to"/>
   <result pre="same concentration, showing the potential for further development as a" exact="dengue virus" post="inhibitor [77]. Fig.Â 16 Chemical structure of compound 75"/>
   <result pre="developmentFront. Immunol.102019167531402910 69FeldmanS.A.HendryR.M.BeelerJ.A.Identification of a linear heparin binding domain for" exact="human respiratory syncytial virus" post="attachment glycoprotein GJ.Â Virol.7319996610661710400758 70YuM.GuanF.CaoF.JiaY.WangC.AÂ new antiviral pregnane from"/>
   <result pre="spNat. Prod. Res.3120171640164628278631 72LiangZ.MaoQ.GaoF.WangJ.Progress on the research and development of" exact="human enterovirus" post="71 (EV71) vaccinesFront. Med.7201311112123247645 73WuK.X.NgM.M.ChuJ.J.H.Developments towards antiviral therapies against"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7458341\results\search\virus\results.xml">
   <result pre="[6] outside traditional endemic areas [7] [8] [9]. The four" exact="dengue virus" post="(DENV) serotypes (DENV 1 to 4) share 65â€&quot;70% of"/>
   <result pre="MessinaJP, BrownsteinJS, HoenAG, et al.Refining the global spatial limits of" exact="dengue virus" post="transmission by evidence-based consensus. PLoS neglect trop dis. 2012;6(8):e1760."/>
   <result pre="RucheG, SouaresY, ArmengaudA, Peloux-PetiotF, DelaunayP, DespresP, et al.First two autochthonous" exact="dengue virus" post="infections in metropolitan France, September 2010. Euro Surveill. 2010;15(39):1967620929659"/>
   <result pre="13GoncalvezAP, EngleRE, St. ClaireM, PurcellRH, LaiC-J. Monoclonal antibody-mediated enhancement of" exact="dengue virus" post="infection in vitro and in vivo and strategies for"/>
   <result pre="CDC real time RT-PCR assay for detection and typing of" exact="dengue virus." post="PLoS Neglect Trop Dis. 2013;7(7):e2311. 20SantiagoGA, VÃ¡zquezJ, CourtneyS, MatÃ­asKY,"/>
   <result pre="TurukJ, SahuSJ, KhajuriaA, KumarS, DeyA, et al.Co-circulation of all four" exact="dengue virus" post="serotypes with concurrent infections in a single dengue season."/>
   <result pre="2018;99(1):204â€&quot;10. 10.4269/ajtmh.17-081929848407 32WaggonerJJ, BalmasedaA, GreshL, SahooMK, MontoyaM, WangC, et al.Homotypic" exact="dengue virus" post="reinfections in Nicaraguan children. J Infect Dis. 2016;214(7):986â€&quot;93. d"/>
   <result pre="33ForsheyBM, ReinerRC, OlkowskiS, MorrisonAC, EspinozaA, LongKC, et al.Incomplete protection against" exact="dengue virus" post="type 2 re-infection in Peru. PLoS Neglect Trop Dis."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7459861\results\search\virus\results.xml">
   <result pre="(Figure 8IV). Furthermore, RNA genome can be packaged into one" exact="adeno-associated virus" post="(AAV) vector, making the CRISPR/Cas13d system more efficient for"/>
   <result pre="protease (3CLpro); 3C-like protease (3CL); Acute respiratory distress syndrome (ARDS);" exact="adeno-associated virus" post="(AAV); angiotensin receptor blockers (ARBs); angiotensin-converting enzyme 2 (ACE2);"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7460442\results\search\virus\results.xml">
   <result pre="their best efforts and resources for the effective treatment of" exact="human coronavirus" post="infections; however, neither vaccines nor antiviral drugs are available"/>
   <result pre="their best efforts and resources for the effective treatment of" exact="human coronavirus" post="(HCoV) infections. However, neither vaccines nor antiviral drugs are"/>
   <result pre="zoonotic prospectiveAsian Pac. J. Trop. Med.202013242246 24.PoonL.L.PeirisM.Emergence of a novel" exact="human coronavirus" post="threatening human healthNat. Med.20202631731910.1038/s41591-020-0796-532108160 25.ZhangT.WuQ.ZhangZ.Probable pangolin origin of 2019-nCoV"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7461160\results\search\virus\results.xml">
   <result pre="al.Acute and persistent infection of human neural cell lines by" exact="human coronavirus" post="OC43J Virol19997343338335010074188 78.ArbourNEkandeSCoteGet al.Persistent infection of human oligodendrocytic and"/>
   <result pre="al.Persistent infection of human oligodendrocytic and neuroglial cell lines by" exact="human coronavirus" post="229EJ Virol19997343326333710074187 79.SwansonPA2ndMcGavernDBViral diseases of the central nervous systemCurr"/>
   <result pre="respiratory syndromeVirus Res2008133141217825937 81.DesforgesMMilettiTCGagnonMTalbotPJActivation of human monocytes after infection by" exact="human coronavirus" post="229EVirus Res20071301â€&quot;222824017669539 82.PattersonSMacnaughtonMRReplication of human respiratory coronavirus strain 229E"/>
   <result pre="nerve is one route of transneural invasion for intranasally inoculated" exact="influenza a virus" post="in miceVet Pathol200441210110715017022 91.MarrieRAWolfsonCSturkenboomMCet al.Multiple sclerosis and antecedent infections:"/>
   <result pre="paradigm for virus-induced demyelinating diseaseTrends Microbiol1997519149025229 97.TalbotPJPaquetteJSCiurliCAntelJPOuelletFMyelin basic protein and" exact="human coronavirus" post="229E cross-reactive T cells in multiple sclerosisAnn Neurol19963922332408967755 98.RavenholtRTFoegeWH1918"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462115\results\search\virus\results.xml">
   <result pre="type of virus that was discovered in 1901 was the" exact="yellow fever virus." post="Every year new types are found, showing a rise"/>
   <result pre="can detect a broad spectrum of enteroviruses, containing the nonculturable" exact="coxsackievirus" post="strains. However, for the detection of parechoviruses, other probes"/>
   <result pre="obtained from candidates who had previously-confirmed viral infections (e.g., hantavirus," exact="dengue virus," post="SARS-CoV-2 NL63 â€&quot; specimen collected 30â€‰days after the first"/>
   <result pre="Chem2019280263271 85.SinghalCPundirCNarangJA genosensor for detection of consensus DNA sequence of" exact="dengue virus" post="using ZnO/Pt-Pd nanocompositesBiosens Bioelectron201797758228577500 86.ChenC-Cet al.Polymerase chain reaction-free detection"/>
   <result pre="for adenosine triphosphateTheranostics2016610168327446501 102.ChenCet al.Functionalized magnetic microparticle-based colorimetric platform for" exact="influenza a virus" post="detectionNanotechnology2016274343510227655150 103.LiuMet al.Interface engineering catalytic graphene for smart colorimetric"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462603\results\search\virus\results.xml">
   <result pre="virus CHB, chronic hepatitis B AIDS, acquired immunodeficiency syndrome HIV," exact="human immunodeficiency virus" post="SARS, severe acute respiratory syndrome SARS-CoV-1, severe acute respiratory"/>
   <result pre="syndrome Acquired Immunodeficiency Syndrome (AIDS) is a disease caused by" exact="human immunodeficiency virus" post="(HIV). HIV can directly weaken the immune system and"/>
   <result pre="of the octapeptidePeptides251120041857186415501516 60EdaY.TakizawaM.MurakamiT.MaedaH.KimachiK.YonemuraH.Sequential immunization with V3 peptides from primary" exact="human immunodeficiency virus" post="type 1 produces cross-neutralizing antibodies against primary isolates with"/>
   <result pre="Natl. Acad. Sci. U. S. A.106332009137971380119666568 114KshatriyaR.CachafeiroA.A.KerrR.J.NelsonJ.A.FiscusS.A.Comparison of two rapid" exact="human immunodeficiency virus" post="(HIV) assays, determine HIV-1/2 and OraQuick advance rapid HIV-1/2,"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent. Sci.63202031533132226821 127LiuQ.SomiyaM.KurodaS.Elucidation of the early infection machinery"/>
   <result pre="virally suppressed patients with chronic hepatitis BJ. Hepatol.653201650951627210427 130Lopez-MartinezR.Ramirez-SalinasG.L.Correa-BasurtoJ.BarronB.L.Inhibition of" exact="influenza a virus" post="infection in vitro by peptides designed in silicoPLoS One8102013e76876"/>
   <result pre="a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of" exact="human immunodeficiency virus" post="type 1 mutants resistant to enfuvirtideAntimicrob. Agents Chemother.53320091013101819114674 148NiY.SonnabendJ.SeitzS.UrbanS.The"/>
   <result pre="152Oâ€™ConnellR.J.MerrittT.M.MaliaJ.A.VanCottT.C.DolanM.J.ZahwaH.Performance of the OraQuick rapid antibody test for diagnosis of" exact="human immunodeficiency virus" post="type 1 infection in patients with various levels of"/>
   <result pre="proteinsNucleic Acids Res.35Web Server issue2007W407W401017517781 211WildC.OasT.McDanalC.BolognesiD.MatthewsT.A synthetic peptide inhibitor of" exact="human immunodeficiency virus" post="replication: correlation between solution structure and viral inhibitionProc. Natl."/>
   <result pre="223XiongS.BorregoP.DingX.ZhuY.MartinsA.ChongH.A helical short-peptide fusion inhibitor with highly potent activity against" exact="human immunodeficiency virus" post="type 1 (HIV-1), HIV-2, and simian immunodeficiency virusJ. Virol.9112017"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7462898\results\search\virus\results.xml">
   <result pre="a vector, such as plasmids, replication-deficient adenoviruses, lentiviruses, or replication-competent" exact="vesicular stomatitis virus," post="to transfer a SARS-CoV-2 gene and express a viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463036\results\search\virus\results.xml">
   <result pre="Dis.210820141260126924795482 30XiaS.YanL.XuW.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci. Adv.542019eaav458030989115 31WrappD.WangN.CorbettK.S.Cryo-EM structure of the 2019-nCoV spike in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7463108\results\search\virus\results.xml">
   <result pre="is critical to examine the mechanisms underlying pathophysiologic interactions between" exact="human immunodeficiency virus" post="(HIV) and opioids in the central nervous system (CNS)."/>
   <result pre="Services 2017). Injection drug use increases the likelihood of contracting" exact="human immunodeficiency virus" post="(HIV) and drug abuse and HIV have long been"/>
   <result pre="Biosci2008131294130717981630 AnthonyICNorrbyKEDingwallTCarnieFWMillarTArangoJCRobertsonRBellJEPredisposition to accelerated Alzheimer-related changes in the brains of" exact="human immunodeficiency virus" post="negative opiate abusersBrain20101333685369821126996 AouizeratBEPearceCLMiaskowskiCThe search for host genetic factors"/>
   <result pre="O, Nonnemacher MR (2011) Role of mu-opioids as cofactors in" exact="human immunodeficiency virus" post="type 1 disease progression and neuropathogenesis. J Neurovirol 17:291â€&quot;302"/>
   <result pre="(2011) Differential induction of rat neuronal excitotoxic cell death by" exact="human immunodeficiency virus" post="type 1 clade B and C Tat proteins. AIDS"/>
   <result pre="Prevention https://www.cdc.gov/drugoverdose/epidemic/index.html ChangSLBeltranJASwarupSExpression of the mu opioid receptor in the" exact="human immunodeficiency virus" post="type 1 transgenic rat modelJ Virol2007818406841117553897 ChangLWangGJVolkowNDErnstTTelangFLoganJFowlerJSDecreased brain dopamine"/>
   <result pre="Exp Med Biol199640229338787640 ChaoCCGekkerGHuSShengWSSharkKBBuDFArcherSBidlackJMPetersonPKÎº opioid receptors in human microglia downregulate" exact="human immunodeficiency virus" post="1 expressionProc Natl Acad Sci U S A199693805180568755601 Chao"/>
   <result pre="Khatavkar P, Saxena SK, Nair MPN (2010) Interactive role of" exact="human immunodeficiency virus" post="type 1 (HIV-1) clade-specific Tat protein and cocaine in"/>
   <result pre="multiple sclerosis. J Neurol Neurosurg Psychiatry 74:495â€&quot;497 GnanakaranSLangDDanielsMBhattacharyaTDerdeynCAKorberBClade-specific differences between" exact="human immunodeficiency virus" post="type 1 clades B and C: diversity and correlations"/>
   <result pre="Rao BS, Satish KS, Kumar M (2007) Neuropsychological deficits in" exact="human immunodeficiency virus" post="type 1 clade C-seropositive adults from South India. J"/>
   <result pre="Acad Sci U S A1999964581458510200305 LiuYLiuHKimBOGattoneVHLiJNathABlumJHeJJCD4-independent infection of astrocytes by" exact="human immunodeficiency virus" post="type 1: requirement for the human mannose receptorJ Virol2004784120413315047828"/>
   <result pre="regulation by Î¼-opioid receptors. Int Rev Neurobiol 118:105â€&quot;128 NathAPathobiology of" exact="human immunodeficiency virus" post="dementiaSemin Neurol19991911312710718533 Nath A (2015) Eradication of human immunodeficiency"/>
   <result pre="human immunodeficiency virus dementiaSemin Neurol19991911312710718533 Nath A (2015) Eradication of" exact="human immunodeficiency virus" post="from brain reservoirs. J NeuroVirol 21:227â€&quot;234 NathABoozeRMHauserKFMactutusCFBellJEMaragosWFBergerJRCritical questions for"/>
   <result pre="The medical clinics of North America 88:751â€&quot;766 RadjaFKayDGAlbrechtSJolicoeurPOligodendrocyte-specific expression of" exact="human immunodeficiency virus" post="type 1 Nef in transgenic mice leads to vacuolar"/>
   <result pre="tensor imaging of subcortical brain injury in patients infected with" exact="human immunodeficiency virus." post="J Neurovirol 11(3):292â€&quot;298 RamageSNAnthonyICCarnieFWBusuttilARobertsonRBellJEHyperphosphorylated tau and amyloid precursor protein"/>
   <result pre="brains of young drug abusersNeuropathol Appl Neurobiol20053143944816008828 RangaUShankarappaRSiddappaNBRamakrishnaLNagendranRMahalingamMMahadevanAJayasuryanNSatishchandraPShankarSKPrasadVRTat protein of" exact="human immunodeficiency virus" post="type 1 subtype C strains is a defective chemokineJ"/>
   <result pre="Kashanchi F, El-Hage N (2017) Importance of autophagy in mediating" exact="human immunodeficiency virus" post="(HIV) and morphine-induced metabolic dysfunction and inflammation in human"/>
   <result pre="system disease in adults and childrenCurr HIV Res2006431932716842084 SchwartzLCivitelloLDunn-PirioARyschkewitschSBerryECavertWKinzelNLawrenceDMHazraRMajorEOEvidence of" exact="human immunodeficiency virus" post="type 1 infection of nestin-positive neural progenitors in archival"/>
   <result pre="addiction necessitate multiple preclinical modelsBiol Psychiatry201986e43e4531668223 SinghKKSpectorSAHost genetic determinants of" exact="human immunodeficiency virus" post="infection and disease progression in childrenPediatr Res20096555R63R19190524 SjogrenPThomsenABOlsenAKImpaired neuropsychological"/>
   <result pre="course of infectionPLoS Pathog201511e100472025811757 SundarKSKamarajuLSDingfelderJMcMahonJGollapudiSWilsonWHKongLYHongJSWeissJMLeeJEÎ²-Endorphin enhances the replication of neurotropic" exact="human immunodeficiency virus" post="in fetal perivascular microgliaJ Neuroimmunol199561971047560019 SuomivuoriCMLatorracaNRWinglerLMEismannSKingMCKleinhenzALWSkibaMAStausDPKruseACLefkowitzRJDrorROMolecular mechanism of biased"/>
   <result pre="and without pre-symptomatic HIV infectionNeuropathol Appl Neurobiol19992536937910564526 TornatoreCMeyersKAtwoodWConantKMajorETemporal patterns of" exact="human immunodeficiency virus" post="type 1 transcripts in human fetal astrocytesJ Virol199468931028254781 Torres-MunozJStocktonPTacoronteNRobertsBMaronpotRRPetitoCKDetection"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464065\results\search\virus\results.xml">
   <result pre="the generation of vaccine, medicaments, and diagnostics A new coronavirus," exact="human coronavirus" post="NL63 (HCoV-NL63) is disclosed herein with a tropism that"/>
   <result pre="Brownlie et al. [239] 2017-10-12 WO2017176596A1 Vaccine Multivalent vaccines for" exact="rabies virus" post="and coronaviruses The present disclosure provides methods and compositions"/>
   <result pre="dual protection against infections by either or both of a" exact="rabies virus" post="and a coronavirus, and which can be used therapeutically"/>
   <result pre="can be used therapeutically for an existing infection with the" exact="rabies virus" post="and a coronavirus to treat at least one symptom"/>
   <result pre="infecting agents. In particular, the present disclosure provides a recombinant" exact="rabies virus" post="vector comprising a nucleotide sequence encoding at least one"/>
   <result pre="The invention discloses a high-efficiency ranilla luciferase gene expression recombinant" exact="human coronavirus" post="OC43 virus and application thereof to a screening of"/>
   <result pre="into accessory genes (ns2 and ns12.9) to be cloned into" exact="human coronavirus" post="OC43 full-length infectious clone pBAC-OC43FL, and four ranilla luciferase"/>
   <result pre="biomedicine field. It is related to the polypeptide for suppressing" exact="human coronavirus" post="infection, and in particular, to polypeptide and its application"/>
   <result pre="invention is the results showed obtain â€œgeneral characterâ€� of the" exact="human coronavirus," post="the identical syncretizing mechanism in, i.e., similar HR regions"/>
   <result pre="the drug candidate for prevention and treatment for the novel" exact="human coronavirus" post="for being still possible to outburst in popular human"/>
   <result pre="human coronavirus for being still possible to outburst in popular" exact="human coronavirus" post="and future at present Shibo et al. [269] 2018-02-13"/>
   <result pre="and pathogenesisNat Rev Microbiol20097643945019430490 44.CormanVMEckerleIBleickerTZakiALandtOEschbach-BludauMvan BoheemenSGopalRBallhauseMBestebroerTMet al.Detection of a novel" exact="human coronavirus" post="by real-time reverse-transcription polymerase chain reactionEurosurveillance201217392028523041020 45.CortiDZhaoJPedottiMSimonelliLAgnihothramSFettCFernandez-RodriguezBFoglieriniMAgaticGVanzettaFet al.Prophylactic and"/>
   <result pre="infection in humansJ Med Virol202092440841731944312 90.CormanVEckerleIBleickerTZakiALandtOEschbach-BludauMvan BoheemenSGopalRBallhauseMBestebroerTDetection of a novel" exact="human coronavirus" post="by real-time reverse-transcription polymerase chain reactionEurosurveillance20121739 91.DhamaKKhanSTiwariRDadarMMalikYSinghKChaicumpaWCOVID-19, an emerging"/>
   <result pre="Delivery SystemsKona201633638527081214 131.ThiEPLeeACHGeisbertJBUrsic-BedoyaRAgansKNRobbinsMDeerDJFentonKAKondratowiczASMacLachlanIet al.Rescue of non-human primates from advanced Sudan" exact="ebolavirus" post="infection with lipid encapsulated siRNANat Microbiol2016110161421614227670117 132.ThiEPMireCELeeACHGeisbertJBZhouJZAgansKNSneadNMDeerDJBarnardTRFentonKAet al.Lipid nanoparticle"/>
   <result pre="LE, Wirblich C, Coleman CM, Frieman MB. Multivalent vaccines for" exact="rabies virus" post="and coronaviruses. 2017 238.Sutter G FR, Volz A, Song"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464173\results\search\virus\results.xml">
   <result pre="influenza viruses, SARS, hepatitis B virus (HBV), herpes viruses (HSV)," exact="human enterovirus" post="71 (EV71), and Epsteinâ€&quot;Barr virus (EBV) [3]. The first"/>
   <result pre="of anti-HIV compoundsJ. Virol. Methods19882030932110.1016/0166-0934(88)90134-62460479 22.ViscidiR.FarzadeganH.LeisterF.FranciscoM.L.YolkenR.Enzyme immunoassay for detection of" exact="human immunodeficiency virus" post="antigens in cells culturesJ. Clin. Microbiol.19882645345810.1128/JCM.26.3.453-458.19882451678 23.FrischM.J.TrucksG.W.SchlegelH.B.ScuseriaG.E.RobbM.A.CheesemanJ.R.ScalmaniG.BaroneV.PeterssonG.A.NakatsujiH.et al.Gaussian 16,"/>
   <result pre="the recent 2019 Novel Coronavirus (SARS-CoV-2) in light of past" exact="human coronavirus" post="outbreaksPathogens2020918610.3390/pathogens9030186 54.Regla-NavaJ.A.Nieto-TorresJ.L.Jimenez-GuardeÃ±oJ.M.Fernandez-DelgadoR.FettC.CastaÃ±o-RodrÃ­guezC.PerlmanS.EnjuanesL.DeDiegoM.L.Severe acute respiratory syndrome coronaviruses with mutations in"/>
   <result pre="biomolecules-10-01148-t001_Table 1Table 1 Anti-human immunodeficiency virus (HIV)-1 replication activities in" exact="human immunodeficiency virus" post="(HIV)-infected CEM-T4 cell line. Compound CC50 (ÂµM) IC50 (ÂµM)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464234\results\search\virus\results.xml">
   <result pre="viral aetiological infectious agents include coronavirus (10â€&quot;15%) and Orthomyxoviridae (5â€&quot;15%)," exact="human parainfluenza" post="virus, human respiratory syncytial virus, adenovirus, enterovirus, and metapneumovirus."/>
   <result pre="agents include coronavirus (10â€&quot;15%) and Orthomyxoviridae (5â€&quot;15%), human parainfluenza virus," exact="human respiratory syncytial virus," post="adenovirus, enterovirus, and metapneumovirus. Besides, similar symptoms can also"/>
   <result pre="of severe acute respiratory syndrome coronavirus and close relatives of" exact="human coronavirus" post="229E in bats, GhanaEmerg. Infect. Dis.2009151377138410.3201/eid1509.09022419788804 7.CormanV.M.BaldwinH.J.TatenoA.F.ZerbinatiR.M.AnnanA.OwusuM.NkrumahE.E.MagangaG.D.Evidence for an"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7464724\results\search\virus\results.xml">
   <result pre="the e2 envelope glycoprotein are associated with the emergence of" exact="venezuelan equine encephalitis" post="virusJ. Virol.2002761718173010.1128/JVI.76.4.1718-1730.200211799167 47.KinneyR.M.TsuchiyaK.R.SneiderJ.M.TrentD.W.Molecular evidence for the origin of the"/>
   <result pre="Trop. Med. Hyg.19671667568710.4269/ajtmh.1967.16.6756053533 154.YuillT.M.HansonR.P.Serological evidence of California encephalitis virus and" exact="western equine encephalitis" post="virus in snowshoe haresZoonoses Res.196431531645895901 155.IversenJ.O.SeawrightG.HansonR.P.Serologic survey for arboviruses"/>
   <result pre="decline in virus virulenceVirology200838017017210.1016/j.virol.2008.08.01218801549 183.LogueC.H.BosioC.F.WelteT.KeeneK.M.LedermannJ.P.PhillipsA.SheahanB.J.PierroD.J.MarleneeN.BraultA.C.et al.Virulence variation among isolates of" exact="western equine encephalitis" post="virus in an outbred mouse modelJ. Gen. Virol.2009901848185810.1099/vir.0.008656-019403754 184.ReisenW.K.FangY.BraultA.C.Limited"/>
   <result pre="the 2005â€&quot;2006 outbreak on ReunionEpidemiol. Infect.200913753454110.1017/S095026880800116718694529 195.Cerbino-NetoJ.MesquitaE.C.AmancioR.T.BrasilP.Events preceding death among" exact="chikungunya virus" post="infected patients: A systematic reviewRev. Soc. Bras. Med. Trop.202053e0431201910.1590/0037-8682-0431-201932401863"/>
   <result pre="France, 2005â€&quot;2006Am. J. Trop. Med. Hyg.20077772773110.4269/ajtmh.2007.77.72717978079 199.Van AalstM.NelenC.M.GoorhuisA.StijnisC.GrobuschM.P.Long-term sequelae of" exact="chikungunya virus" post="disease: A systematic reviewTravel Med. Infect. Dis.20171582210.1016/j.tmaid.2017.01.00428163198 200.PadmakumarB.JayanJ.B.MenonR.KottaratharaA.J.Clinical profile"/>
   <result pre="ModelsmBio20189e02449-1710.1128/mBio.02449-1729511072 204.AlthouseB.M.GuerboisM.CummingsD.A.T.DiopO.M.FayeO.FayeA.DialloD.SadioB.D.SowA.FayeO.et al.Role of monkeys in the sylvatic cycle of" exact="chikungunya virus" post="in SenegalNat. Commun.20189104610.1038/s41467-018-03332-729535306 205.CoffeyL.L.FaillouxA.B.WeaverS.C.Chikungunya virus-vector interactionsViruses201464628466310.3390/v611462825421891 206.DialloM.ThonnonJ.Traore-LamizanaM.FontenilleD.Vectors of Chikungunya"/>
   <result pre="Med. Hyg.19996028128610.4269/ajtmh.1999.60.28110072152 207.JuppP.G.McIntoshB.M.Aedes furcifer and other mosquitoes as vectors of" exact="chikungunya virus" post="at Mica, northeastern Transvaal, South AfricaJ. Am. Mosq. Control."/>
   <result pre="Med. Hyg.196991895497110.4269/ajtmh.1969.18.9545355242 213.Arias-GoetaC.MoussonL.RougeonF.FaillouxA.B.Dissemination and transmission of the E1-226V variant of" exact="chikungunya virus" post="in Aedes albopictus are controlled at the midgut barrier"/>
   <result pre="at the midgut barrier levelPLoS ONE20138e5754810.1371/journal.pone.005754823437397 214.TsetsarkinK.A.VanlandinghamD.L.McGeeC.E.HiggsS.A single mutation in" exact="chikungunya virus" post="affects vector specificity and epidemic potentialPLoS Pathog.20073e20110.1371/journal.ppat.003020118069894 215.RezzaG.NicolettiL.AngeliniR.RomiR.FinarelliA.C.PanningM.CordioliP.FortunaC.BorosS.MaguranoF.et al.Infection"/>
   <result pre="of Chikungunya, SingaporeEmerg. Infect. Dis.2009151243124910.3201/eid1508.08148619751586 218.TheamboonlersA.RianthavornP.PraianantathavornK.WuttirattanakowitN.PoovorawanY.Clinical and molecular characterization of" exact="chikungunya virus" post="in South ThailandJpn. J. Infect. Dis.20096230330519628911 219.WuD.WuJ.ZhangQ.ZhongH.KeC.DengX.GuanD.LiH.ZhangY.ZhouH.et al.Chikungunya outbreak"/>
   <result pre="221.XavierJ.GiovanettiM.FonsecaV.ThezeJ.GrafT.FabriA.Goes de JesusJ.Lima de MendoncaM.C.Damasceno Dos Santos RodriguesC.Mares-GuiaM.A.et al.Circulation of" exact="chikungunya virus" post="East/Central/South African lineage in Rio de Janeiro, BrazilPLoS ONE201914e021787110.1371/journal.pone.021787131185030"/>
   <result pre="Cycles in South AmericaFront. Cell Infect. Microbiol.2019925910.3389/fcimb.2019.0025931380302 227.Lourenco-de-OliveiraR.FaillouxA.B.High risk for" exact="chikungunya virus" post="to initiate an enzootic sylvatic cycle in the tropical"/>
   <result pre="by Aedes aegyptiAm. J. Trop. Med. Hyg.20118575075710.4269/ajtmh.2011.11-035921976583 240.SerraO.P.CardosoB.F.RibeiroA.L.SantosF.A.SlhessarenkoR.D.Mayaro virus and" exact="dengue virus" post="1 and 4 natural infection in culicids from Cuiaba,"/>
   <result pre="1981-96: Possible factors explaining a peculiar disease patternEpidemiol. Infect.200212933534510.1017/S095026880200740912403109 265.SaneJ.GuedesS.OllgrenJ.KurkelaS.KlemetsP.VapalahtiO.KelaE.LyytikainenO.NuortiJ.P.Epidemic" exact="sindbis virus" post="infection in Finland: A population-based case-control study of risk"/>
   <result pre="evolution of Sindbis virus in AustraliaJ. Gen. Virol.19998073974810.1099/0022-1317-80-3-73910092014 281.EidenM.ZieglerU.KellerM.MullerK.GranzowH.JostH.Schmidt-ChanasitJ.GroschupM.H.Isolation of" exact="sindbis virus" post="from a hooded crow in GermanyVector Borne Zoonotic Dis.20141422022210.1089/vbz.2013.135424575742"/>
   <result pre="and Passeriformes) Inoculated With Ockelbo VirusJ. Wildl. Dis.19932918919510.7589/0090-3558-29.2.1898387608 283.LundstromJ.O.LindstromK.M.OlsenB.DufvaR.KrakowerD.S.Prevalence of" exact="sindbis virus" post="neutralizing antibodies among Swedish passerines indicates that thrushes are"/>
   <result pre="in South AfricaS. Afr. Med. J.19643829129414146460 288.Ben-PorathE.FattalB.GoldblumN.YofeJ.Occurrence of antibodies to" exact="sindbis virus" post="in children from a west nile endemic areaIsr. J."/>
   <result pre="Americasâ€&quot;Yet Another Arbovirus ThreatN. Engl. J. Med.201637460160410.1056/NEJMp160029726761185 334.TsetsarkinK.A.ChenR.WeaverS.C.Interspecies transmission and" exact="chikungunya virus" post="emergenceCurr. Opin. Virol.20161614315010.1016/j.coviro.2016.02.00726986235 335.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive landscape for chikungunya"/>
   <result pre="chikungunya virus emergenceCurr. Opin. Virol.20161614315010.1016/j.coviro.2016.02.00726986235 335.TsetsarkinK.A.ChenR.YunR.RossiS.L.PlanteK.S.GuerboisM.ForresterN.PerngG.C.SreekumarE.LealG.et al.Multi-peaked adaptive landscape for" exact="chikungunya virus" post="evolution predicts continued fitness optimization in Aedes albopictus mosquitoesNat."/>
   <result pre="continued fitness optimization in Aedes albopictus mosquitoesNat. Commun.20145408410.1038/ncomms508424933611 336.WeaverS.C.Arrival of" exact="chikungunya virus" post="in the new world: Prospects for spread and impact"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7465216\results\search\virus\results.xml">
   <result pre="as Mycobacterium tuberculosis (M. tb), and the survival of the" exact="human immunodeficiency virus" post="(HIV). The altered response of dendritic cells leads to"/>
   <result pre="the bacterium [11]. 3. Incidence and Epidemiology of HIV The" exact="human immunodeficiency virus" post="(HIV) is a species of Lentivirus belonging to the"/>
   <result pre="a model of a less virulent infectionAIDS Rev.201618445326936760 25.Campbell-YesufuO.T.GandhiR.T.Update on" exact="human immunodeficiency virus" post="(HIV)-2 infectionClin. Infect. Dis.20115278078710.1093/cid/ciq24821367732 26.Lugo-VillarinoG.CougouleC.MeunierE.RomboutsY.VerolletC.BalboaL.Editorial: The mononuclear phagocyte system"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466376\results\search\virus\results.xml">
   <result pre="and B viruses, Chikungunya virus, Dengue virus, Zika virus, the" exact="rabies virus," post="poliovirus, Lassa virus, Nipah and Hendra viruses, Crimean-Congo hemorrhagic"/>
   <result pre="acid residues as receptors such as the orthomyxoviruses and the" exact="human coronavirus" post="HCoV-O43 [55]. Hydroxychloroquine is different from chloroquine since it"/>
   <result pre="29.BanalesJ.M.HuebertR.C.KarlsenT.StrazzaboscoM.LaRussoN.F.GoresG.J.Cholangiocyte pathobiologyNat. Rev. Gastroenterol. Hepatol.20191626928110.1038/s41575-019-0125-y30850822 30.LingX.JiaL.MengjiL.DongliangY.XinZ.Liver injury during highly pathogenic" exact="human coronavirus" post="infectionsLiver Int.202040998100432170806 31.BangashM.N.PatelJ.ParekhD.COVID-19 and the liver: Little cause for"/>
   <result pre="Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and" exact="dengue virus" post="infectionAsian Pac. J. Trop. Med.201691710.1016/j.apjtm.2015.12.00226851778 132.SpeerE.M.DowlingD.J.OzogL.S.XuJ.YangJ.KennadyG.LevyO.Pentoxifylline inhibits the production"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7466926\results\search\virus\results.xml">
   <result pre="in Wuhan, China: a descriptive studyLancet20203951022350751310.1016/s0140-6736(20)30211-732007143 38.ChafekarAFieldingBCMERS-CoV: understanding the latest" exact="human coronavirus" post="threatViruses20181029310.3390/v10020093 39.WHO (World Health Organization). Coronavirus diseases (COVID-19) pandemic."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7467230\results\search\virus\results.xml">
   <result pre="the incidence of injection drug use (IDU)-related infections such as" exact="human immunodeficiency virus" post="(HIV), hepatitis C virus (HCV), hepatitis B virus (HBV),"/>
   <result pre="criminal justice involved populations. Abbreviations: HCV, hepatitis C virus; HIV," exact="human immunodeficiency virus;" post="IDU, injection drug use; MOUD, medication for treatment of"/>
   <result pre="Mortal Wkly Rep2019; 68:253â€&quot;4.30870405 11.GoldenMR, LechtenbergR, GlickSN, et al.Outbreak of" exact="human immunodeficiency virus" post="infection among heterosexual persons who are living homeless and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7468341\results\search\virus\results.xml">
   <result pre="to the family Coronaviridae and is closely related to another" exact="human coronavirus" post="SARS-CoV with 89.1% nucleotide similarity (Cascella etÂ al., 2020;"/>
   <result pre="etÂ al., 2020; Wu etÂ al., 2020). SARS-CoV and another" exact="human coronavirus" post="MERS-CoV (Middle East respiratory syndrome-CoV) caused two previous global"/>
   <result pre="exhaustive list of 394 host proteins interacting with the novel" exact="human coronavirus" post="that was referred to as SIPs (Table S1). This"/>
   <result pre="A549, Calu-3, and NHBE cells that were infected with the" exact="human respiratory syncytial virus" post="(RSV), influenza A/Puerto Rico/8/1934 (H1N1) virus (IAV), human parainfluenza"/>
   <result pre="respiratory syncytial virus (RSV), influenza A/Puerto Rico/8/1934 (H1N1) virus (IAV)," exact="human parainfluenza" post="virus 3 (HPIV3), and SARS-CoV-2 (Blanco-Melo etÂ al., 2020),"/>
   <result pre="viruses, Epstein-Barr virus, hepatitis C virus, influenza virus, human papillomavirus," exact="dengue virus," post="Ebola virus, HIV-1, and SARS-CoV (Ackerman etÂ al., 2018;"/>
   <result pre="al., 2018). In case of herpes simplex virus type 1," exact="varicella-zoster virus," post="and simian varicella virus, induction of nuclear factor ÎºB"/>
   <result pre="was recently shown to be required for the entry of" exact="rabies virus" post="(Shuai etÂ al., 2020). Whether ITGB1 could also promote"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472125\results\search\virus\results.xml">
   <result pre="in Porto Velho, where the serotype 1 of the isolated" exact="dengue virus" post="showed a 98% similarity with isolated sequences in Rio"/>
   <result pre="11.BonicaM.B.GoenagaS.MartinM.L.FerociM.LuppoV.MuttisE.FabbriC.MoralesM.A.EnriaD.MicieliM.V.et al.Vector competence of Aedes aegypti for different strains of" exact="zika virus" post="in ArgentinaPLoS Negl. Trop. Dis.20191311210.1371/journal.pntd.0007433 12.HonÃ³rioN.A.WigginsK.EastmondB.CÃ¢maraD.C.P.AltoB.W.Experimental vertical transmission of"/>
   <result pre="virus in ArgentinaPLoS Negl. Trop. Dis.20191311210.1371/journal.pntd.0007433 12.HonÃ³rioN.A.WigginsK.EastmondB.CÃ¢maraD.C.P.AltoB.W.Experimental vertical transmission of" exact="chikungunya virus" post="by brazilian and florida aedes albopictus populationsViruses20191135310.3390/v1104035330999594 13.ShroyerD.A.RosenL.LienJ.C.FreierJ.E.TeshR.B.Transovarial transmission"/>
   <result pre="metabolic activity in a mouse model of infection with the" exact="chikungunya virus" post="East/Central/South African GenotypeViruses20201216910.3390/v12020169 23.Goes De JesusJ.Da Luz WallauG.Lima MaiaM.XavierJ.Oliveira"/>
   <result pre="medium class neighborhood in Northeast BrazilPLoS ONE202015e022609810.1371/journal.pone.022609831914137 24.AhmadF.U.PaulS.K.AungM.S.MazidR.AlamM.AhmedS.HaqueN.HossainM.A.PaulS.SharminR.et al.Co-circulation of" exact="dengue virus" post="type 3-genotype I and type 2-Cosmopolitan genotype in 2018"/>
   <result pre="Southeast BrazilJ. Infect. Public Health2014754755210.1016/j.jiph.2014.07.01625179890 30.Bertolacci-RochaL.G.da CunhaR.V.de LichsG.G.C.FabbroM.M.F.J.D.Motta-CastroA.R.C.Introduction of the" exact="dengue virus" post="type 4 in the State of Mato Grosso do"/>
   <result pre="de RondÃ´niaAvailable online: https://rededengue.fiocruz.br/images/rededengue/Analise_epidemiologica_molecular_Rondonia.pdf(accessed on 1 June 2020) 33.VieiraD.S.HondaE.R.PereiraS.S.BifanoG.D.S.TadaM.S.BatistaW.C.Characterization of" exact="dengue virus" post="serotype 1 in epidemics in Porto Velho, RondÃ´nia, in"/>
   <result pre="de Minas GeraisBelo Horizonte, Brazil2006 41.ShrivastavaS.TirakiD.DiwanA.LalwaniS.K.ModakM.MishraA.C.ArankalleV.A.Co-circulation of all the four" exact="dengue virus" post="serotypes and detection of a novel clade of DENV-4"/>
   <result pre="2016 seasonPLoS ONE201813e019267210.1371/journal.pone.019267229470509 42.TouretF.BarontiC.GoethalsO.Van LoockM.de LamballerieX.QueratG.Phylogenetically based establishment of a" exact="dengue virus" post="panel, representing all available genotypes, as a tool in"/>
   <result pre="patient with dengue hemorrhagic feverPLoS Negl. Trop. Dis.200931510.1371/journal.pntd.0000423 57.DhanoaA.HassanS.S.NgimC.F.LauC.F.ChanT.S.AdnanN.A.A.EngW.W.H.GanH.M.RajasekaramG.Impact of" exact="dengue virus" post="(DENV) co-infection on clinical manifestations, disease severity and laboratory"/>
   <result pre="viruses in the AmericasMolecular Biol. Evol.20122915331543 63.Villabona-ArenasC.J.de ZanottoP.M.A.Worldwide spread of" exact="dengue virus" post="type 1PLoS ONE20138e6264910.1371/journal.pone.006264923675416 64.Villabona-ArenasC.J.de Andrade ZanottoP.M.Evolutionary history of Dengue"/>
   <result pre="SantosL.L.Molecular surveillance of dengue in Minas Gerais provides insights on" exact="dengue virus" post="1 and 4 circulation in BrazilJ. Med. Virol.20178996697310.1002/jmv.2472927926790 68.NunesM.R.T.FariaN.R.VasconcelosH.B.de"/>
   <result pre="in BrazilJ. Med. Virol.20178996697310.1002/jmv.2472927926790 68.NunesM.R.T.FariaN.R.VasconcelosH.B.de MedeirosD.B.A.de LimaC.P.S.CarvalhoV.L.da SilvaE.V.P.CardosoJ.F.SousaE.C.NunesK.N.B.et al.Phylogeography of" exact="dengue virus" post="serotype 4, Brazil, 2010â€&quot;2011Emerg. Infect. Dis.2012181858186410.3201/eid1811.12021723092706 69.AndradeE.H.P.FigueiredoL.B.VilelaA.P.P.RosaJ.C.C.OliveiraJ.G.ZibaouiH.M.AraÃºjoV.E.M.MirandaD.P.J.FerreiraP.C.P.AbrahÃ£oJ.S.et al.Spatial-temporal co-circulation"/>
   <result pre="serotype 4, Brazil, 2010â€&quot;2011Emerg. Infect. Dis.2012181858186410.3201/eid1811.12021723092706 69.AndradeE.H.P.FigueiredoL.B.VilelaA.P.P.RosaJ.C.C.OliveiraJ.G.ZibaouiH.M.AraÃºjoV.E.M.MirandaD.P.J.FerreiraP.C.P.AbrahÃ£oJ.S.et al.Spatial-temporal co-circulation of" exact="dengue virus" post="1, 2, 3, and 4 associated with coinfection cases"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7472297\results\search\virus\results.xml">
   <result pre="a well-studied class of oncoviruses causing T cell leukemia, while" exact="human immunodeficiency virus" post="(HIV) leads to acquired immunodeficiency syndrome (AIDS), which is"/>
   <result pre="can be employed as prospective anti-cancer modalities. human endogenous retroviruses" exact="human immunodeficiency virus" post="carcinogenesis cancer treatment antiviral strategies immunotherapy 1. Introduction Retroviruses"/>
   <result pre="[1]. Currently, there are two exogenous retroviruses affecting human health:" exact="human immunodeficiency virus" post="(HIV) and human T lymphotropic virus (HTLV). While HTLV"/>
   <result pre="nodes, lungs, and bones [2]. Kaposiâ€™s sarcoma is caused by" exact="human herpesvirus 8," post="also known as Kaposiâ€™s sarcoma-associated herpesvirus (KSHV). KSHV does"/>
   <result pre="immune recognition [82,83,84]. Kraus et al. [85] developed a recombinant" exact="vaccinia virus" post="that expressed HERV-K(HML2) Env protein (MVA-HKenv) and tested it"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7474329\results\search\virus\results.xml">
   <result pre="an alarming rate over the past decades. The most recent" exact="human coronavirus" post="known as COVID-19 (SARS-CoV-2) has already spread around the"/>
   <result pre="et al. [54] indicated that, depending on the surface, the" exact="human coronavirus" post="can persist for up to 9Â days and at"/>
   <result pre="influenza virus and has potential against different viruses, such as" exact="human coronavirus" post="or SARS-CoV [98]. This use of nanomaterial for facemasks"/>
   <result pre="activity against several viral infections, including hepatitis, influenza, Zika virus," exact="chikungunya virus" post="and other sexually transmitted viruses. Just recently, Loutfy et"/>
   <result pre="carbon quantum dots (CQDs) combined with boric acid to inhibit" exact="human coronavirus" post="HCoV-229E (Fig.Â 5). In this study, the interaction of"/>
   <result pre="developed 10,333 guide RNAs targeting 10 virus peptides and used" exact="adeno-associated virus" post="(AAV) for the targeted transport of cas13d and guide"/>
   <result pre="Pre-clinical COVID-19 vaccine candidate BIOCAD (Russia) LNPs formulated with recombinant" exact="vesicular stomatitis virus" post="(rVSV) that expresses mRNA from SARS-CoV-2 Pre-clinical COVID-19 vaccine"/>
   <result pre="VriesRDRimmelzwaanGFet al.Matrix-Mâ&quot;¢ adjuvant enhances immunogenicity of both protein- and modified" exact="vaccinia virus" post="Ankara-based influenza vaccines in miceImmunol Res20186622423329594879 193.Novavax. Novavax to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476354\results\search\virus\results.xml">
   <result pre="2019; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV," exact="human immunodeficiency virus;" post="HSV, herpes simplex virus; RCT, randomized controlled trial; SARS-CoV-2,"/>
   <result pre="hydroxychloroquine; HBV, hepatitis B virus; HCV, hepatitis C virus; HHV-8," exact="human herpesvirus 8;" post="HIV, human immunodeficiency virus; HSV, herpes simplex virus; HTLV-1,"/>
   <result pre="virus; HCV, hepatitis C virus; HHV-8, human herpesvirus 8; HIV," exact="human immunodeficiency virus;" post="HSV, herpes simplex virus; HTLV-1, human T-cellâ€&quot;lymphotrophic virus-1; IMPDH,"/>
   <result pre="immunosuppressants. Medications Viral susceptibility Proposed antiviral mechanisms ChloroquineHCQ SARS-CoV, HIV," exact="dengue virus," post="chikungunya virus, influenza A virus, HCV, Zika virus (1)â€ƒIncrease"/>
   <result pre="Viral susceptibility Proposed antiviral mechanisms ChloroquineHCQ SARS-CoV, HIV, dengue virus," exact="chikungunya virus," post="influenza A virus, HCV, Zika virus (1)â€ƒIncrease endosomal pH"/>
   <result pre="HCV, and influence protein folding and trafficking Flavivirus (Zika virus," exact="dengue virus," post="West Nile virus, yellow fever virus) Block the interaction"/>
   <result pre="ATLL, adult T-cell lymphoma/leukemia; BKV, BK virus; CMV, cytomegalovirus; DENV," exact="dengue virus;" post="DMARDs, disease-modifying anti-rheumatic drugs; DNA, deoxyribonucleic acid; dTNP, deoxynucleoside"/>
   <result pre="active antiretroviral therapy; HBV, hepatitis B virus; HCQ, hydroxychloroquine; HHV-8," exact="human herpesvirus 8;" post="HIV, human immunodeficiency virus; HTLV-I, human T-cell lymphotrophic virus-1;"/>
   <result pre="hepatitis B virus; HCQ, hydroxychloroquine; HHV-8, human herpesvirus 8; HIV," exact="human immunodeficiency virus;" post="HTLV-I, human T-cell lymphotrophic virus-1; IMPDH, inosine monophosphate dehydrogenase;"/>
   <result pre="disease112 AD, atopic dermatitis; CMV, cytomegalovirus; CsA, cyclosporine A; DENV," exact="dengue virus;" post="DMARDs, disease-modifying anti-rheumatic drugs; HAART, highly active antiretroviral therapy;"/>
   <result pre="hepatitis B virus; HCQ, hydroxychloroquine; HCV, hepatitis C virus; HHV-8," exact="human herpesvirus 8;" post="HIV, human immunodeficiency virus; HSV, herpes simplex virus; HTLV-I,"/>
   <result pre="hydroxychloroquine; HCV, hepatitis C virus; HHV-8, human herpesvirus 8; HIV," exact="human immunodeficiency virus;" post="HSV, herpes simplex virus; HTLV-I, human T cell lymphotrophic"/>
   <result pre="in vitro studies.86â€&quot;91 On the contrary, an animal experiment with" exact="rabies virus" post="infection treated by minocycline caused the exacerbation of encephalomyelitis"/>
   <result pre="benefit for both prophylaxis and treatment.31,32 Human immunodeficiency virus (HIV)," exact="dengue virus," post="chikungunya virus, influenza A virus, hepatitis C virus (HCV)"/>
   <result pre="both prophylaxis and treatment.31,32 Human immunodeficiency virus (HIV), dengue virus," exact="chikungunya virus," post="influenza A virus, hepatitis C virus (HCV) Some in"/>
   <result pre="viruses belonging to this genus (dengue virus, West Nile virus," exact="yellow fever virus" post="and Zika virus). The efficacy of CsA is through"/>
   <result pre="Pharmacol2001; 61: 1531â€&quot;1535.11377382 35SperberKLouieMKrausT, et al.Hydroxychloroquine treatment of patients with" exact="human immunodeficiency virus" post="type 1. Clin Ther1995; 17: 622â€&quot;636.8565026 36NeelyMKalyesubulaIBagendaD, et al.Effect"/>
   <result pre="Clin Ther1995; 17: 622â€&quot;636.8565026 36NeelyMKalyesubulaIBagendaD, et al.Effect of chloroquine on" exact="human immunodeficiency virus" post="(HIV) vertical transmission. Afr Health Sci2003; 3: 61â€&quot;67.12913796 37MurraySMDownCMBoulwareDR,"/>
   <result pre="receiving antiretroviral therapy. HIV Med2015; 16: 48â€&quot;56.24889179 41FariasKJMachadoPRDa FonsecaBA.Chloroquine inhibits" exact="dengue virus" post="type 2 replication in Vero cells but not in"/>
   <result pre="ScientificWorldJournal2013; 2013: 282734.23431254 42FariasKJMachadoPRMunizJA, et al.Antiviral activity of chloroquine against" exact="dengue virus" post="type 2 replication in Aotus monkeys. Viral Immunol2015; 28:"/>
   <result pre="Hepatol2012; 11: 951â€&quot;954.23109461 54LiCZhuXJiX, et al.Chloroquine, a FDA-approved drug, prevents" exact="zika virus" post="infection and its associated congenital microcephaly in mice. EBioMedicine2017;"/>
   <result pre="62BarrowsNJCamposRKPowellST, et al.A screen of FDA-approved drugs for inhibitors of" exact="zika virus" post="infection. Cell Host Microbe2016; 20: 259â€&quot;270.27476412 63Montano-LozaAJWasilenkoSBintnerJ, et al.Cyclosporine"/>
   <result pre="targeting the cell with a drug targeting the virus controls" exact="human immunodeficiency virus" post="type 1 resistance. AIDS Res Hum Retroviruses1997; 13: 1403â€&quot;1409.9359660"/>
   <result pre="749â€&quot;754.26940953 78SiQCosenzaMKimMO, et al.A novel action of minocycline inhibition of" exact="human immunodeficiency virus" post="type 1 infection in microglia. J Neurovirol2004; 10: 284â€&quot;292.15385251"/>
   <result pre="Dis2016; 16: 67.26847071 86LeelaSLSrisawatCSreekanthGP, et al.Drug repurposing of minocycline against" exact="dengue virus" post="infection. Biochem Biophys Res Commun2016; 478: 410â€&quot;416.27396621 87BawageSSTiwariPMPillaiS, et"/>
   <result pre="81: 6248â€&quot;6253.17409147 93ChapuisAGPaolo RizzardiGDâ€™AgostinoC, et al.Effects of mycophenolic acid on" exact="human immunodeficiency virus" post="infection in vitro and in vivo. Nat Med2000; 6:"/>
   <result pre="JOQUER randomized trial. Rheumatology (Oxford)2020; 59: 107â€&quot;111.31237947 120WangLFLinYSHuangNC, et al.Hydroxychloroquine-inhibited" exact="dengue virus" post="is associated with host defense machinery. J Interferon Cytokine"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7476961\results\search\virus\results.xml">
   <result pre="spike proteinCell. Mol. Immunol.20201310.1038/s41423-020-0374-231611651 23LuG.HuY.WangQ.QiJ.GaoF.LiY.ZhangY.ZhangW.YuanY.BaoJ.ZhangB.ShiY.YanJ.GaoG.F.Molecular basis of binding between novel" exact="human coronavirus" post="MERS-CoV and its receptor CD26Nature500201322723110.1038/nature1232823831647 24F. Li, W. Li,"/>
   <result pre="Commun.5201410.1038/ncomms4067 27XiaS.YanL.XuW.AgrawalA.S.AlgaissiA.TsengC.T.K.WangQ.DuL.TanW.WilsonI.A.JiangS.YangB.LuL.A pan-coronavirus fusion inhibitor targeting the HR1 domain of" exact="human coronavirus" post="spikeSci. Adv.5201910.1126/sciadv.aav4580 28XiaS.LiuM.WangC.XuW.LanQ.FengS.QiF.BaoL.DuL.LiuS.QinC.SunF.ShiZ.ZhuY.JiangS.LuL.Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by"/>
   <result pre="coronavirus entryProc. Natl. Acad. Sci. USA1022005118761188110.1073/pnas.050557710216081529 44HuangI.C.BoschB.J.LiF.LiW.KyoungH.L.GhiranS.VasilievaN.DermodyT.S.HarrisonS.C.DormitzerP.R.FarzanM.RottierP.J.M.ChoeH.SARS coronavirus, but not" exact="human coronavirus" post="NL63, utilizes cathepsin L to infect ACE2-expressing cellsJ. Biol."/>
   <result pre="repurposingACS Infect. Dis.1201631732610.1021/acsinfecdis.5b00030 120DelvecchioR.HigaL.M.PezzutoP.ValadÃ£oA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.M.AliotaM.T.CaineE.A.OsorioJ.E.BellioM.Oâ€™ConnorD.H.RehenS.De AguiarR.S.SavarinoA.CampanatiL.TanuriA.Chloroquine, an endocytosis blocking agent, inhibits" exact="zika virus" post="infection in different cell modelsViruses8201610.3390/v8120322 121FreibergA.N.WorthyM.N.LeeB.HolbrookM.R.Combined chloroquine and ribavirin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7479232\results\search\virus\results.xml">
   <result pre="Italy. BMJ Glob. Heal.5 (6), e002564. 10.1136/bmjgh-2020-002564 ChannappanavarR.PerlmanS. (2017). Pathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7480504\results\search\virus\results.xml">
   <result pre="known to infect humans. The emergence of SARS-CoV-2 as a" exact="human coronavirus" post="came after the emergence of MERS-CoV in less than"/>
   <result pre="humidity on viral activity is challenging to assess [25]. The" exact="human coronavirus" post="associated with the common cold was reported to remain"/>
   <result pre="for many days in liquid suspension [26]. In aerosolized form," exact="human coronavirus" post="229E is generally less stable in high humidity [27]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7481143\results\search\virus\results.xml">
   <result pre="in 37 countries. In September 2012, the second highly pathogenic" exact="human coronavirus" post="arose in Saudi Arabia and spread across Middle Eastern"/>
   <result pre="verified in preclinical trials against HIV, herpes simplex virus (HSV)," exact="varicella-zoster virus" post="(VZV), Epstein-Barr virus (HSV-4) and adenovirus, in order to"/>
   <result pre="a broad antiviral spectrum including diverse RNA viruses such as" exact="human respiratory syncytial virus" post="(HSRV), MERS-CoV, SARS-CoV and Nipah virus.129, 130 RDV inhibits"/>
   <result pre="synthesis of viral RNA for a spectrum of viruses, including" exact="human coronavirus." post="Thus, it is a promising drug against SARS-CoV-2.107 A"/>
   <result pre="pathogenesisJ Microbiol Immunol Infect202010.1016/j.jmii.2020.03.022[Epub ahead of print] 22ForniD.CaglianiR.ClericiM.SironiM.Molecular evolution of" exact="human coronavirus" post="genomesTrends Microbiol252017354810.1016/j.tim.2016.09.00127743750 23Abd El-AzizT.M.StockandJ.D.Recent progress and challenges in drug"/>
   <result pre="al. Beyond members of the flaviviridae family, sofosbuvir also inhibits" exact="chikungunya virus" post="replication. Antimicrob Agents Chemother 2018;63:e01389-18. https://doi.org/10.1128/AAC.01389-18. 117Sayad B, Sobhani"/>
   <result pre="and binding free energy calculationBioRxiv202010.1101/2020.01.27.921627 182BustiA.J.HallR.G.MargolisD.M.Atazanavir for the treatment of" exact="human immunodeficiency virus" post="infectionPharmacotherapy12200417321747 183MastanS.K.KumarK.E.Influence of atazanavir on the pharmacodynamics and pharmacokinetics"/>
   <result pre="inhibitorsJ Gen Virol99201861963029557770 219CoyneC.B.BergelsonJ.M.Virus-induced Abl and Fyn kinase signals permit" exact="coxsackievirus" post="entry through epithelial tight junctionsCell124200611913116413486 220MinS.LimY.S.ShinD.Abl tyrosine kinase regulates"/>
   <result pre="expense of efficient nuclear vRNP importSci Rep620162313826988202 270TayM.Y.F.FraserJ.E.ChanW.K.K.Nuclear localization of" exact="dengue virus" post="(DENV) 1â€&quot;4 non-structural protein 5; protection against all 4"/>
   <result pre="novel multi-target indole-based derivatives as potent and selective inhibitors of" exact="chikungunya virus" post="replicationBioorg Med Chem25201732733727856239 285PatilS.A.PatilS.A.PatilR.Medicinal applications of (benz)imidazole- and indole-based"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7484576\results\search\virus\results.xml">
   <result pre="of SARSâ€�CoV replication.36 Papainâ€�like protease inhibitors Papainâ€�like protease encoded by" exact="human coronavirus" post="has a unique and novel deubiquitinating activity. It is"/>
   <result pre="BALB/c mice 32265331 PMC7157776 Li et al.31 Vector vaccine Modified" exact="vaccinia virus" post="Ankara (MVA)-based vaccine S protein No 32325037 PMC7172913 Koch"/>
   <result pre="FathiA, KupkeA, KrÃ¤hlingV, OkbaNM, HesterkampTSafety and immunogenicity of a modified" exact="vaccinia virus" post="Ankara vector vaccine candidate for Middle East respiratory syndrome:"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseases. ACS Cent Sci. 2020;6:315â€&quot;31. doi:10.1021/acscentsci.0c00272.32226821 59.BuchholzUJ, BukreyevA, YangL,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7485819\results\search\virus\results.xml">
   <result pre="coronavirus (OC43, NL63, and 229E), 4 human bocavirus (HBoV), 4" exact="human enterovirus" post="(HEV), 4 human rhinovirus (HRV), and 4 metapneumovirus (MPV)."/>
   <result pre="229E), 4 human bocavirus (HBoV), 4 human enterovirus (HEV), 4" exact="human rhinovirus" post="(HRV), and 4 metapneumovirus (MPV). All virus specimens were"/>
   <result pre="B 4 0/4 4/4 0/4 0/4 0/4 0/4 0/4 HEV:" exact="human enterovirus," post="AdV: adenovirus, PIV(1â€&quot;4): parainfluenza virus(1â€&quot;4), MPV: human metapneumovirus, HBoV:"/>
   <result pre="PIV(1â€&quot;4): parainfluenza virus(1â€&quot;4), MPV: human metapneumovirus, HBoV: human bocavirus, HRV:" exact="human rhinovirus," post="229E: human coronavirus 229E, NL63: human coronavirus NL63, OC43:"/>
   <result pre="MPV: human metapneumovirus, HBoV: human bocavirus, HRV: human rhinovirus, 229E:" exact="human coronavirus" post="229E, NL63: human coronavirus NL63, OC43: human coronavirus OC43,"/>
   <result pre="human bocavirus, HRV: human rhinovirus, 229E: human coronavirus 229E, NL63:" exact="human coronavirus" post="NL63, OC43: human coronavirus OC43, RSV A: respiratory syncytial"/>
   <result pre="rhinovirus, 229E: human coronavirus 229E, NL63: human coronavirus NL63, OC43:" exact="human coronavirus" post="OC43, RSV A: respiratory syncytial virus A, RSV B:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7486822\results\search\virus\results.xml">
   <result pre="as a protease inhibitor (PI), used in the treatment of" exact="human immunodeficiency virus" post="(HIV) infection.4 Lopinavir has antiviral activity, while ritonavir acts"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7489051\results\search\virus\results.xml">
   <result pre="effects.71 Various studies showed that matrine exhibited antiviral activities against" exact="coxsackievirus" post="B3 (CVB3) in Vero cells and influenza H3N2 virus"/>
   <result pre="reported to inhibit poliomyelitis virus, Bunyamwera virus, herpes simplex virus," exact="dengue virus," post="West Nile virus, and SARS-CoV in vitro.(74,75) Lycorine exhibited"/>
   <result pre="CoV coronavirus COVID-19 coronavirus disease 2019 CPE cytopathogenic effect CVB3" exact="coxsackievirus" post="B3 GL glycyrrhizic acid (glycyrrhizin) HAE human airway epithelial"/>
   <result pre="B3 GL glycyrrhizic acid (glycyrrhizin) HAE human airway epithelial HCoV-229E" exact="human coronavirus" post="229E GFP green fluorescent protein HCoV-HKU1 human coronavirus HKU1"/>
   <result pre="epithelial HCoV-229E human coronavirus 229E GFP green fluorescent protein HCoV-HKU1" exact="human coronavirus" post="HKU1 HCoV-NL63 human coronavirus NL63 HCoV-OC43 human coronavirus OC43"/>
   <result pre="229E GFP green fluorescent protein HCoV-HKU1 human coronavirus HKU1 HCoV-NL63" exact="human coronavirus" post="NL63 HCoV-OC43 human coronavirus OC43 HSBDT Huashi Baidu Tang"/>
   <result pre="protein HCoV-HKU1 human coronavirus HKU1 HCoV-NL63 human coronavirus NL63 HCoV-OC43" exact="human coronavirus" post="OC43 HSBDT Huashi Baidu Tang IC50 the half maximal"/>
   <result pre="VijgenL.; RysmanE.; VerbeeckJ.; Van RanstM.; MaesP.Antiviral activity of chloroquine against" exact="human coronavirus" post="OC43 infection in newborn mice. Antimicrob. Agents Chemother.2009, 53,"/>
   <result pre="LiangP. H.; WongC. H.Small molecules targeting severe acute respiratory syndrome" exact="human coronavirus." post="Proc. Natl. Acad. Sci. U. S. A.2004, 101, 10012â€&quot;10017."/>
   <result pre="injection on a mouse model combining disease with syndrome of" exact="human coronavirus" post="pneumonia with cold-dampness pestilence attacking the lung. Acta Pharm."/>
   <result pre="L.; ChenW.; YatesM. V.Rapid identification of inhibitors that interfere with" exact="poliovirus" post="replication using a cell-based assay. Antiviral Res.2008, 77, 232â€&quot;236."/>
   <result pre="620â€&quot;635. 10.1080/13880209.2016.1262433.27951737 ChengP.; NgL.; ChiangL.; LinC.Antiviral effects of saikosaponins on" exact="human coronavirus" post="229E in vitro. Clin. Exp. Pharmacol. Physiol.2006, 33, 612â€&quot;616."/>
   <result pre="KimS.; JinY. H.; KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit" exact="human coronavirus" post="Oc43 infection of Mrc-5 human lung cells. Biomolecules2019, 9,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7493775\results\search\virus\results.xml">
   <result pre="influenza and Parkinson disease, has showed the antiviral activity against" exact="human coronavirus" post="OC43 and SARS-CoV.9,45 SARS-CoV-2 entry into host cells might"/>
   <result pre="system might be delivered to the SARS-CoV-2-infected lung tissue by" exact="adeno-associated virus" post="vector. Therefore, the CRISPR system against the SARS-CoV-2 might"/>
   <result pre="an antiviral agent against several viruses such as influenza, HIV," exact="dengue virus," post="West Nile virus, and Venezuelan equine encephalitis virus in"/>
   <result pre="Venezuelan Equine Encephalitis virus replication.Antiviral Res2013;100:662â€&quot;72.24161512 71.TayMYFraserJEChanWKMorelandNJRathoreAPWangCet al.Nuclear localization of" exact="dengue virus" post="(DENV) 1-4 non-structural protein 5; protection against all 4"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7496561\results\search\virus\results.xml">
   <result pre="for viral replication [25]. Chloroquine demonstrates broad-spectrum antiviral activity against" exact="human coronavirus" post="HCoV-O43 and orthomyxoviruses by interfering with sialic acid biosynthesis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498411\results\search\virus\results.xml">
   <result pre="[5]. Similarly, approximately 37.9 million people worldwide suffered from the" exact="human immunodeficiency virus" post="(HIV) around the end of 2018 [6], leading to"/>
   <result pre="B virus (HBV), hepatitis C virus (HCV), herpesvirus, influenza virus," exact="human cytomegalovirus," post="varicella-zoster virus, respiratory syncytial virus (RSV), and human papilloma"/>
   <result pre="(HBV), hepatitis C virus (HCV), herpesvirus, influenza virus, human cytomegalovirus," exact="varicella-zoster virus," post="respiratory syncytial virus (RSV), and human papilloma virus (HPV)"/>
   <result pre="a high level of antibody to neutralizing DENV. [38] aDENV:" exact="dengue virus;" post="VSV: vesicular stomatitis virus; BV: baculovirus; ED III: domain"/>
   <result pre="of antibody to neutralizing DENV. [38] aDENV: dengue virus; VSV:" exact="vesicular stomatitis virus;" post="BV: baculovirus; ED III: domain III of envelope glycoprotein"/>
   <result pre="domain III of envelope glycoprotein derived from serotype 2 of" exact="dengue virus." post="RANTES: regulated upon activation, normal T expressed and secreted."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7498997\results\search\virus\results.xml">
   <result pre="target against COVID-19 [5]. An inÂ vitro study showed that" exact="human coronavirus" post="(HCoV-NL63) infection can downregulate ACE2 [37] and similar findings"/>
   <result pre="different viral infections including HIV, hepatitis C virus, Ebola, and" exact="human cytomegalovirus" post="[91]. Estrogen was shown to inhibit influenza A virus"/>
   <result pre="al.Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by" exact="human coronavirus" post="nl63J Gen Virol2012931924192922718567 38.Kuba K, Imai Y, Rao S,"/>
   <result pre="immunity by inhibiting t-helper 1 differentiation. 2014;111:9887â€&quot;92. 82.MuehlenbeinMPCogswellFBJamesMAKoterskiJLudwigGVTestosterone correlates with" exact="venezuelan equine encephalitis" post="virus infection in macaquesVirol J200631916571136 83.FurmanDHejblumBPSimonNJojicVDekkerCLThiÃ©bautRet al.Systems analysis of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7499567\results\search\virus\results.xml">
   <result pre="J Antimicrob Chemother. 2012;67:1295â€&quot;6.22287233 ForniD, CaglianiR, ClericiMet al.Molecular evolution of" exact="human coronavirus" post="genomes. Trends Microbiol. 2017;25:35â€&quot;48.27743750 FranciscoAF, deÂ AbreuÂ VieiraPM, ArantesJMet"/>
   <result pre="by trypsin treatment. Virology. 1975;68:426â€&quot;39.173078 KoetzA, NilssonP, LindÃ©nMet al.Detection of" exact="human coronavirus" post="NL63, human metapneumovirus and respiratory syncytial virus in children"/>
   <result pre="Int J Infect Dis. 2012;16:e321â€&quot;31.22387143 MilewskaA, NowakP, OwczarekKet al.Entry of" exact="human coronavirus" post="NL63 into the cell. J Virol. 2018;92:e01933â€&quot;17.29142129 MilewskaA, ZarebskiM,"/>
   <result pre="virus. J Virol. 2015;89:10993â€&quot;1001.26311890 RenL, ZhangY, LiJet al.Genetic drift of" exact="human coronavirus" post="OC43 spike gene during adaptive evolution. Sci Rep. 2015;5:11451.26099036"/>
   <result pre="non-infectious diseases. Adv Ther. 2019;36:1878â€&quot;905.31168764 SlootsTP, McErleanP, SpeicherDJet al.Evidence of" exact="human coronavirus" post="HKU1 and human bocavirus in Australian children. J Clin"/>
   <result pre="TorreJC, HollandJJHigh nucleotide substitution error frequencies in clonal pools of" exact="vesicular stomatitis virus." post="J Virol. 1989;63:2063â€&quot;71.2539502 SteinhauerDARole of hemagglutinin cleavage for the"/>
   <result pre="2005;24:645â€&quot;6.15999010 SzczepanskiA, OwczarekK, BzowskaMet al.Canine respiratory coronavirus, bovine coronavirus, and" exact="human coronavirus" post="OC43: receptors and attachment factors. Viruses. 2019;11:E328.30959796 TanDX, KormazA,"/>
   <result pre="viruses. PLoS Pathog. 2013;9:e1003657.24130481 TortoriciMA, WallsAC, LangYet al.Structural basis for" exact="human coronavirus" post="attachment to sialic acid receptors. Nat Struct Mol Biol."/>
   <result pre="XueFet al.Structure of the main protease from a global infectious" exact="human coronavirus," post="HCoV-HKU1. J Virol.2008;82:8647â€&quot;55.18562531 ZhengJ, YamadaY, FungTSet al.Identification of N-linked"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501082\results\search\virus\results.xml">
   <result pre="affinity) and to prevent the processing of HIVâ€�1 Env and" exact="measles virus" post="F in vitro[38], [46], [47] (see Table 1). Similarly,"/>
   <result pre="the following, we will present a discussion on inhibitors for" exact="human coronavirus" post="Mpro. First, results for known Mpro inhibitors will be"/>
   <result pre="of a series of potent and highly selective inhibitors of" exact="human coronavirus" post="papain-like proteasesJ. Med. Chem.5720142393241210.1021/jm401712t24568342 165GuzikT.J.MohiddinS.A.DimarcoA.PatelV.SavvatisK.Marelli-BergF.M.MadhurM.S.TomaszewskiM.MaffiaP.D'AcquistoF.NicklinS.A.MarianA.J.NosalskiR.MurrayE.C.GuzikB.BerryC.TouyzR.M.KreutzR.WangD.W.BhellaD.SaglioccoO.CreaF.ThomsonE.C.McInnesI.B.COVID-19 and the cardiovascular system:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501538\results\search\virus\results.xml">
   <result pre="2019;8(1):244. doi:10.1186/s13643-019-1176-431661030 21WilliamsEC, HahnJA, SaitzR, BryantK, LiraMC, SametJHAlcohol use and" exact="human immunodeficiency virus" post="(HIV) infection: current knowledge, implications, and future directions. Alcohol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501552\results\search\virus\results.xml">
   <result pre="version 6.0Molecular Biology and Evolution201330122725272910.1093/molbev/mst19724132122 27LoleK. S.BollingerR. C.ParanjapeR. S.et al.Full-length" exact="human immunodeficiency virus" post="type 1 genomes from subtype C-infected seroconverters in India,"/>
   <result pre="Infection and Immunosuppressive Disorders2013547381 36RoudinskiiN. I.SukhanovaA. L.KazennovaE. V.et al.Diversity of" exact="human immunodeficiency virus" post="type 1 subtype A and CRF03_AB protease in eastern"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7501848\results\search\virus\results.xml">
   <result pre="vaccines7220008992 36ZhouJ.RossiJ.Cell-typeâ€&quot;specific aptamer and aptamer-small interfering RNA conjugates for targeted" exact="human immunodeficiency virus" post="type 1 therapyJ.Â Invest. Med.6272014914919 37TrobaughD.W.KlimstraW.B.MicroRNA regulation of RNA"/>
   <result pre="offers a potential target for antiviral developmentAntivir. Res.178202010479232272173 128PyrcK.Inhibition of" exact="human coronavirus" post="NL63 infection at early stages of the replication cycleAntimicrob."/>
   <result pre="150KlasseP.J.Modeling how many envelope glycoprotein trimers per virion participate in" exact="human immunodeficiency virus" post="infectivity and its neutralization by antibodyVirology3692200724526217825343 151MagnusC.Estimating the stoichiometry"/>
   <result pre="infectivity and its neutralization by antibodyVirology3692200724526217825343 151MagnusC.Estimating the stoichiometry of" exact="human immunodeficiency virus" post="entryJ.Â Virol.83320091523153119019953 152WoutersO.J.McKeeM.LuytenJ.Estimated research and development investment needed to"/>
   <result pre="factors7613200266526659 172LiS.S.DNA priming increases frequency of T-cell responses to a" exact="vesicular stomatitis virus" post="HIV vaccine with specific enhancement of CD8+ T-cell responses"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7502134\results\search\virus\results.xml">
   <result pre="L.Latent classes of polydrug and polyroute use and associations with" exact="human immunodeficiency virus" post="risk behaviours and overdose among people who inject drugs"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7503980\results\search\virus\results.xml">
   <result pre="in patients with mild COVID-19 [22]. Raltegravir, the first approved" exact="human immunodeficiency virus" post="type 1 (HIV-1) integrase inhibitor and the best Mpro"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505219\results\search\virus\results.xml">
   <result pre="Kong, 2015â€&quot;16Influenza Other Respir Viruses2017111616510.1111/irv.1239927313064 63.ChiuSSLoJYChanKHChanELSoLYet al.Population-based hospitalization burden of" exact="influenza a virus" post="subtypes and antigenic drift variants in children in Hong"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7505852\results\search\virus\results.xml">
   <result pre="and xylomannan sulphate (from Nothogenia fastigiata) exhibit antiviral activity against" exact="human immunodeficiency virus," post="herpes simplex viruses types 1, 2 and respiratory syncytial"/>
   <result pre="replication cycleAntiviral Research753200717918710.1016/j.antiviral.2007.03.00317428553 KimD.E.MinJ.S.JangM.S.LeeJ.Y.ShinY.S.SongJ.H.KimH.R.KimS.JinY.-H.KwonS.Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit" exact="human coronavirus" post="OC43 infection of MRC-5 human lung cellsBiomolecules911201910.3390/biom9110696 KorkinaL.KostyukV.De LucaC.PastoreS.Plant"/>
   <result pre="the Brazilian Society of Infectious Diseases165201246647110.1016/j.bjid.2012.08.014 PyrcK.BoschB.J.BerkhoutB.JebbinkM.F.DijkmanR.RottierP.van der HoekL.Inhibition of" exact="human coronavirus" post="NL63 infection at early stages of the replication cycleAntimicrobial"/>
   <result pre="receptor-binding domain complexed with human receptor DPP4Cell Research238201398699310.1038/cr.2013.9223835475 WanZ.LuY.LiaoQ.WuY.ChenX.Fangchinoline inhibits" exact="human immunodeficiency virus" post="type 1 replication by interfering with gp160 proteolytic processingPloS"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7507004\results\search\virus\results.xml">
   <result pre="Introduction In 2018, nearly 38Â million people were living with" exact="human immunodeficiency virus" post="(HIV), of whom 20.64Â million live in subâ€�Saharan Africa."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7508045\results\search\virus\results.xml">
   <result pre="respiratory tract infections [[106], [107], [108]]. Cross-reactivity between SARS-CoV-2 and" exact="human coronavirus" post="is a plausible explanation for why children appear to"/>
   <result pre="infection in Beijing and Shanghai, ChinaBMC Infect Dis19201972931429710 108GilcaR.CarazoS.AminiR.CharestH.De SerresG.Common" exact="human coronavirus" post="seem at least as severe as influenza in patients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7509820\results\search\virus\results.xml">
   <result pre="2 is a functional receptor for the SARS coronavirusNature2003426696545045410.1038/nature0214514647384 37.ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7510719\results\search\virus\results.xml">
   <result pre="10.1371/journal.pone.010447425148412 7. StecherM, ChaillonA, Eis-HubingerAM, LehmannC, FatkenheuerG, WasmuthJC, et al.Pretreatment" exact="human immunodeficiency virus" post="type 1 (HIV-1) drug resistance in transmission clusters of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7511040\results\search\virus\results.xml">
   <result pre="arrhythmogenicity Lopinavir/ritonavir (a potent CYP3A4-inhibiting drug) is used to treat" exact="human immunodeficiency virus" post="(HIV) infection and is now under investigation for use"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7511596\results\search\virus\results.xml">
   <result pre="route for hepatitis C virus (HCV) of growing importance among" exact="human immunodeficiency virus" post="(HIV)â€�positive populations. In Western countries, HCV epidemics have been"/>
   <result pre="a European study, a rapid upsurge of HCV incidence among" exact="human immunodeficiency virus" post="(HIV)â€�positive men who have sex with men (MSM) was"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7512176\results\search\virus\results.xml">
   <result pre="therapy RNA virus antiretroviral resistance drug resistance evolution gene sequencing" exact="human immunodeficiency virus" post="phylogenetic analysis surveillance studies fig-count: table-count: equation-count: ref-count: page-count:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7517057\results\search\virus\results.xml">
   <result pre="without the involvement of animal hosts (many vector-borne diseases, e.g.," exact="dengue virus," post="yellow fever virus, cholera, influenza A, typhus); and the"/>
   <result pre="involvement of animal hosts (many vector-borne diseases, e.g., dengue virus," exact="yellow fever virus," post="cholera, influenza A, typhus); and the fifth is when"/>
   <result pre="encephalitis--New York, 1999MMWR Morb Mortal Wkly Rep19994884510563521 13.RezzaGNicolettiLAngeliniRRomiRFinarelliACPanningMet al.Infection with" exact="chikungunya virus" post="in Italy: an outbreak in a temperate regionLancet.20073701840184618061059 14.van"/>
   <result pre="acute respiratory syndrome in Hong KongLancet.20033611761176612781533 193.IjazMKBrunnerAHSattarSANairRCJohnson-LussenburgCMSurvival characteristics of airborne" exact="human coronavirus" post="229EJ Gen Virol198566274327482999318 194.MangenMJNielenMBurrellAMSimulated effect of pig-population density on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7517806\results\search\virus\results.xml">
   <result pre="in Bangkok and Chiang MaiDrug Alcohol Depend2015148412613510.1016/j.drugalcdep.2014.12.03425640153 9.HaganHPougetERDes JarlaisDCLelutiu-WeinbergerCMeta-regression of" exact="hepatitis c virus" post="infection in relation to time since onset of illicit"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7518973\results\search\virus\results.xml">
   <result pre="East Respiratory syndrome coronavirus (MERS-CoV)BMC Med.14201613210.1186/s12916-016-0686-327604081 11ChafekarA.FieldingB.C.MERS-CoV: understanding the latest" exact="human coronavirus" post="threatViruses.1020189310.3390/v10020093 12HanH.-J.YuH.YuX.-J.Evidence for zoonotic origins of Middle East respiratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7520644\results\search\virus\results.xml">
   <result pre="and neurological symptoms[2]. Except SARS-CoV-2, there are six other reported" exact="human coronavirus" post="members. These are HCoV-OC43, HCoV229E, SARS-CoV, HCoV-HKU1, Middle East"/>
   <result pre="to bedside?PLoS One20149e8871624551142 45JossetLMenacheryVDGralinskiLEAgnihothramSSovaPCarterVSYountBLGrahamRLBaricRSKatzeMGCell host response to infection with novel" exact="human coronavirus" post="EMC predicts potential antivirals and important differences with SARS"/>
   <result pre="56CameronMJBermejo-MartinJFDaneshAMullerMPKelvinDJHuman immunopathogenesis of severe acute respiratory syndrome (SARS)Virus Res2008133131917374415 57ChannappanavarRPerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathologySemin"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7525249\results\search\virus\results.xml">
   <result pre="Lopinavir are protease inhibitors that are usually used to treat" exact="human immunodeficiency virus" post="infection with and a booster drug ritonavir. Lopinavir and/or"/>
   <result pre="1 heterodimer (accountable for nuclear importation of integrase protein) and" exact="human immunodeficiency virus" post="1. This confirms that ivermectin is responsible for inhibiting"/>
   <result pre="responsible for inhibiting the nuclear import of integrase protein and" exact="human immunodeficiency virus" post="type-1 replication. Other effects of ivermectin have been reported,"/>
   <result pre="Phase 1 ChiCTR2000034112 Abbreviations: CCHF, Crimeanâ€&quot;Congo haemorrhagic fever virus; DENV," exact="dengue virus;" post="EBOV, Ebola virus; HIV, human immunodeficiency virus; HPV, human"/>
   <result pre="haemorrhagic fever virus; DENV, dengue virus; EBOV, Ebola virus; HIV," exact="human immunodeficiency virus;" post="HPV, human papillomavirus; Inf (H7N9), influenza virus H7N9; LASV,"/>
   <result pre="B; MERS, Middle East respiratory syndrome; NIPV, Nipah virus; RABV," exact="rabies virus;" post="REV, reticuloendothelial virus; RSV, respiratory syncytial virus; SARS, severe"/>
   <result pre="Off Publ Infect Dis Soc Am71152020793798 6LoeffelholzM.J.TangY.W.Laboratory diagnosis of emerging" exact="human coronavirus" post="infectionsâ€&quot;the state of the artEmerg Microbe. Infect92020747756 7ParkG.S.KuK.BaekS.H.KimS.J.KimS.I.KimB.T.Development of"/>
   <result pre="Sci6120042738274315549175 22CollinsA.R.HLA class I antigen serves as a receptor for" exact="human coronavirus" post="OC43Immunol Invest221993951038505072 23RajV.S.MouH.SmitsS.L.DekkersD.H.MÃ¼llerM.A.DijkmanR.Dipeptidyl peptidase 4 is a functional receptor"/>
   <result pre="COVID-19 associated pneumonia in clinical studiesBiosci Trends142020727332074550 38TortoriciM.A.WallsA.C.LangY.WangC.LiZ.KoerhuisD.Structural basis for" exact="human coronavirus" post="attachment to sialic acid receptorsNat Struct Mol Biol26201948148931160783 39PlantoneD.KoudriavtsevaT.Current"/>
   <result pre="diagnose novel coronavirus disease (COVID-19)Clin Infect Dis2020 88PatrickD.M.PetricM.SkowronskiD.M.GuaspariniR.BoothT.F.KrajdenM.An outbreak of" exact="human coronavirus" post="OC43 infection and serological cross-reactivity with SARS coronavirusCan J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7527651\results\search\virus\results.xml">
   <result pre="21st century. J Infect Dis2007; 195: 1018â€&quot;1028. doi:10.1086/51198917330793 69ChannappanavarR, PerlmanSPathogenic" exact="human coronavirus" post="infections: causes and consequences of cytokine storm and immunopathology."/>
   <result pre="Virol2004; 29: 13â€&quot;22. doi:10.1016/j.jcv.2003.09.01114675864 206BonnyTS, YezliS, LednickyJAIsolation and identification of" exact="human coronavirus" post="229E from frequently touched environmental surfaces of a university"/>
   <result pre="295: 4773â€&quot;4779. doi:10.1074/jbc.AC120.01305632094225 238BustiAJ, HallRG, MargolisDMAtazanavir for the treatment of" exact="human immunodeficiency virus" post="infection. Pharmacotherapy2004; 24: 1732â€&quot;1747. doi:10.1592/phco.24.17.1732.5234715585441 239collab: Shionogi &amp;amp; Co."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7533477\results\search\virus\results.xml">
   <result pre="diseases (neurovirulence).11 Some common pathogens include the respiratory syncytial virus," exact="measles virus," post="influenza virus, West Nile Virus, emerging pathogens such as"/>
   <result pre="spinal cord.22â€&quot;26 The close structural and biological similarities of the" exact="human coronavirus" post="(HCoV) to the neurotropic animal coronaviruses have led to"/>
   <result pre="most common.109 Myelitis following an infection with Epstein-Barr virus, cytomegalovirus," exact="measles virus" post="or rhinovirus is common. CoV-OC43 has been associated with"/>
   <result pre="known risk of GBS, often succeeding influenza virus, Zika virus," exact="dengue virus," post="H1N1 and Epstein-Barr virus, among others.114 Rare instances of"/>
   <result pre="TalbotP.Acute and persistent infection of human neural cell lines by" exact="human coronavirus" post="OC43. J Virol1999;73(4):3338â€&quot;50.10074188 29.ArbourN, EkandÃ©S, CÃ´tÃ©G, LachanceC, ChagnonF, M"/>
   <result pre="persistent infection of human oligodendrocytic and neuroglial cell lines by" exact="human coronavirus" post="229e. J Virol1999;73(4):3326â€&quot;37.10074187 30.BonaviaA, ArbourN, YongV, TalbotP.Infection of primary"/>
   <result pre="33.DesforgesM, MilettiT, GagnonM, TalbotP.Activation of human monocytes after infection by" exact="human coronavirus" post="229e. virus research. Virus Res.2007;130(1â€&quot;2):228â€&quot;40.17669539 34.CollinsA.In vitro detection of"/>
   <result pre="Res.2007;130(1â€&quot;2):228â€&quot;40.17669539 34.CollinsA.In vitro detection of apoptosis in monocytes/macrophages infected with" exact="human coronavirus." post="Clin Vaccine Immunol.2002;9(6):1392â€&quot;5. 35.WentworthD, TresnanD, TurnerB, LermanI, BullisB. Cells"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7534958\results\search\virus\results.xml">
   <result pre="is used together with other antiretrovirals for the treatment of" exact="human immunodeficiency virus" post="since the beginning of the century.209 Ritonavir (2) is"/>
   <result pre="agent targeting COVID-192020https://www.biorxiv.org/content/10.1101/2020.03.11.986836v1 165KimDEMinJSJangMSLeeJYShinYSParkCMNatural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit" exact="human coronavirus" post="OC43 infection of MRC-5 human lung cellsBiomolecules2019911696696 166JoSKimSShinDHKim M-SInhibition"/>
   <result pre="development on therapeutic agents and vaccines for COVID-19 and related" exact="human coronavirus" post="diseasesACS Cent Sci20206331533132226821 241collab: Inquartik [homepage on Internet]Coronavirus patents2020Coronavirus"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7536086\results\search\virus\results.xml">
   <result pre="medical examinations and clinical evaluation for hepatitis B and C," exact="human immunodeficiency virus" post="(HIV), human T-cell lymphotropic virus types 1 and 2,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7537045\results\search\virus\results.xml">
   <result pre="broad antiviral activity by inhibiting the host cell entry of" exact="human immunodeficiency virus" post="(HIV), vesicular stomatitis virus (VSV), Zika virus (ZIKV), Ebola"/>
   <result pre="inhibiting the host cell entry of human immunodeficiency virus (HIV)," exact="vesicular stomatitis virus" post="(VSV), Zika virus (ZIKV), Ebola virus (EBOV), Nipah virus"/>
   <result pre="lines (FigÂ 1A). Similar results were obtained from infections by" exact="human parainfluenza" post="virus type 3 (HPIV3) and respiratory syncytial virus (RSV)"/>
   <result pre="These results strongly support a function for 25HC in blocking" exact="human coronavirus" post="spikeâ€�mediated fusion with the plasma membrane, thereby suppressing virus"/>
   <result pre="cholesterol pool (Das etÂ al, 2014). Considering that 25HC blocked" exact="human coronavirus" post="fusion at the plasma membrane of lung epithelial cells,"/>
   <result pre="collected and filtered through 0.22Â Î¼m filters to remove residual" exact="vaccinia virus." post="293FT cells transfected with pMD2.G (addgene 12259) encoding VSVâ€�G"/>
   <result pre="ZhangNN, WatanabeM, DongHL, LiuPetÂ al (2017) 25â€�hydroxycholesterol protects host against" exact="zika virus" post="infection and its associated microcephaly in a mouse model."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7544206\results\search\virus\results.xml">
   <result pre="Rrp6 and Dis3, were shown to restrict the replication of" exact="vesicular stomatitis virus," post="Sindbis virus and Rift Valley fever virus (11). Conversely,"/>
   <result pre="vanÂ derÂ WerfS., EscriouN.Naked RNA immunization with replicons derived from" exact="poliovirus" post="and Semliki Forest virus genomes for the generation of"/>
   <result pre="Genome-Wide small interfering RNA screen identifies host factors required for" exact="vesicular stomatitis virus" post="infection. J. Virol.2014; 88:8355.24829348 57.KhaperskyyD.A., SchmalingS., Larkins-FordJ., McCormickC., GagliaM.M.Selective"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7544963\results\search\virus\results.xml">
   <result pre="of viremia in infected hosts as shown in case of" exact="yellow fever virus" post="administration.68 The number of confirmed cases and deaths due"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545115\results\search\virus\results.xml">
   <result pre="the HIV Epidemic: A Plan for Americaâ€� aims to reduce" exact="human immunodeficiency virus" post="(HIV) incidence in the United States by at least"/>
   <result pre="Puerto Rico, that accounted for more than 50% of new" exact="human immunodeficiency virus" post="(HIV) diagnoses during 2016 and 2017 are shown in"/>
   <result pre="the United States including Texas (Figure 3). Figure 3. New" exact="human immunodeficiency virus" post="(HIV) diagnoses, persons with HIV (PWH), and deaths among"/>
   <result pre="Texas and nationwide. Figure 4. Texas and Harris County diagnosis-based" exact="human immunodeficiency virus" post="(HIV) care continuum, 2018. Data source [5]; HIV diagnosed"/>
   <result pre="Ending the HIV Epidemic; FQHC, federally qualified health centers; HIV," exact="human immunodeficiency virus;" post="MAT, medication-assisted treatment; PrEP, pre-exposure prophylaxis; STI, sexually transmitted"/>
   <result pre="4.HarrisNS, JohnsonAS, HuangYA, et al. Â Vital signs: status of" exact="human immunodeficiency virus" post="testing, viral suppression, and HIV preexposure prophylaxisâ€&quot;United States, 2013â€&quot;2018."/>
   <result pre="Policy Institute, 2015. 53.MenaL, CrosbyRAPortrait of an epidemic: extremely high" exact="human immunodeficiency virus" post="prevalence and incidence among young black men having sex"/>
   <result pre="al. Â Clinical impact and cost-effectiveness of genotype testing at" exact="human immunodeficiency virus" post="diagnosis in the United States. Clin Infect Dis Â"/>
   <result pre="not happen if the status quo continues: modeled projections for" exact="human immunodeficiency virus" post="incidence in 6 US Cities. Clin Infect Dis Â"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7545798\results\search\virus\results.xml">
   <result pre="data. Abstract Background The triple burden of COVID-19, tuberculosis and" exact="human immunodeficiency virus" post="is one of the major global health challenges of"/>
   <result pre="Co-infection Background The triple burden of COVID-19, tuberculosis (TB) and" exact="human immunodeficiency virus" post="(HIV) is one of the major and persistent global"/>
   <result pre="pathology of emerging coronavirus infectionsJ Pathol2015235218519510.1002/path.445425270030 16.OgimiCWaghmareAAKuypersJMXieHYeungCCLeisenringWMet al.Clinical significance of" exact="human coronavirus" post="in Bronchoalveolar lavage samples from hematopoietic cell transplant recipients"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7546461\results\search\virus\results.xml">
   <result pre="9PyrcK, SimsAC, DijkmanR, JebbinkM, LongC, DemingD, et al.Culturing the unculturable:" exact="human coronavirus" post="HKU1 infects, replicates, and produces progeny virions in human"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7547437\results\search\virus\results.xml">
   <result pre="States and CanadaJAIDS J Acquir Immune Defic Syndr2017751354428225437 4.OhlMEPerencevichEFrequency of" exact="human immunodeficiency virus" post="(HIV) testing in urban vs. rural areas of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7550130\results\search\virus\results.xml">
   <result pre="2020; Lu et al., 2020). Other epidemics such as the" exact="human immunodeficiency virus" post="(HIV) (Pike et al., 2010; Sharp and Hahn, 2010),"/>
   <result pre="2017). Retroviruses such as human T-cell lymphotropic (HTLV) virus and" exact="simian foamy virus" post="(SFV) have emerged into human populations because of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551450\results\search\virus\results.xml">
   <result pre="cluster analysis pandemic health policy 1. Introduction The third zoonotic" exact="human coronavirus" post="of the century emerged in December 2019, with a"/>
   <result pre="of Infectious Diseases The development of a new vaccine against" exact="human coronavirus" post="that causes severe pneumonia 48,100 144,300 1 April 2016"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551807\results\search\virus\results.xml">
   <result pre="8.ShankarappaR.MargolickJ.B.GangeS.J.RodrigoA.G.UpchurchD.FarzadeganH.GuptaP.RinaldoC.R.LearnG.H.HeX.et al.Consistent viral evolutionary changes associated with the progression of" exact="human immunodeficiency virus" post="type 1 infectionJ. Virol.199973104891050210.1128/JVI.73.12.10489-10502.199910559367 9.McNearneyT.HornickovaZ.MarkhamR.BirdwellA.ArensM.SaahA.RatnerL.Relationship of human immunodeficiency virus"/>
   <result pre="of human immunodeficiency virus type 1 infectionJ. Virol.199973104891050210.1128/JVI.73.12.10489-10502.199910559367 9.McNearneyT.HornickovaZ.MarkhamR.BirdwellA.ArensM.SaahA.RatnerL.Relationship of" exact="human immunodeficiency virus" post="type 1 sequence heterogeneity to stage of diseaseProc. Natl."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7551931\results\search\virus\results.xml">
   <result pre="belongs to the Flaviviridae family, which encompasses viruses such as" exact="dengue virus," post="yellow fever virus, West Nile virus, tick-borne encephalitis virus,"/>
   <result pre="the Flaviviridae family, which encompasses viruses such as dengue virus," exact="yellow fever virus," post="West Nile virus, tick-borne encephalitis virus, and Japanese encephalitis"/>
   <result pre="such as influenza A and B virus [14,15], herpesviruses [16,17,18,19,20,21,22,23,24,25]," exact="human immunodeficiency virus" post="(HIV) [23,26,27], human metapneumovirus (hMPV) [28], and other viruses"/>
   <result pre="fetuses and infants of US women with evidence of possible" exact="zika virus" post="infection during pregnancyJAMA J. Am. Med. Assoc.2017317596810.1001/jama.2016.1900627960197 8.RobinsonC.L.ChongA.C.N.AshbrookA.W.JengG.JinJ.ChenH.TangE.I.MartinL.A.KimR.S.KenyonR.M.et al.Male"/>
   <result pre="and in VivoACS Appl. Mater. Interfaces201911267452675210.1021/acsami.9b1030231287654 26.LeydetA.BarraganV.BoyerB.MontÃ©roJ.L.RoqueJ.P.WitvrouwM.EsteJ.SnoeckR.AndreiG.De ClercqE.Polyanion inhibitors of" exact="human immunodeficiency virus" post="and other viruses. 5. Telomerized anionic surfactants derived from"/>
   <result pre="hydrochloride) as inhibitors of human metapneumovirusPLoS ONE201914e021464610.1371/journal.pone.021464630921418 29.TalaricoL.B.NosedaM.D.DucattiD.R.B.DuarteM.E.R.DamonteE.B.Differential inhibition of" exact="dengue virus" post="infection in mammalian and mosquito cells by iota-carrageenanJ. Gen."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7553131\results\search\virus\results.xml">
   <result pre="C Ascorbic Acid Viral pneumonia 1 Introduction Most cases of" exact="human coronavirus" post="infection are mild, and patients usually can recover without"/>
   <result pre="there is no vaccine or anti-viral treatment approved to treat" exact="human coronavirus." post="Therapeutic options are being explored in vitro and animal"/>
   <result pre="can be used as an inactivating agent for the fixed" exact="rabies virus" post="[30]. Other studies have used this vitamin as an"/>
   <result pre="activities of ascorbic acidSubcellular biochemistry1996Springer215231 30MadhusudanaS.N.ShamsundarR.SeetharamanS.In vitro inactivation of the" exact="rabies virus" post="by ascorbic acidInternational journal of infectious diseases812004212514690777 31ZarubaevV.SlitaA.LavrentyevaI.SmirnovVProtective Activity"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7558548\results\search\virus\results.xml">
   <result pre="inhibitors also showed substantial activity against other viruses such as" exact="cowpox virus" post="(CPXV) and herpes simplex virus (HSV1) [23]. Sigma receptors"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7567380\results\search\virus\results.xml">
   <result pre="Med2017; 167: 446â€&quot;7. 10.7326/L17-027828785761 30HallHI, FrazierEL, RhodesP, et al.Differences in" exact="human immunodeficiency virus" post="care and treatment among subpopulations in the United StatesJAMA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="drug\PMC7568023\results\search\virus\results.xml">
   <result pre="Song D (2020) Porous gold nanoparticles for attenuating infectivity of" exact="influenza a virus." post="J Nanobiotechnology 18:1â€&quot;11 LateefAOjoSAFolarinBIGueguim-KanaEBBeukesLSKolanut (Cola nitida) mediated synthesis of"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
